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SUMMARY 
Staphylococcus aureus is a major human pathogen causing a wide range of illnesses 
from the trivial to the life-threatening. S. aureus produces many surface-associated 
and exoproteins, several of which have been implicated in its virulence. Production 
of these virulence determinants is co-ordinately controlled by several global 
regulatory elements in a growth phase dependent manner. The best characterised of 
these regulators are the accessory gene regulator (agr) and staphylococcal accessory 
regulator (sar). The agr locus comprises a quorum sensing system and encodes a 
signalling pheromone that autoregulates agr in a density dependent manner. 
Upregulation of agr expression leads to production of an mRNA transcript, RNAHI 
which is the actual effector of virulence gene expression. The RNAIII molecule 
upregulates several extracellular toxins including haemolysins, toxic shock syndrome 
toxin 1 (TSST-1) and epidermolytic toxin A (Eta), and down-regulates surface 
proteins such as protein A and fibronectin binding protein (FnBP) during late 
exponential growth and stationary phase. 
The regulation of toxin production by S. aureus is extremely complex and it is not yet 
understood exactly how this organism responds to environmental stimuli in order to 
mediate changes in virulence gene expression. In order to determine whether 
environmental signals are transduced via agr, the effect of several stimuli on both agr 
expression and a-haemolysin production was examined using a ß-galactosidase 
reporter gene fusion to the hid gene, which is encoded as part of the RNAIII 
transcript. A number of environmental stimuli were identified which led to changes 
in agr expression. Several of these stimuli resulted in different effects on a- 
haemolysin activity when compared to RNAIII levels. This suggests the presence of 
novel regulatory elements involved in the control of Hla production, independently of 
agr. 
ii 
In order to identify other novel regulators which interact with, or control, agr, 
transposon libraries have been created using Tn917 and Tn551. Two Tn917 
transposon mutants were isolated as deficient in production of ß-haemolysin, which is 
also positively controlled by agr. These mutants were found to contain novel 
transposon insertions in the agr locus. Five Tn551 mutants were isolated which 
showed pleiotropic effects on virulence determinant levels and did not contain the 
transposon in previously mapped regulators. The Tn551 insertions may have 
therefore occurred in novel regulators of virulence determinant production. 
The regulation of toxin production by S. aureus in response to environmental stimuli 
is discussed. 
iii 
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CHAPTER 1 
Introduction 
I 
1. - INTRODUCTION 
1.1 The staphylococci 
The genus Staphylococcus is currently composed of twenty seven species with seven 
subspecies (Kloos and Lambe, 1991). Members of the genus are Gram positive cocci, 
approximately 0.5-1.5 mm in diameter, which occur singly, in pairs, tetrads, short 
chains of three to four cells and, particularly in the case of S. aureus, in irregular 
grape like clusters. It was this latter form that, in 1883, led Ogston to introduce the 
name staphylococcus (from staphyle which means a bunch of grapes), for a group of 
micrococci which caused inflammation and suppuration (Kloos and Lambe, 1991). 
The staphylococci are non-motile, do not form spores and are commonly catalase 
positive (Kloos and Lambe, 1991). They are not usually encapsulated but they do 
have limited capsule formation. Staphylococci are able to ferment, slowly, many 
carbohydrates producing lactic acid but not gas. Strains of S. aureus are alkaline 
phosphatase positive, urease variable and show no ß-galactosidase activity. Most 
staphylococcal species are facultative anaerobes although apart from two species, S. 
saccharolyticus and S. aureus subsp, anaerobiosis, their growth is quicker under 
aerobic conditions (Kloos and Lambe, 1991). Staphylococci are relatively resistant to 
drying, to heat (they withstand 50 OC for 30 minutes) and to 9% (w/v) sodium 
chloride. 
The staphylococci are widespread in the environment although they are mainly found 
living on the skin, skin glands and mucous membranes of mammals and birds. In 
addition, they are sometimes found in the mouth, blood, intestinal, genito-urinary and 
upper respiratory tracts of these hosts. The identification of pathogenic 
staphylococci is most commonly by the ability to produce coagulase and thus clot 
plasma (Kloos and Lambe, 1991). In particular, only three species are coagulase 
positive, namely, S. aureus which causes acute infections in humans and S. 
2 
intermedius and S. hyicus which are found in animals (Devriese et al., 1978; Hajek, 
1976). Some of the remaining coagulase negative staphylococci can also cause 
disease but are generally considered as opportunistic pathogens causing infection 
following trauma, pre-disposing diseases, or due to indwelling foreign bodies (Kloos 
and Lambe, 1991). 
Cultured colonies of S. aureus are usually large (6-8 mm diameter), smooth, entire, 
slightly raised and translucent (Kloos and Lambe, 1991). The colonies of most 
strains are pigmented ranging from creamy yellow to orange. 
1.2 S. aureus - its effect on man and other animals 
Staphylococcal infections cover the complete spectrum from the trivial to the life 
threatening and are most commonly caused by the coagulase positive species of S. 
aureus (Kloos and Lambe, 1991). These infections include folliculitis, carbuncles, 
furuncles, cellulitis, impetigo, and post-operative wound infections of various sites. 
S. aureus is also a particular problem following invasive hospital techniques. For 
example, 20 % of infections involving long term intravascular canulae are caused by 
S. aureus, together with 29 % of all pacemaker infections, usually due to 
. 
contamination at the time of pacemaker implantation (Bluhm, 1985), with permanent 
pacemaker infections occurring in more than 6% of patients (Heimberger and Duma, 
1989). The staphylococci cause prosthetic joint infections in up to 1% of patients 
undergoing total hip replacement and in up to 1.5 % of patients following knee- 
replacement (Fitzgerald, 1989). 
Bacteraemia caused by S. aureus is generally the consequence of a local infection 
with dissemination into the blood stream, but may also be secondary to direct 
inoculation, i. e. intravenous drug abuse. Septicaemia, or blood poisoning, is the 
result of the multiplication of micro-organisms in the blood often resulting in 
3 
secondary sites of infection. Early reports indicated a 60 % risk of endocarditis with 
S. aureus septicaemia but more recent studies suggest an incidence of 10 % 
(Waldvogel, 1990). 
A particularly serious community-acquired disease, toxic shock syndrome (TSS), has 
been attributed to infection or colonisation with S. aureus. S. aureus also causes food 
poisoning due to ingestion of one, or more, heat-stable, pre-formed toxins resulting in 
nausea, vomiting, abdominal pains and diarrhoea, 2-6 hours after eating contaminated 
food (Bergdoll, 1989). The amount of enterotoxin required to cause illness in man is 
not known but as little as 1 gg of toxin per 100 g of food will induce clinical 
symptoms (Tranter, 1991). 
S. aureus is also a recognised avian pathogen that is responsible for the majority of 
staphylococcal infections in poultry causing major financial loss (Devriese, 1980). 
1.3 Treatment of S. aureus infections 
The introduction of penicillin for the treatment of severe S. aureus infections in the 
1940's had a profound effect on morbidity and mortality from this disease. However, 
by the late 1940's approximately 60 % of hospital-acquired strains were resistant to 
penicillin (Barber and Rozwadowska-Dowzenko, 1948) with, currently, 80-90 % of 
community acquired S. aureus strains being resistant due to the production of ß- 
lactamase. The staphylococci have proved to be extremely versatile in developing 
resistance to the commonly used antimicrobial agents although many strains are still 
susceptible to methicillin and first generation cephalosporins. Resistance to 
streptomycin emerged soon after its discovery in 1944 (Demerec, 1948) and 
tetracycline resistance became a major problem during the 1950's. In 1952 
erythromycin was introduced, however, in some centres, resistance occurred after 
only 7-10 days treatment (Haight and Finland, 1952). Shortly following the 
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introduction into clinical practice 'of a new ß-lactamase resistant penicillin, 
methicillin, strains resistant to this new drug were reported (Jevons, 1961). Parker 
and Hewitt (1970) of the Cross-Infection Reference Laboratory in London monitored 
the frequency of methicillin resistance in S. aureus strains and found there was a 
moderate increase between 1960 and 1963 followed by a stationary phase. In 1968 a 
second increase began and analysis of the antibiotic resistance pattern of some 100 
separate strains showed that, in addition to methicillin resistance, all were ß- 
lactamase producers and were resistant to streptomycin and tetracycline. 
Methicillin resistance is chromosomally mediated and results partly from the presence 
of a novel penicillin binding protein (PBP) 2' which has reduced affinity for 
methicillin and other anti-staphylococcal ß-lactams, thus retaining critical functions 
necessary for cell survival (Hartman and Tomasz, 1984; Chambers et al., 1985; 
Boyce, 1989). 
Currently, the ß-lactamase resistant penicillins are the preferred drugs for all 
staphylococcal infections caused by penicillin resistant, methicillin susceptible 
strains. Such agents are bactericidal and, like other penicillins, have a low incidence 
of adverse reactions. The emergence of methicillin resistant S. aureus (MRSA) as a 
major nosocomial pathogen has led to a significant role for vancomycin in the 
treatment of serious infections since resistance of S. aureus to this drug had not, until 
recently, been demonstrated in a clinical setting. In 1997 an intermediate level 
vancomycin resistant strain of S. aureus was isolated in a Japanese hospital. It has 
since been found that up to 20 % of MRSA isolates from hospitals throughout' Japan 
are heterogeneously resistant to vancomycin and that this resistance develops into 
VRSA upon exposure to vancomycin (Hiramatsu et al., 1997). 
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1.4 . 
Virulence factors of S. aureus - genetics and biochemistry 
S. aureus produces more than 25 different extracellular proteins, several of which 
have been implicated in its virulence (Arvidson, 1983). For example fibrinogen 
binding protein (a. k. a. clumping factor), encoded by the clf gene, is located on the 
bacterial cell surface anchored by a dipeptide repeat region to an LPXTG motif 
(Hartford et al., 1997). Some of the genes encoding these extracellular proteins have 
been mapped on the S. aureus chromosome to one of 16 fragments, designated A-P, 
resulting from a SmaI digest of total chromosomal DNA (Pattee et al., 1990). In 
addition, the genes for some toxins have been found to be located on mobile genetic 
elements or carried by lysogenic phages (Lindsay et al., submitted; Novick, 1963; 
Winkler et al., 1965). 
1.4.1 Pyrogenic exotoxins 
1.4.1.1 TSST-1 
Toxic shock syndrome is manifested by the clinical features of fever, profuse 
diarrhoea, mental confusion and both renal and hepatic impairment (Turnidge and 
Grayson, 1993). Although TSS was originally described in menstruating females and 
was associated with a particular type of high-absorbence tampon, the condition has 
now been associated with a variety of ailments. due to strains of S. aureus in both 
sexes, such as abscesses, osteomyelitis, post-surgical infections and following vaginal 
and caesarean section deliveries. TSS is due to the presence of toxic shock syndrome 
toxin-1 (TSST-1) which is a potent superantigen. The gene encoding TSST-1, tst, 
was first cloned and sequenced by Kreiswirth et al. (1983), and was thought to be 
found on an accessory genetic element, such as a plasmid, prophage or transposon. 
However, more recent studies have suggested that the tst gene is in fact likely to be 
carried on a mobile pathogenicity island. Pathogenicity islands range in size from 10- 
6' 
200 kb and are accessory genetic elements containing one or more pathogenicity 
genes bordered by directly repeated sequences (Lindsay et al., submitted). 
1.4.1.2 Enterotoxins 
It has been known for some time that S. aureus produces seven serologically distinct 
enterotoxins which are wholly responsible for the symptoms of food poisoning and 
whose production is dependent on various environmental factors (Halpin-Dohnalek 
and Marth, 1989). However, more recently, two new enterotoxins have been 
identified (Betley et al., 1992; Su and Lee-Wong, 1995). These toxins are produced 
over a wide range of temperatures (10 OC-44 OC; optimum 35 °C-40 °C and the 
organism will grow and form toxin in many foods with the exception of those below 
pH 5 or water activity below 0.86. These enterotoxins are thermostable molecules, 
inactivated only by prolonged boiling with the amount of inactivation depending not 
only on temperature but also on composition and pH of the heating medium and 
purity of the toxin preparations. 
The enterotoxins may be considered as "superantigens" since they stimulate 
production of T-cells and induction of cytokines such as interleukin-1, interferon-y 
and tumour necrosis factor (Fast et al., 1989; Parsonnet et al., 1986). Their ability to 
cause illness may be due to interaction with macrophages causing production of the 
cytokines mentioned above (Betley et al., 1990). 
Of the seven enterotoxins, enterotoxin A (Sea) is encoded by a family of temperate 
phages (Betley and Mekalanos, 1985) and enterotoxin D (Sed) is encoded within a 
27.6 kb plasmid (Bayles and landolo, 1989). Enterotoxin B (Seb) and the enterotoxin 
C's are probably chromosomally encoded (Betley et al., 1990). 
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1.4.2 Haemolysins 
There are four haemolysins of S. aureus, a, ß, y, and S, which are all antigenically 
distinct. 
1.4.2.1 a-haemolysin 
a-haemolysin is the 30 kDa protein product of the hla gene which lies in Smal 
fragment A of the S. aureus chromosome (Pattee et al., 1990). It binds firmly to 
target membranes and causes membrane damage resulting in the formation of pores 
(Bhakdi and Tranum-Jensen, 1991). It shows great variation in its ability to lyse 
erythrocytes of different animal species. For example, a 400-fold increase in 
concentration of a-haemolysin is required to lyse human compared to rabbit 
erythrocytes against which its activity is 100- to 1000-fold greater than in any other 
species (Bhakdi and Tranum-Jensen, 1991; Möllby, 1983). In fact, clinical isolates 
from serious illnesses of humans, such as TSS (Clyne et al., 1988) and septicaemia 
(Christensson and Hedstrom, 1986), have been found not to produce a-toxin. 
However, this toxin is still considered an important virulence factor in S. aureus since 
human platelets are a highly sensitive target and may be the primary target in vivo 
(Bhakdi et al., 1988). a-toxin also has a powerful action on vascular smooth muscle. 
1.4.2.2 haemolysin 
ß-haemolysin is a phospholipase C and is specific for sphingomyelin in cell 
membranes. Degradation of 'sphingomyelin in erythrocyte membranes occurs at 37 
OC but does not cause lysis of the cell until cooling to 4 OC (Möllby, 1983). It is thus 
the amount of sphingomyelin in erythrocyte membranes which dictates the sensitivity 
of erythrocytes from different mammalian species to ß-haemolysin. Sheep 
erythrocytes are very sensitive since 50 % of their erythrocyte membrane 
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phospholipids consist of sphingomyelin (Rouser et al., 1968). Sheep blood is 
therefore used to assay the enzyme. This haemolysin needs Mg2+ for its activity and 
is inhibited by chelating agents (M611by, 1983). ß-toxin is encoded by the hlb gene 
which is located in the Smal fragment F of the S. aureus chromosome (Pattee et al., 
1990). 
1.4.2.3 y-haemolysin 
This is the least understood S. aureus haemolysin, most probably because it 
is inhibited by agar (Jackson, 1963) and hence its presence is missed when strains are 
assayed for haemolysis on blood agar plates. It is also inhibited by lipids (Möllby, 
1983). y-haemolysin is encoded by the hlg gene which has been mapped to fragment 
C of Smal digested chromosomal DNA (Pattee et al., 1990). Although Möllby and 
Wadstrom (1971) suggested it consisted of a single polypeptide, it has subsequently 
been reported to consist of two proteins that are expressed from closely linked genes 
(Taylor and Bernheimer, 1974; Cooney et al., 1988; Clyne et al., 1992). Each 
component is weakly haemolytic but together they act synergistically against rabbit, 
sheep and human erythrocytes, although its activity is 4-8 times greater against rabbit 
cells compared to sheep or human (Möllby, 1983). It has also been reported that one 
of the components of y-haemolysin is a protease which acts on the other peptide to 
give enhanced haemolysis (Clyne et al., 1992). 
1.4.2.4 8-haemolysin 
This haemolysin is encoded by the hid gene which comprises part of the accessory 
gene regulator (agr) locus which lies in fragment F of Smal digested S. aureus 
chromosomal DNA (Pattee et al., 1990). It comprises a 26-residue peptide that acts, 
possibly as a surfactant, to affect several cell types, including erythrocytes and 
9 
leukocytes, by forming pores in phospholipid bilayers (Mellor et al., 1988). This 
haemolysin is not species specific. 
1.4.3 Fibronectin binding protein (FnBP) 
There are two forms of fibronectin, a soluble form secreted into the bloodstream and 
a cross-linked form which acts as an adhesive protein made by many cell types 
including fibroblasts and epithelial cells (Ruoslahti, 1988). S. aureus, together with 
many other pathogenic micro-organisms binds fibronectin by a fibronectin binding 
protein (FnBP) on the surface of the cell wall (Höök et al., 1989). In addition, S. 
aureus produces a free extracellular FnBP (Lindberg et al., 1990). The relative levels 
of cell wall-associated and free extracellular FnBP is most likely affected by calcium 
concentration since addition of EGTA (6.25 mM) to a growth medium results in a 6- 
fold increase in cell wall-associated FnBP and a >40-fold decrease in free 
extracellular FnBP (Lindberg et al., 1990). It has been postulated that the ability of S. 
aureus to bind to fibronectin represents a mechanism of host-tissue adhesion, i. e. a 
substrate for bacterial attachment and colonisation (Lindberg et al., 1990). It has 
been proposed that plasma-fibronectin could serve as an opsonin such that after 
coating of bacterial cells it mediates recognition and uptake of bacteria by phagocytic 
cells. It is thus possible that the extracellular free FnBP produced by S. aureus could 
serve to reduce the binding of plasma fibronectin to the bacterial cell itself. (Lindberg 
et al., 1990). 
1.4.4 Coagulase 
The coagulase protein is encoded by the coa gene, which is located in Smal fragment 
E, and is considered an important virulence factor of S. aureus (Pattee et al., 1990). It 
is an extracellular protein that coagulates plasma. To assay for coagulase activity in 
vitro, it is necessary to'use a plasma that contains a sufficient level of coagulase- 
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reactive factor and fibrinogen as a substrate (Jeljaszewicz et al., 1983). For in vitro 
assays, the plasma should also contain oxalic acid or citrate to prevent the 
physiological clotting of fibrinogen (Jeljaszewicz et al., 1983). The coagulase 
reactive factor of sera reacts with coagulase to generate both esterase and clotting 
activities in a manner similar to the activation of prothrombin to thrombin. The 
coagulase actually binds prothrombin to form staphylothrombin (Hemker et al., 
1975). Staphylothrombin stimulates the clotting reaction in plasma. Coagulase may 
deposit fibrin on the surface of staphylococci, possibly altering their ingestion by 
phagocytic cells, or their destruction within such cells. 
1.4.5 Protein A 
Between 93 and 99 % of S. aureus strains of human origin have been found to contain 
Protein A as a cell wall protein (Forsgren, 1970). Protein A is the product of the spa 
gene which lies in fragment G of Smal digested S. aureus chromosomal DNA (Pattee 
et al., 1990). It is a 42 kDa protein which, at its COOH-terminal end, is anchored in 
the cell membrane with its N112-terminal immunoglobulin-binding domain extending 
outside the cell wall (Schneewind et al., 1995). This ability to anchor to the cell wall 
depends on 35 amino acid residues at the COOH-terminus of protein A, partly 
comprising an LPXTG motif (Schneewind et al., 1992; Schneewind et al., 1995). In 
vivo, protein A produces several immunological responses, in particular, allergic 
reactions including anaphylaxis and histamine release (Forsgren et al., 1983). It 
binds to several immunoglobulins and, through its interaction with immunoglobulin 
G (IgG) in particular, causes platelet injury (Forsgren et al., 1983; Hawiger et al., 
1979). Phagocytosis is inhibited by the presence of protein A and it initiates blood 
coagulation. 
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1.4.6 Hydrolases 
1.4.6.1 Lil2ase 
Lipases catalyse the hydrolysis or formation of ester bonds of water insoluble 
substrates, particularly lipids (Götz, 1990). Many strains of staphylococci, including 
S. aureus, produce a true extracellular lipase (or glycerol ester hydrolase) which is 
active against oils and fats in their emulsified states (Lee and landolo, 1986; Shah and 
Wilson, 1965). Within staphylococcal abscesses there are at least two host-derived 
bactericidal lipids which aid in bacterial clearance (Engler and Kapral, 1992; Shryock 
et al., 1992) and it is thought that the staphylococcal lipase inactivates these 
bactericidal lipids to enhance the survival of staphylococci within abscesses (Kapral 
et al., 1992). The gene (geh) encoding this 76 kDa lipase is 2070 bp and has been 
mapped to fragment E of Smal digested chromosomal DNA of S. aureus strain 8325 
(Lee and Iandolo, 1986: Pattee et al., 1990). The activity of the geh gene has been 
shown to be negatively regulated by bacteriophage lysogenization (Rosendal and 
Bulow, 1965). Bacteriophage L54a interrupts the lipase gene between nucleotides 
2608 and 2698 (Lee and landolo, 1986). 
Ideally lipase activity should be measured using the long chain fatty acid 
triacylglycerol, triolein. Tributyrin or Tweens have been used as substrates for lipase 
activity although these are not specific since esterases can also cause their 
degradation (Farrell et al., 1990; Tyski et al., 1983). Agar containing egg yolk has 
also been used to assay for lipase activity (Arvidson, 1983) although it has been 
reported that extracellular enzymes from S. aureus produce two types of zones on egg 
yolk agar, one on the surface, and one sub-surface (Owens, 1974). It has been 
suggested that, whilst the granular surface zone may be attributed to the action of the 
staphylococcal lipase, the sub-surface zone of opacity is the result of the hydrolysis of 
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phosphatidylcholine (Owens, 1974). Thus, it may be best to avoid the use of egg yolk 
as a definitive, or quantitative, test for lipase activity. 
1.4.6.2 Proteases 
Most strains of S. aureus are proteolytic (Baird-Parker, 1965) producing at least three 
different types of protease including serine protease, metallo-protease and thiol- 
protease (Arvidson, 1983). Serine protease (protease I) is produced by at least 67 % 
of S. aureus strains, mainly during post-exponential growth (Björklind and Arvidson, 
1977; Björklind and Arvidson, 1978). It is produced as an inactive precursor which is 
activated by the metallo-protease (Drapeau, 1978). The serine protease specifically 
cleaves the peptide bonds on the carboxyl terminal side of aspartic or glutamic acid 
residues (Drapeau et al., 1972). The extracellular metallo-protease of S. aureus was 
identified by Arvidson et al. (1972) and has been shown to specifically cleave peptide 
bonds involving the amino terminal side of hydrophobic residues (Björklind and 
Jornvall, 1974). Arvidson et al. (1973) also demonstrated the existence of the thiol- 
protease. This protease is only active in the presence of reducing agents and has only 
been identified in one strain of S. aureus. The enzyme is very unstable at 37 OC, 
losing 50 % of its activity within 3 hours (Arvidson, 1983). All three proteases can 
be assayed on casein agar plates where each gives a different type of zone of clearing 
(Arvidson, 1973). 
1.4.6.3 Nuclease 
In 1956, Cunningham et al. identified a very thermostable extracellular DNase 
produced by S. aureus which was shown to require Ca2+ for its activity. It has both 
endonuclease and exonuclease activities on DNA and RNA molecules (Novick, 
1993). The gene (nuc) encoding this 149 amino acid staphylococcal nuclease, known 
as nuclease'A, has been isolated and sequenced (Shortle, 1983). It was found that 
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immediately preceding the 149 codons specifying nuclease A, there were nineteen 
codons encoding the amino terminal end of nuclease B, which is the membrane- 
bound precursor of nuclease A, found in exponentially growing cells (Davis, et al., 
1977; Shortle, 1983). 
1.4.6.4 Staphvlokinase 
Staphylokinase dissolves blood clots by activating the conversion of the proenzyme, 
plasminogen to the fibrinolytic enzyme, plasmin by cleavage of a single arginine- 
valine bond (Arvidson, 1983). The gene encoding this enzyme can be located in the 
bacterial genome or may be carried by at least 15 lysogenic phages (Arvidson, 1983; 
Winkler et al., 1965). 
1.4.7 ß-lactamase 
Extracellular p-lactamase is responsible for the resistance of S. aureus to penicillins 
and cephalosporins (Barber, 1962). Vlactamases hydrolyse the C-N bond in the p- 
lactam ring of both these antibiotics. This enzyme is encoded by the bla gene which 
has been mapped to fragment F of Smal digested chromosomal DNA of S. aureus 
(Pattee et al., 1990). 
1.4.8 Hyaluronate lvase 
Hyaluronic acid is a major glycosaminoglycan, that is the polysaccharide chain in 
proteoglycans. Pioteoglycans consist of units made up of polysaccharides 
(approximately 95 %) and proteins (approximately 5 %) and bind water and cations 
thus forming the extracellular medium, or ground substance, of connective tissue 
(Stryer, 1973). Hyaluronate lyase appears to be produced by 95-100 % of S. aureus 
strains (Arvidson, 1983). The hyaluronate lyase gene (hysA) of S. aureus 8325-4 
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shows 35 % amino acid sequence homology with group B streptococcal hyaluronate 
lyase (Farrell et al., 1995). From work on the group B streptococcal hyaluronate 
lyase it has been suggested that its role as a virulence factor may lie in its ability to 
facilitate the invasiveness of the producing organism and to subvert some normal host 
defence mechanisms (Lin et al., 1994). 
1.5 Genetic control of production of virulence determinants 
Bacterial survival is competitive, uncertain and, to a large extent, depends on a cell's 
ability to adapt quickly to environmental changes. For example, the supply of 
nutrients is often scarce and cells need to be able to respond quickly to take advantage 
of the appearance of novel nutrients and metabolites by producing transport and 
metabolic machinery to utilise them. In pathogenic bacteria, including S. aureus, 
several conditions characteristic of a host environment, such as temperature and 
concentration of various chemicals including iron, calcium etc., will induce the 
production of toxins and other virulence factors (Bliska et al., 1993) (see section 1.7). 
Thus, a co-ordinated signalling system is necessary such that environmental stimuli 
can be sensed by the bacteria and then translated into appropriate gene expression. 
There are many different modes of genetic regulation involving both repressors and 
transcriptional activators. A common mechanism of transduction of environmental 
stimuli to bring about changes in gene expression has been identified in many 
bacteria and eukaryotes (Kavanaugh and Williams, 1996; Parkinson and Kofoid, 
1992). These so-called, two component sensor regulator systems have been found to 
mediate an adaptive response to many stimuli, including metabolite utilization such as 
carbon by Escherichia coli and Salmonella typhimurium, (Island et at, 1992) 
phosphate by E. coli and Klebsiella pneumoniae (Lee et al., 1989) and nitrogen by E. 
coli (Miranda-Rios et al., 1987). Other adaptive systems include stress from 
antibiotics, heavy metals and osmolarity by & coli for example (Comeau et al., 
1985). Bacterial interaction with its host leading to production of virulence factors 
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can also be mediated by two component sensor regulator systems* (Parkinson and 
Kofoid, 1992). 
1.5.1 Two component sensor regulator systems 
These systems are generally characterised by two protein components, a sensor 
protein often located in the cytoplasmic membrane and a response regulator protein 
which is usually located in the cytoplasm (Parkinson, 1993). The sensor monitors 
environmental stimuli and causes the response regulator to mediate a response, 
generally causing changes in gene expression (Parkinson, 1993). Sensor proteins 
commonly contain 5-8 transmembrane segments in their N-terminal domain and these 
segments are connected to a C-terminal domain that functions as a signal transmitter 
(Kleerebezem et al., 1997) (Fig. 1.1). The signal sensed by the N-terminal input 
domain of the sensor protein will cause the C-terminal transmitter domain to 
transduce the signal to the response regulator. The response regulator detects the 
incoming signal from the sensor, also at its N-terminal domain, and alters the activity 
of its C-terminal domain to trigger a response (Parkinson, 1993) (Fig. 1.1). Of the 
many two component sensor regulators so far characterized, the mechanism of 
communication has always been found to involve phosphorylation and 
dephosphorylation reactions (Parkinson and Kofoid, 1992). The sensor transmitter 
has an autokinase activity and can thus attach phosphoryl groups from ATP to a 
histidine residue which is located near the N-terminus of the transmitter domain. This 
phosphohistidine acts as a high energy intermediate and can transfer the phosphoryl 
group to an aspartate residue in the receiver domain of the response regulator 
(Sanders et at., 1992) (Fig. 1.1). The receiver catalyses hydrolytic loss of its 
phosphoryl group, this process occurring from within a few seconds to many minutes 
(Parkinson, 1993). The output domain of the response regulator, in most cases, has a 
DNA binding or. other regulatory function that provides transcriptional control of one 
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or more target genes. NMR studies have shown that phosphorylation of the receiver 
causes substantial changes in conformation but it is not yet known how this actually 
effects the output mechanism of the response regulator (Parkinson, 1993). 
1.5.2 The role of two component sensor regulator systems in virulence 
Two component sensor regulator systems have been found to have a role in 
pathogenesis in a number of species. The bvg (Bordetella virulence gene) 
regulon of Bordetella pertussis and the pho regulons of E. coli and S. 
typhimurium are examples. The bvg locus of B. pertussis contains two genes, bvgS 
and bvgA which encode the sensor and response regulator of a two component signal 
transduction system, respectively. The bvg regulon co-ordinately regulates 
expression of several toxins, including pertussis toxin, in response to environmental 
stimuli such as temperature and the presence of Mg2+ (Arico et al, 1991) (see section 
1.7). The pho regulon of E. coli and S. typhimurium is controlled by the phoP and 
phoQ genes, encoding a sensor and regulator protein respectively (Parkinson and 
Kofoid 1992). In Salmonellae, the phoP product regulates the expression of genes 
encoding factors that protect against the bactericidal activity of macrophage proteins 
(Miller et al., 1989b). The phoP gene is required for the expression of three, and 
perhaps more, unlinked loci, at least one of which, pagC is likely to encode a 
virulence factor required for intracellular survival in macrophages (Miller et al., 
1989b). 
1.5.3 Quorum sensing systems 
Another mode of global regulation of gene expression has been described in many 
species. This involves a process of intercellular communication which enables cells 
to sense population levels. This signalling mechanism uses diffusable signalling 
molecules (pheromones) to regulate physiological processes in a cell density 
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(quorum) or growth phase dependent manner (Kleerebezem et al., 1997). 
Pheromones are substances which are secreted by a cell and received by a second cell 
in which they cause a specific action (Karlson and Löscher, 1959). The first 
identified and best understood quorum sensing system is the bioluminescent (lux) 
phenotype of Vibriofischeri. Here, synthesis of the signalling molecule necessary for 
induction of the luminescence system, L-homoserine lactone, is mediated by the luxI 
gene (Engebrecht and Silverman, 1984). The protein product of the luxR gene binds 
the L-homoserine lactone and becomes the transcriptional activator of the 
bioluminescence genes (Engebrecht and Silverman, 1986). Cultures of V. fischeri 
express lux genes only weakly during early growth phase with expression being 
strongly activated in late exponential growth, i. e. in a density dependent manner 
(Eberhard, 1972). 
The phenomenon of quorum sensing has also been identified in several Gram positive 
bacteria but has not been found to involve an N-acyl homoserine lactone-like 
signalling molecule (Kleerebezem et al., 1997). Examples of quorum sensing 
systems in Gram positive bacteria include the competence inducing systems of 
Bacillus subtilis and Streptococcus pneumoniae, the virulence response of S. aureus 
and the production of antimicrobial peptides by several different species (HAvarstein 
et al., 1995; Ji et al., 1995; Magnuson et al., 1994). In Gram positive bacteria, the 
signalling molecule seems most often to be a post-translationally processed peptide. 
This peptide pheromone is commonly recognised by the sensor component of a two 
component signal transduction system. Further, in Gram positive bacteria, the genes 
encoding the signalling molecule precursor and its processor protein, together with 
the genes encoding the proteins involved in the two component sensor regulator, are 
often transcriptionally linked (Kleerebezem et al., 1997). Thus the increase in 
expression of such a locus is auto-regulatory. 
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Quorum sensing in B. subtilis is utilised in developing genetic competence, whereby 
cells can take up exogenous DNA, in a cell density dependent manner (Magnuson et 
al., 1994). Four genes are involved in this regulatory process, comQ, X, A and P. 
The comQ gene post-translationally modifies the product of the comK gene to a 10 
amino acid peptide. The cellular response to this peptide is mediated by a two 
component sensor regulator with comP encoding the sensor and the comA gene 
encoding the response regulator (Magnuson et al., 1994). 
The signalling pheromone inducing competence in S. pneumoniae cells is a 17 amino 
acid peptide which is processed by the comB gene product from a 41 amino acid 
proform encoded by the comC gene (HAvarstein et al., 1995; Zhou et al., 1995). This 
peptide signal is transduced by the gene products of the comD and E genes 
comprising the sensor and regulator of a classical two component sensor regulator 
system (HAvarstein et al., 1996). 
The quorum sensing system of S. aureus is discussed in detail in section 1.6. 
1.6 Control of virulence determinant production in S. aureus 
S. aureus has been found to control production of a whole range of virulence 
determinants by means of several regulatory loci which act either independently or 
co-ordinately. These global regulators include the accessory gene regulator (agr) 
(Recsei et al., 1986; Morfeldt et al., 1988); the staphylococcal accessory regulator 
(sar) (Cheung et al., 1992), extracellular protein regulator (xpr) (Smeltzer et al., 
1992; Smeltzer et al., 1993) and sae (S. aureus exoprotein expression) (Giraudo et al., 
1994b). The S. aureus virulence response is regulated, at least partly, by a density 
dependent signalling system that is analogous to the quorum sensing systems of other 
Gram positive and Gram negative bacteria (see section 1.5.2). In particular, agr 
expression is growth phase dependent occurring at mid to late'exponential phase. 
20 
Accordingly, those genes which are positively controlled by agr are up-regulated at 
this time and those genes which are negatively regulated by agr are down-regulated at 
mid-late exponential phase (see section 1.6.1.1). The expression of individual 
transcripts of the sar locus is also dependent on growth phase (Bayer et al., 1996). 
For example, expression of sarB occurs during early-mid log phase whilst sarC 
transcription is most active during stationary phase. There is also evidence for co- 
ordinate transcriptional control of some virulence factors such as protein A and a- 
haemolysin (Hla) synthesis (Janzon et al., 1986; Vandenesch et al., 1991). 
Production of a-haemolysin is controlled temporally as well as by agr (Vandenesch et 
al., 1991) (see section 3.1). It has also been demonstrated that environmental 
conditions, such as pH, temperature, availability of divalent cations and 02, together 
with glucose and NaCl concentration, affect the production of virulence determinants 
under the control of at least one global regulator, agr, and also production of a- 
haemolysin both via and independently of this global regulator (Regassa and Betley, 
1993; Regassa et al., 1992; Sheehan et al., 1992; Vandenesch et al., 1991). 
1.6.1 Regulators of virulence determinant production 
1.6.1.1 agr (accessory gene regulator) 
The accessory gene regulator was the first discovered and is the best understood of all 
the known global regulators of virulence determinant production in S. aureus. It has 
been shown to up-regulate production of, amongst others, the haemolysins, 
enterotoxin B, TSST-1, epidermolytic toxin A, staphylokinase, serine protease and 
acid phosphatase. It also down-regulates coagulase and protein A production. 
Regulation by agr occurs in a growth phase dependent manner, during late 
exponential-early stationary phase (Björklind and Arvidson, 1980; Recsei et al., 
1986). The agr locus was identified at almost the same time in two separate 
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laboratories, although several years were to elapse before either group of workers 
were to realise that they had identified a global regulatory system. 
1.6.1.1.1 The discovery of agr 
In 1982, Mallonee et al. isolated a Tn551 insertion mutant in what was thought to be 
the a-haemolysin (hla) gene. Transformation of this mutation into an isolate that 
produced a-, 0- and 8-haemolysin, together with a range of other extracellular 
proteins, showed that the mutation caused loss not only of a-haemolysin but also 
and 8-haemolysin, a 100-fold drop in TSST-1 and a 50-fold drop in staphylokinase 
(Kreiswirth et al., 1983; Recsei et al., 1986). In contrast, synthesis of the 
extracellular protein, surface protein A, was elevated 20-fold (Recsei et al., 1986). 
It was established by probing wild type and mutant chromosomal DNA with probes 
originating from both the a-haemolysin and TSST-1 structural genes, that Tn551 had 
not inserted into either of these structural genes. These data indicated that the 
transposon had inactivated a trans-active positive control element. This locus was 
subsequently designated agr for accessory gene regulator (Recsei et al., 1986). 
At the same time, a class of pleiotropic mutants were isolated, designated exp, which 
also showed decreased production of a-toxin, serine protease, staphylokinase, 
nuclease and acid phosphatase and a simultaneous increase in the production of 
coagulase and protein A (Björklind and Arvidson, 1980). Subsequent analysis of 
specific exoprotein mRNA in one of these exp mutants showed that the regulation of 
exoprotein gene expression exerted by exp was at the level of transcription (Janzon et 
al., 1986). 
It was noted by Morfeldt et al. (1988) that the exp mutant showed an almost identical 
phenotype to the agr mutant described by Recsei et al. (1986). In order to facilitate 
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further study of this regulatory mechanism and to enable cloning of this element they 
used Tn551 to create mutants which were phenotypically identical to the exp mutants 
(Morfeldt et al., 1988). The mutation in one of the clones with an exp phenotype 
(WA205) was phage transduced into strain 8325-4 using phage 80a. More than 90 % 
of the transductants had the exp phenotype, indicating that the Tn551 insertion was 
closely linked to, or caused the exp phenotype. 
A transductant (WA250) was used for Northern blot analysis to demonstrate that 
transcription of protein A and a-haemolysin was altered by the Tn551 insertion. 
Following cloning of the exp locus and further Northern blot analysis it was shown 
that exp coded for an RNA transcript of approximately 3.5 kb. It was concluded that 
exp and agr are identical since both exp and agr mutants have a reduced level of this 
3.5 kb RNA compared to wild type strains (Morfeldt et al., 1988). 
1.6.1.1.2 The agr locus 
The agr locus was first cloned and partially sequenced by Peng et al. (1988). A 6.1 
kb chromosomal fragment which was cloned was found to contain a 241 codon open 
reading frame (ORF) which was designated agrA. Gene fusion analysis using a 
promoterless ß-lactamase gene showed that there was a weak, but constitutive 
promoter 5' to the agrA gene (Peng et al., 1988). The remainder of the agr locus was 
subsequently sequenced and found to contain six more ORFs, three of which were 
transcribed in the same direction as agrA and three transcribed in the opposite 
direction (Kornblum et al., 1990; Arvidson et al., 1990) (Fig. 1.2). The ORF 
upstream of agrA, together with the agrA gene, were found to be related to a gene 
encoding a sensor and response regulator of a two component signal transduction 
system (Kornblum et al., 1990). In addition, agr was found to contain two other 
promoters, P2 and P3 (Morfeldt et al., 1988). P2 initiates a. 3 kb transcript, 
designated RNAII, starting at position 1750 (Fig 1.2) and P3, transcribed in the 
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opposite direction to P2, initiates a transcript of 0.5 kb, designated RNAIII, starting at 
position 1566 (Fig. 1.2). The 0.5 kb RNAIII transcript is an abundant, long-lived 
mRNA with a half life of 15 minutes (Arvidson et al., 1989). It was found to contain 
an ORF of 160 nucleotides encoding a 26 amino acid residue protein identical to the 
sequence of the S. aureus 6-haemolysin (Janzon et al., 1989; Fitton et al., 1980). 
Approximately 110 nucleotides downstream of the 6-haemolysin (hid) gene is a 
second ORF with a poor ribosome binding site which could ostensibly encode a 21 
amino acid peptide. There is also a third ORF contained within the RNAIII transcript 
comprising 19 codons. However, this latter ORF does not appear to have a ribosome 
binding site. Thus, it appears that the 3' end of the transcript is untranslated although 
it has been reported that an insertion in the 3' end of RNAIII reduced agr activity but 
did not affect P2 or P3 transcription (Janzon and Arvidson, 1990). The role of 
RNAIII as the molecule regulating exoprotein gene expression was largely confirmed 
by the finding that an insertion in the RNAIII 3' region did not impair 6-haemolysin 
production but resulted in a typical agr phenotype (Arvidson et al., 1989). In 
addition, it has been shown that a cloned RNAIII defective in 6-haemolysin 
production can restore the positive and negative effects on virulence gene expression 
in both an RNAIII deletion mutant and an agr null strain (Janzon and Arvidson, 1990; 
Novick et al., 1993). From these experiments it was not possible to determine 
whether RNAIII was acting at a transcriptional or post-transcriptional level. This was 
addressed by transcriptionally fusing promoters from the a-haemolysin (hla) and 
protein A (spa) genes to the staphylococcal plasmid p1258 ß-lactamase gene (bla) and 
examining expression from these promoters in agr+ and agr' strains (Novick et al., 
1993). Expression from the hla and spa promoter in each strain was thus reflected in 
the levels of ß-lactamase activity which, in each case, were found to correlate with 
the respective levels of the native proteins. Thus, hla:: bla was expressed during post- 
exponential growth phase in the agr+ strain but not in the agr- strain and the 
converse for the spa:: bla fusion. Similar fusions using the tst (TSST-1) or hlb (ß- 
haemolysin) promoters gave similar results to the hla:: bla fusion (Novick et al., 
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1993). It has also been demonstrated that RNAIII affects translation of, at least, a- 
haemolysin since hla mRNA is not translated in the absence of the 5' region of 
RNAIII (Novick et al., 1993). The mechanism by which RNAIII regulates translation 
of a-haemolysin has since been deduced. It has been shown that RNAIII binds to the 
hla transcript in a way that exposes its ribosome binding site, thus allowing 
translation (Morfeldt et al., 1995). This prevents a stem-loop structure being formed 
within hla mRNA which blocks its ribosome binding site in the absence of RNAIH 
(Morfeldt et al., 1995) (Fig. 1.3). These results confirm that RNAIII has two 
functions, one as a transcriptional activator and another as an activator of translation 
(Morfeldt et al., 1995). This was probably the first example of an "antisense RNA" 
stimulating translation of target mRNA (Morfeldt et al., 1995). 
It is now known that the four genes encompassed in the RNAII transcript comprise a 
quorum sensing signal transduction system (Balaban and Novick, 1995; Ji et al., 
1995). This is mediated via an extracellular signalling peptide and two component 
sensor regulator system which are transcriptionally linked and encoded by the 
agrBDCA operon (Fig. 1.2). 
1.6.1.1.2.1 The agr two component sensor regulator system 
agrC and agrA (Fig. 1.2) are homologous to genes encoding the signal sensor and 
response regulator of a classical two component signal transduction system, 
respectively (see section 1.5.1). AgrC resembles a histidine phosphokinase signal 
transducer and acts as a peptide pheromone sensor. Via phosphorylation of AgrA, it 
stimulates RNAIII production. It has not yet been demonstrated that AgrA binds 
directly to DNA and it has been suggested that it might rather influence binding of 
another regulatory component, SarA, to the P2 and P3 promoters of agr (Morfeldt et 
al., 1996a/b) (see section 1.7.2.2) (Fig. 1.4). 
26 
S'hla 
3"RNA Ill 
1ýI 
5'hla 
FIGURE 1.3 
AUG -3' 
Model for the translational control of a-haemolysin. The figure shows how the 
intramolecular base pairing in hla mRNA blocks the SD (ribosome binding site), and 
thereby translation, and how this is released by the interaction with RNAIH (from 
Morfeldt et al., 1995). 
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Model of interaction between the agr and sar gene products (depicted in bold type) 
which mediate changes in expression from the P2 and P3 promoters of agr. AgrC 
and AgrA represent the sensor and response regulator, respectively, of a two 
component signal transduction system. RAP (RNAHI activating protein) is encoded 
within the agrD gene and is modified from a 46 amino acid pre-peptide to an 
octapeptide, probably by the product of the agrB gene. RAP has been proposed as a 
signalling pheromone that, probably via AgrC, leads to increased transcription from 
the P2 and P3 promoters of agr in a density dependent manner (see section 1.6.1.2.2). 
The RNAIII transcript has been shown to up- or down-regulate production of some 
exoproteins, as indicated. (Not to scale). 
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1.6.1.1.2.2 The agr signalling pheromone 
Transcription of the agr operon from P2 is auto-regulated in a density dependent 
manner by the gene product of agrD (Ji et al., 1995) (Fig. 1.2). agrD encodes a 46 
amino acid residue pre-peptide which is subsequently processed, probably by the 
gene product of agrB, to give an octapeptide known as RAP (RNAIII activating 
protein) (Balaban and Novick, 1995; Ji et al., 1995) (Fig. 1.4). RAP accumulates 
gradually during growth of a culture (Balaban and Novick, 1995) but the response 
exhibits a sharp concentration dependent activation threshold (Ji et al., 1995). 
Addition of exogenous RAP to early exponential phase cultures causes immediate 
activation of transcription from both the P2 and P3 promoters (Balaban and Novick, 
1995; Ji et al., 1995). 
Interestingly, it has also been demonstrated that a secreted factor produced by one 
strain of S. aureus is able to inhibit agr expression by different strains (Balaban and 
Novick, 1995; Ji et al., 1997). It was found that S. aureus strains could be divided 
into three groups, with members of one group inhibiting agr expression by members 
of the other groups (Ji et al., 1997). Ji et al. (1997) confirmed that RAP was also 
responsible for this strain specific inhibition as well as activating agr in the producing 
strains. In the different strains it was found that RAP varied in length from 7-9 
amino acid residues which were again processed from the agrD product (Ji et al., 
1997). 
1.6.1.2 sar (staphylococcal accesso regulator) 
Another regulator of exoprotein expression in S. aureus, designated sar, was 
identified as a Tn917 (see section 1.7.2) transposon mutant (Cheung et al., 1992). 
The strain used for transposon mutagenesis was a wild type strain of S. aureus 
isolated from blood, designated DB. Transposition of Tn917 into the host, DB, 
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chromosome was found to be high (5 x 10-4, i. e. one Tetr transposant out of every 
2000 cfu). Mutants were selected for a fibrinogen binding protein negative 
phenotype. One clone, designated 11D2, exhibiting this characteristic was identified 
out of 17,000 clones screened following enrichment for this phenotype. The mutant 
phenotype when transduced back into the parental strain DB led to a total lack of 8- 
haemolysin and a decrease in levels of fibrinogen and fibronectin binding proteins by 
73 and 65 % respectively and extracellular protein A by 87 % compared to the 
parental strain. There was an increase in serine protease and lipase activity and a 64 
% increase in a-haemolysin production (Cheung et al., 1992). Southern blot 
hybridisation using a probe derived from the agr locus, showed that the novel locus is 
distinct from agr and was designated sar (staphylococcal accessory regulator) 
(Cheung et al, 1992). Subsequently the sar.: LTV1 mutation was phage transduced 
into two other strains, one a-haemolysin negative and one haemolytic lab strain 
(Cheung and Ying, 1994). Similar levels of DNase and ß-lactamase were found in 
the transductants compared to their parental strains, but both transductants showed 
decreased levels of a-, ß- and 6-haemolysin and fibronectin binding protein (FnBP). 
Both transductants displayed increased protease levels. Northern blot analysis 
confirmed that the levels of transcripts for both a- and ß-haemolysin were decreased 
throughout the growth cycle indicating that these haemolysins are regulated by sar at 
the transcriptional level (Cheung and Ying, 1994). The regulation of a- and ß- 
haemolysin by the sar locus was found to begin at mid-log phase and continue into 
post-exponential phase in a similar way to that in which agr regulates gene 
transcription (Cheung and Ying, 1994). By Northern blot analyses it was found that 
RNAIII transcript levels were significantly reduced or absent in sar mutants (Cheung 
and Projan, 1994). Thus the effect of sar on a- and ß-haemolysin transcription may 
be mediated via agr. Chromosomal DNA flanking the Tn917-LTV 1 insertion was 
cloned and sequenced. 
30 
1.6.1.2.1 The sar locus 
The transposon was found to have inserted into an ORF of 372 bp, designated sarA 
(Cheung and Projan, 1994). The sar phenotype (reduction in RNAIII levels) could be 
partially complemented by the provision of an intact copy of sarA in trans. This 
suggested that the levels of RNAIII were related to a functional sarA gene possibly by 
binding of SarA to the promoter region of RNAIII (Cheung and Projan, 1994). 
Analysis of the SarA amino acid sequence showed that it shared homology with 
DNA-binding proteins. In fact, sarA shares sequence similarity with the virF gene of 
Shigella flexneri (Cheung and Projan, 1994). VirF regulates genes involved in 
bacterial invasion via the control of virB, a second positive regulatory gene (Hale, 
1991). Thus Cheung and Projan (1994) hypothesised that the similarity between 
SarA and VirF suggested that SarA may control the expression of some exoproteins, 
such as a- and ß-haemolysins by positively controlling RNAIII levels. The sequence 
of the entire sar locus was found to be 1.2 kb in size. There are three overlapping sar 
transcripts, designated sarA, sarC and sarB (Bayer et al., 1996; Heinrichs et al., 
1996) (Fig. 1.5). These three transcripts have common 3' ends but originate from 
three distinct promoters, P1, P2 and P3 respectively (Fig 1.5). Of the three 
promoters, P1 and P2 sequences are similar to those of a70 dependent promoters 
whilst the P3 promoter is very similar to a B. subtilis aB dependent promoter (Deora 
et al., 1997) (see section 1.6.2.3). The sarA transcript is 0.58 kb and has a single 
ORF, sarA, with a predicted molecular size of 14.7 kDa. The sarC transcript is 0.8 
kb and sarB is 1.15 kb (Bayer et al., 1996). The sarB transcript encompasses the 
sarA gene and two upstream ORFs (ORF3 and ORF4) encoding peptides of 39 and 18 
amino acids, respectively. All three transcripts are under temporal, growth phase 
dependent regulation with sarA and sarB expression at their highest during early 
exponential phase and sarC expression being highest at the end of stationary phase 
(Bayer et al., 1996). It was suggested that maximum agr expression was dependent 
on an intact särB transcript (Heinrichs et al., 1996) and, in fact, a single copy of the 
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FIGURE 1.5 
sarB transcript 
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Transcription of the sar locus (modified from Bayer et al., 1996). The map of the sar 
region shows the location of the three sar promoters and the approximate extent of 
their transcripts. (The scale of this diagram is marked on the top, right). 
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whole sar locus was found to be necessary to restore RNAIII levels in an sar mutant 
to those found in wild type strains (Heinrichs et al., 1996). The SarA protein has 
been found to bind to both the P2 and P3 promoter regions of agr (Morfeldt et al., 
1996; Cheung et al., 1997). It has also been suggested that the 18 and 39 amino acid 
peptides encoded by the sar locus may play a role with the SarA protein at a 
physiological level to influence agr transcription (Cheung et al., 1997). 
It appears that sar and agr do interact at some level but also act independently in vivo 
since an sar agr double mutant shows markedly reduced virulence compared to either 
single mutant (Booth et al., 1997; Cheung et al., 1994). 
1.6.1.2.2 The role of SigB in sar transcription 
Sigma factors are proteins that bind to core RNA polymerase to form holoenzymes 
that bind to, and utilise, specific promoters (Moran, 1993). Sigma factors can be 
divided into two broad groups with the primary sigma factor being necessary for the 
expression of housekeeping genes whose products are necessary for exponential cell 
growth (Deora et al., 1997). The second group comprises the alternative sigma 
factors that control expression of a wide range of genes involved in many cellular 
functions. The first alternative sigma factor identified in prokaryotes was SigB of B. 
subtilis (Haldenwang and Losick, 1980). SigB controls the expression of many genes 
in response to several environmental stresses, such as entry into stationary phase, 
starvation, heat and osmotic shock (Boylan et al., 1993). The sar P3 promoter has 
been shown to be SigB dependent and thus, like other SigB dependent promoters, is 
most active during stationary phase (Cheung et al., 1997). A putative operon 
comprising four ORFs has recently been identified in S. aureus which showed close 
similarities to the sigB operon of B. subtilis (Wu et aL, 1996). The protein encoded 
by the putative sigB gene of S. aureus has since been purified and found to be similar 
to sigma B of B. subtilis and has thus been designated SigSB (S. aureus derived SigB 
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protein) (Deora et al., 1997). It was also demonstrated that SigSB initiated 
transcription from the sar P3 promoter producing a transcript of the expected size 
(Deora et at., 1997). This confirms the earlier observation of a SigB-like consensus 
sequence for this promoter. The importance of SigB in the regulation of virulence 
has not however been established. 
1.6.1.3 sae (S, aureus exoprotein expression) 
Another class of pleiotropic mutant defective in the production of several exoproteins 
has been identified by Tn551 mutagenesis and designated sae (S. aureus exoprotein 
expression) (Giraudo et al., 1994b). The mutant showed decreased ß-haemolysis on 
sheep blood agar plates, reduced DNase activity and a lack of extracellular protein A 
in comparison to the parental strain. However the parental strain itself was deficient 
in the production of several exoproteins, so the insertional mutation was transduced 
into a strain (ISP479-C) which was positive for all characteristics tested, except for 
enterotoxin A. Following transduction of the mutation into this strain it was found 
that a- and ß-haemolysin levels dropped by 97 and >99.9 % respectively whilst 8- 
haemolysin remained constant compared to ISP479-C. DNase production decreased 
by 75 % and the strain was coagulase and extracellular protein A negative. Cell wall 
protein A, staphylokinase, proteases, lipase and acid phosphatase levels remained 
unaffected. It was originally thought unlikely that sae is a positive regulatory locus 
but perhaps that the Sae phenotype results from some defect at the level of protein 
processing (Giraudo et al., 1994b). However, subsequent Northern blot analysis 
revealed that, in an sae mutant, the genes for a- and ß-haemolysins and coagulase are 
not transcribed and the gene for protein A is transcribed at a lower level indicating 
that the sae locus does regulate these genes at a transcriptional level (Giraudo et al., 
1997). 
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An sae agr double mutant has been constructed, characterized and, in this strain, the 
high coagulase levels found in an agr mutant are diminished to the near null levels 
found in an sae mutant (Giraudo et al., 1996). Conversely, in this double mutant the 
low levels of protein A found in the sae mutant are raised to the high levels 
characteristic of an agr mutant. Also, ß-haemolysin is reduced to an even lower 
level than that found in either single mutant. These observations suggests that sae 
and agr interact, but how and at what level is not yet understood (Giraudo et al., 
1997). 
1.6.1.4 Xj2r (Extracellular protein regulator) 
In 1992 Smeltzer et al. described a Tn551 chromosomal insertion in a S. aureus strain 
which caused an almost complete abolition of expression of extracellular lipase. It 
was subsequently found that this insertion affected the expression of several 
exoproteins at the mRNA level with a marked reduction in transcript levels of 
enterotoxin B, lipase, a- and S-haemolysin, while mRNA levels for coagulase and 
protein A were elevated (Hart et al., 1993). The phenotype of this mutant was found 
to be similar to that of an agr mutant. However, genetic and physical mapping 
showed that insertion of Tn551 was distinct from the agr locus and that this genetic 
element was in fact a new regulatory locus, designated xpr (extracellular protein 
regulator) (Smeltzer et al., 1993). Due to the reduction in mRNA encoding the S- 
haemolysin, thus affecting not only S-haemolysin but also expression of RNAIII, it 
was concluded that xpr and agr are interactive at the genetic level (Hart et al., 1993). 
1.6.1.5 Other putative regulatory loci of S. aureus 
A further putative regulatory locus has been identified by screening a Tn551 
transposon insertion library for fibrinogen binding protein negative mutants (Cheung 
et al., 1995). A mutant was found to show increased secretion of a-, ß- and 8- 
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haemolysin compared to the parental strain and a decrease in fibrinogen binding 
capacity and nil levels of cell wall protein A. This pattern was also observed when 
the mutation was transduced back into its parental strain. Following pulsed field gel 
electrophoresis the mutation was localised to SmaI fragment B of the S. aureus 
chromosome and phenotypic analysis showed that this locus was distinct to the other 
regulatory loci, agr, sar and xpr, described above (Cheung et al., 1995). It has been 
suggested that this locus represents a genetic element that is involved in the 
expression of potential cell wall virulence determinants, such as protein A (Cheung et 
al., 1995). 
A putative regulatory locus that affects autolysis has also been identified in S. aureus 
(Brunskill and Bayles, 1996). In this work, two genes have been identified, lytS and 
lytR, which share homology with genes encoding the sensor and response regulator 
proteins of a two component signal transduction system (see section 1.5.1). A 
mutation in the lytS gene results in an increased rate of autolysis of cells compared to 
a parental strain with a functional lytS gene. 
1.7 The role of environmental stimuli in virulence determinant gene 
expression 
The interaction between a pathogen and its host during the disease process involves 
microbial survival and multiplication in the face of the rapid and vigorous defence of 
the host immune system. It is thus important that a bacterium can sense the often 
subtle environmental signals that indicate that it has entered a host. Such parameters 
include low iron concentration, temperature, osmolarity, pH, oxygen concentration 
and the concentrations of other divalent cations such as Mg2+ and Ca2+ (Mekalanos, 
1992) and are discussed below. 
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1.7.1 Iron 
Iron is essential for the growth of virtually all living cells. In vivo, intracellular iron is 
plentiful however extracellular iron is bound to specific iron binding proteins such as 
transferrin, lactoferrin etc. and thus is not readily available. Therefore, for pathogenic 
bacteria to survive and multiply in host tissues, they must possess a mechanism for 
scavenging iron, often by the production of siderophores (Neilands, 1981a). These 
are low molecular weight chelators and form what is known as a "high affinity" iron 
transport system thus allowing bacteria to grow in environments where there is <1 
µM of free iron (Neilands, 198 lb). The best studied siderophore is enterobactin 
(a. k. a. enterochelin), a complex phenolic derivative which, under conditions of iron 
deprivation, is produced by E. coli, Klebsiella pneumoniae, S. typhimurium and some 
species of Shigella (O'Brien and Gibson, 1970; Pollack and Neilands, 1970; Rogers, 
1973; Rogers et al., 1977; Perry and San Clemente, 1979). A novel hydroxamate- 
type siderophore was found in some clinical isolates of E. coli in 1979 and was later 
confirmed to be aerobactin (Warner et al., 1981; Williams, 1979). 
Another mechanism for iron acquisition by bacteria is the production of haemolysins 
to release iron from intracellular haem and haemoglobin present in erythrocytes 
(Litwin and Calderwood, 1993). However, not all pathogens which produce 
häemolysins are able to utilise the iron from haem since it is quickly complexed by 
haptoglobin in the host as a defence mechanism. 
The molecular basis of transcriptional regulation by iron has been most studied in E. 
coli in which co-ordinate regulation of gene expression by iron relies on the product 
of a single gene, fur (ferric uptake regulator). The protein product of the fur gene 
functions as a co-repressor with ferrous iron via interaction with the promoter region 
of Fur-regulated genes, including aerobactin. Using a transcriptional fusion between 
IacZ and the promoter of the aerobactin gene it was demonstrated that aerobactin 
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expression is repressed by iron and that this regulation occurs at the transcriptional 
level (Bindereif and Neilands, 1985). It has been shown that production of shiga 
toxin by S. dysenteriae is repressed in the presence of excess iron and conversely is 
enhanced under conditions of iron deficiency (Litwin and Calderwood, 1993; Van 
Heyningen and Gladstone, 1953). In S. aureus, it has been found that deficiency of 
iron up-regulates activity of the accessory gene regulator and production of a- 
haemolysin (P. F. Chan, personal communication). 
1.7.2 Temperature 
Temperature is an obvious environmental cue to signal that an organism has entered a 
host. The transition from usually low ambient temperature to mammalian or avian 
body temperature causes marked changes in virulence determinant production in 
several organisms. For example, in B. pertussis the bvgA and S genes encoding a two 
component regulator system (see section 1.5.1) undergo thermoregulation (Melton 
and Weiss, 1989). The products of these two genes co-ordinately regulate production 
of several virulence determinants. 
In S. flexneri, a change from 30 °C to 37 °C causes the organism to become fully 
virulent and invasive (Maurelli et al., 1984). Virulence gene expression is mediated 
in response to increased temperature, by de-repression of a set of genes and steady 
state expression of these genes at 37 °C (Maurelli et al., 1992). The virR gene of 
Shigella is allelic to has which encodes a histone-like protein that binds to DNA, 
increases its thermal stability and strongly inhibits initiation of transcription (Maurelli 
et al., 1992; Spassky et al., 1984). H-NS is believed to mediate changes in DNA 
supercoiling, by a mechanism which is not yet understood, and thus repress gene 
transcription (Maurelli et al., 1992). Therefore the ability of Shigella to withstand 
changes in temperature and co-ordinate a regulatory response could be achieved by 
38 
the temperature regulation of virR expression. It is possible that this model may be 
applicable to other temperature sensitive systems in other organisms. 
1.7.3 Osmolarity 
Osmolarity has also been noted as an environmental signal affecting virulence gene 
expression in several different pathogens. For example, production of enterotoxin, 
Yst by Yersinia enterocolitica can be induced when osmolarity is increased to that 
found in an intestinal environment (Alvydas et al., 1994). In Listeria monocytogenes 
cultures, production of a haemolysin is stimulated in the presence of 2.5 % (w/v) 
NaCl (Dallmier and Martin, 1990). Some organisms are extremely sensitive to 
osmotic levels. In particular, expression of cholera toxin by V. cholerae is optimal at 
66 mM NaCl but expression is inhibited at <60 mM or > 250 mM NaC1(Gardel and 
Mekalanos, 1994). In S. aureus high salt concentrations (1.2 M NaCl) resulted in a 
16-fold decrease in production of enterotoxin C (Regassa and Betley, 1993). From 
work done with E. coli, S. typhimurium and S. aureus it appears that one mechanism 
of control exerted by osmolarity may be the effect on DNA supercoiling (Higgins et 
al., 1988; Sheehan et al., 1992). In S. aureus, NaC1(0.7 M) causes DNA to become 
more negatively supercoiled which has been shown to cause a decrease in production 
of epidermolytic toxin A (Eta) (Sheehan et al., 1992). It is well established that 
promoter activity is influenced by the level of DNA supercoiling. Higgins et al., 
(1988), have shown that an increase in extracellular osmolarity increases in vivo DNA 
supercoiling, this seems to be responsible for induction of at least one genetic locus, 
pro U, in E. coli and S. typhimurium. proU plays a role in adaptation to growth at 
high osmolarity (Higgins et al., 1988). The proU locus encodes a glycine-betaine 
transport system which not only balances external osmolarity, but also protects 
intracellular proteins against denaturation by high ionic strength. 
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1.7.4 12H 
The ability of pathogens to survive the changes in pH during passage through the host 
digestive tract can be an important factor in their ability to cause disease. Indeed, 
changes in pH can be interpreted as a signal of exactly where the pathogen is. For 
example, Vibrio cholerae needs to pass through the low pH of the stomach, penetrate 
the mucus gel layer of the small intestine where pH is more alkaline and then grow 
and produce cholera toxin. Cholera toxin is optimally produced at pH 8.0 (Gardel 
and Mekalanos, 1994). Expression of genes in other organisms can also be affected 
by pH, including the pagC gene of S. tyhphimurium, which is controlled by the 
phoPQ regulon, is necessary for survival in macrophages and is increased in media of 
low pH (Miller et al., 1989a). 
1.7.5 Anaerobiosis 
Changes in oxygen levels can indicate that an organism is entering a host. For 
example, an anaerobic micro-environment at the site of infection is an environmental 
signal which can induce an invasive phenotype (Dorman, 1994). It has been shown 
that growth of S. typhimurium under anaerobic conditions leads to increased invasion 
in tissue culture cell models (Ernst et al., 1990; Francis et al., 1992). In addition, 
some enteric promoters are sensitive to both osmolarity and anaerobiosis which 
suggests there might be a collaborative response to those environmental stimuli which 
indicate that up-regulation of genes necessary for an invasive phenotype is required 
(Dorman, 1994; Ni Bhriain et al., 1989). 
It has been suggested that anaerobiosis can affect the level of supercoiling in 
chromosomal DNA and it is possible that these changes can play a role in modulating 
gene expression in response to anaerobic growth (Yamomoto and Droffner, 1985; 
Higgins et al., 1988). 
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1.7.6 Divalent cations 
1.7.6.1 Ca2+ 
The level of available calcium has been increasingly implicated in a number of 
bacterial functions, including differentiation, chemotaxis, heat shock and 
pathogenicity (Norris et al., 1996). For example, in Yersinia species a virulence 
associated phenomenon known as the low-Ca2+ response (lcr+) confers on the 
bacterium a dependence on Ca2+ for growth at 37 OC and expression of some 
virulence determinants of Y. pestis (Straley and Bowmer, 1986). In addition, the 
threshold of haemolysin induction in Actinobacillus pleuropneumoniae serotype 1 is 
approximately 700 pM free Ca2+ which is the concentration found in blood serum 
(Frey and Nicolet, 1988). Calcium and magnesium ions have been shown to repress 
transcription from the promoters of the cell wall protein gene operon of Bacillus 
brevis (Adachi et al., 1991). 
In E. coli, DnaK, the equivalent of the eukaryotic heat shock protein 70, is induced by 
stress and has an autophosphorylation activity that is stimulated 10-fold by calcium in 
vitro (Norris et al., 1996). It has been shown in vivo that phosphorylation of DnaK 
increases with temperature (Sherman and Goldberg, 1993). Although the calcium 
dependence of this phosphorylation is not known, it has been suggested that calcium 
levels may serve as part of an intracellular thermometer (Norris et al., 1996). A 
region of DnaK has been shown to have 60 % homology to a classic calmodulin 
binding site (Stevenson and Calderwood, 1990). Calmodulin is the most common 
small acidic Ca2+ binding protein found in eukaryotic cells and via which calcium 
regulates a number of cellular processes. Calmodulin has been shown to activate 
enzymes involved in eukaryotic cellular regulation (Swan et al., 1987). Although the 
role of calcium binding proteins in bacteria is not well understood, calmodulin-like 
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activity has also been reported in B. subtilis, E. coli and Streptomyces erythraeus (Fry 
et al., 1991; Iwasa et al., 1981; Swan et al., 1987). 
1.7.6.2 MR, + 
Several studies have been carried out to determine the effects of magnesium 
concentration on toxin production in pathogens, in particular TSST-1 in S. aureus. 
Mills et al. (1986) found that increasing the concentration of Mg2+ from 40 µM to 400 
µM in a CDM caused a reduction in TSST-1 production, but a concomitant increase 
in growth. Similarly, the rate of TSST-1 production was greater in the presence of 20 
µM than 1.3 mM. Similar experiments using higher concentrations of Mg2+ (25 µM- 
1.5 mM) showed that Mg2+ concentration did not affect production of TSST-1 
(Schlievert, 1985). Both these experiments were performed using batch cultures 
which makes it difficult to measure the effects of changing a single component of a 
growth medium. However, using a chemostat continuous culture, Taylor and Holland 
(1989b) showed that, in a Mg2+ limited medium, the rate of TSST-1 production is 
reduced. 
1.8 Rationale for this project 
It can be seen that there are many factors involved in the response of S. aureus to its 
environment and the consequential regulation of production of virulence 
determinants. The ways in which these environmental signals cause changes in gene 
expression is only partially understood. In addition, it remains unclear how, and at 
what level, the regulators which have been identified to date interact to effect an 
appropriate response to a changing environment. For this reason it was considered 
necessary to examine a wide range of environmental stimuli in order to identify those 
conditions which affect virulence gene expression via the major global regulator, agr. 
It also seems likely that there are other regulators involved in this complex response 
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system of S. aureus. Thus, the work described in this thesis addresses this hypothesis 
in the attempt to further clarify the mechanism of control of pathogenicity by this 
organism. 
1.9 Reporter gene fusions as tools for analysing gene expression 
Reporter gene fusions work by inserting promoterless genes encoding a measurable 
gene product downstream of a promoter of interest. Thus, when the promoter is 
transcriptionally active, the reporter gene is transcribed and the resulting gene product 
can be assayed to give a quantitative measure of promoter activity. Fusions can be 
made such that the reporter is either transcriptionally or translationally fused to the 
gene of interest. The use of gene fusions now constitutes a well established method 
for the study of gene expression and characterization of transcriptional control signals 
(Silhavy and Beckwith, 1985). Reporter gene fusions have been constructed in a 
wide variety of bacteria including Bacillus species, L monocytogenes, Mycobacteria 
and, of course, S. aureus (Gordon et al., 1994; Park et al., 1992; Wang et al., 1987; 
Zuber and Losick, 1983). There are several different reporter gene systems in use. 
1.9.1 Classes of reporter genes 
Gene fusions using the lacZ gene, which encodes ß-galactosidase, have been used 
since the early 1970's (Silhavy and Beckwith, 1985). The lac system is probably the 
most widely used reporter gene system, partly because the lac operon has been one of 
the most intensively studied genetic systems, so that the genetic and biochemical 
aspects of this system are well understood (Silhavy and Beckwith, 1985). In addition 
there are several substrate systems which are available. The lacZ reporter gene 
system can be used in both transcriptional and translational fusion studies thus 
providing a method for distinguishing transcriptional from post-transcriptional 
control. 
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Another reporter gene system in wide use employs luciferase encoded by the lux 
operon. Activity is measured by bioluminescence. The advantage of this reporter 
gene system is that very low levels of luminescence can be detected, for example, 
transduction of Salmonella with the luxAB genes (which encode luciferase) has 
demonstrated that after one hour as few as 10-100 cells can be detected (Stewart et 
at., 1989). Also the direct measurement of in vivo function without disruption of the 
cell and loss of viability is a major advantage. However, this system cannot easily be 
used under anaerobic conditions, interpretation of the intensity of light emission can 
be complicated and changes in intensity of in vivo bioluminescence is dependent of 
the level of luciferase and is substrates (Meighen, 199 1). lux gene fusions have been 
used to detect and measure the strength of promoters under temporal or other 
regulation during sporulation and germination of Bacillus (Stewart et al., 1989) and 
the osmotic regulation of E. coli (Park et al., 1989). In S. aureus, a lux reporter gene 
fusion to the tst promoter has been used to study the expression of TSST-1 (Timmins 
et al., 1995). 
ß-lactamase has been used as an indicator/reporter for analysing gene expression and 
its regulation in S. aureus. The staphylococcal (3-lactamase gene (blaZ) has been 
used to create transcriptional and translational fusions, and in fact transcriptional 
fusions were used to elucidate the activities of the three promoters of the agr locus 
(Kornblum et al., 1990). The advantage of using ß-lactamase as a reporter gene 
system is that assays are rapid and straightforward and yet it has been shown that the 
system is sensitive enough to detect activity corresponding to one molecule of 
enzyme per 103 cells (Novick, 1962). Also a variety of colorimetric assays for ß- 
lactamase activity exist (Sykes and Matthew, 1979). 
Various other reporter genes have been used to a lesser extent in bacteria including 
gus and cat. 
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2 MATERIALS AND METHODS 
Components of all the following media and buffers are given in appendix A. 
2.1 Media 
S. aureus was grown in several media, including two chemically defined media and 
Tryptic Soy Broth (TSB). However, except where stated otherwise in the following 
text, Brain Heart Infusion (BHI) was routinely used. Unless stated otherwise, Agar 
No. 1 [Oxoid] (1 % w/v) was used to make agar plates. Luria-Bertani broth or agar 
was used for the growth of E. coli. 
2.2 Antibiotics/inhibitory agent 
Antibiotic solutions used in this study are listed in Table 2.1. The stock solutions 
were filter sterilised where necessary, stored at -20 oC and added to media as 
appropriate once the media cooled to below 60 °C. Concentrations of antibiotics/ 
inhibitory agent used for selection were as in Table 2.1, unless stated otherwise in the 
text. 
2.3 Chemicals and enzymes 
In general, all chemicals and enzymes were of analytical'grade and were obtained 
from either Sigma, Fisons or BDH, unless otherwise stated. X-Gal (5-bromo-4- 
chloro-3-indolyl-VD-galactopyranoside) (Northumbria Biologicals Limited (NBL)) 
was dissolved in dimethylformamide (DMF) to 20 mg/ml and stored at -20 OC. All 
restriction enzymes, T4 ligase and buffers for restriction and ligation were purchased 
from Bethesda Research Laboratories (BRL), NBL or Promega. RNase A (DNase- 
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Antibiotic/Inhibitory 
agent 
Stock solution Working conc. 
Ampicillin (Amp) 50 mg/ml in H2O 50 gg/ml 
Cadmium (Cd) CdC12 (25 mM) in H2O 0.25 mM 
Chloramphenicol (Cm) 30 mg/ml in 95 % Ethanol 5 gg/ml 
Erythromycin (Em) 10 mg/ml in 50 % Ethanol 5 gg/ml 
Spectinomycin (Sp) 100 mg/ml in H2O 100 gg/ml 
TABLE 2.1 
. 
Antibiotics/inhibitory agent used in this study. 
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free) was purchased from Sigma, 'dissolved in distilled water to 10 mg/ml, and stored 
at -20 °C. Lysozyme solutions were prepared fresh on the day of use. Lysostaphin 
(Applied Microbiology Inc. ) was dissolved in 20 mM sodium acetate to 5 mg/ml. 
Pronase E (Sigma) was dissolved in TES to 10 mg/ml, predigested for 30 minutes at 
37 °C, and stored at -20 0C. Phenol was purchased pre-equilibrated from NBL. The 
constituents of all the buffers and solutions used in this work are described in 
Appendix A. 
2.4 Bacterial strains, plasmids and phages 
Bacterial strains and plasmids used in this study are listed in Tables 2.2 and 2.3, 
respectively. Two bacteriophages (411 and 485) were used. Both are S. aureus 
specific, temperate, transducing phages of serological group B (Novick, 1991), 
requiring Ca2+ ions for maintenance. Both phages have a genome of approximately 
45 kb in size (Novick, 1991). 
2.5 Bacterial maintenance, culture and storage conditions 
2.5.1 S. aureus strains 
S. aureus strains were grown on BHI agar plates, containing antibiotics as required. 
Strains were grown at 37 OC unless otherwise stated. Plate cultures were stored at 4 
OC for up to 2 weeks. Long-term storage of strains was at -20 °C in TSB containing 
20 % (v/v) glycerol. Liquid cultures were normally inoculated with a colony from an 
-overnight plate into 250 ml flasks containing 100 ml of culture: medium and were 
aerated by shaking on a rotary shaker at 250 rpm. 
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Strain Relevant characteristics Source 
S. aureus: 
NCTC 8325 General laboratory strain Novick, 1990 
NCTC 8325-4 Strain 8325 cured of 4)11,012 and 013 prophages Novick, 1990 
RN4220 Restriction minus, modification plus strain based Novick, 1990 
on 8325-4 
WA250 8325-4 containing Tn551 within the agr locus Morfeldt et al., 
1988 
SH100 RN4220 containing a chromosomally integrated This study 
copy of pHF23 to give hld:: lacZ fusion and Emr 
SH101 8325-4 containing a chromosomally integrated This study 
fragment of genomic DNA from SH100, 
containing pHF23 to give hld:: lacZ fusion and 
Emr 
SH106 RN4220 containing a chromosomally integrated This study 
copy of pHF25 to give hld:: lacZ fusion and Cmr 
SH107 SH100 containing a chromosomally integrated This study 
switching casette, pEr:: Sp to change Emr to Spr 
E. coli: 
XLOLR &(mcrA)183,, &(mcrCB-hsdSMR-mrr)173, endA 1, 
thi 1, recA1, gyrA96, relAl, lac[F', proAB, 
lacIgZtM 15, Tn10, (Tetr)] Xr, su- (non- 
suppressing) 
DHSa F-(O 80elacZM15), endA1, thi1, recA1, gyrA96, 
relA1, deoR, supE44, hsdR17 (rk-Mk+) 
e(lacZYA-argF') U169 
XL2-Blue &(mcrA)183,, &(mcrCB-hsdSMR-mrr)173, endA 1, Stratagene 
MRF . supE44, thi 1, recAl, gyrA96, relA1, lac [F, 
proAB, lacIgZAM 15, Tn10 (Tetr), Cmr] 
TABLE 2.2 
Bacterial strains used in this study. 
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Plasmids Characteristics Source 
pUBS1 pUC 18 (see below) with multiple cloning site from Foster, 1995 
pBluescript II KS (+/-) phagemid 
pAZ106 Suicide vector for use in Gram +ve bacteria, Kemp et al., 1991 
promoterless lacZ with spoVG rbs, bla and erm 
pEr:: Sp pIC56 with Err:: Spr Steinmetz and Richter, 1994 
pEr: Cm pIC56 with Err:: Cmr Steinmetz and Richter, 1994 
pTKlac Suicide vector for use in Gram +ve bacteria, Kenney and Moran, 1991 
promoterless lacZ with spoVG rbs, bla and cat 
pUC18 E. coli plasmid cloning vector, bla Vieira and Messing, 1982 
pRN3208 Tn551 delivery vector, Cdr, cat, erm Novick, 1991 
pEXO pSP64 containing 770 bp fragment of Tn551 plus 3.8 kb Morfeldt et al., 1988 
of S. aureus flanking chromosomal DNA 
pEX7 pSP65 containing a 2.1 kb BgIII/Pstl fragment Janzon and Arvidson, 1990 
containing the hld gene of the agr locus 
pLTV 1 Tn917 delivery vector, let, erm, bla Camilli et al., 1990 
pLTV3 Tn917 delivery vector, let, erm, phe Camilli et al., 1990 
pHF21 677 bp PstIlEcoRV fragment of agr in Pstl/EcoRV This study 
digested pUBS I 
pHF23 Xbal/EcoRV 701 bp fragment from pHF21 in This study 
XbaItSmal digested pAZ106 
pHF24 701 bp BamHUHindIII fragment of agr from pHF21 in This study 
BamHllHindIII digested pTKIac 
pHF25 1.8 kb Asp700/EcoRV fragment of agr (from pEXO) in This study 
Smal digested pTKlac 
pHF26 As pHF25, except insert in opposite orientation This study 
pHF30 1.2 kb EcoRI digested PCR product comprising the 3' This study 
end of Tn917 and flanking chromosomal DNA from 
strain 10.1 in EcoRldigested pUBSI 
pHF31 1.5 kb EcoRI digested PCR product comprising the 3' This study 
end of Tn917 and flanking chromosomal DNA from 
strain 5B. 1 in EcoRI digested pUBS I 
TABLE 2.3 
Plasmids used in this study. 
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2.5.2 E. coli strains 
E. coli was grown on LB agar plates, containing antibiotics if necessary to ensure the 
maintenance of plasmid bearing strains. Plate cultures were stored at 4 °C for 2 
weeks before re-streaking onto fresh agar plates. Liquid cultures were prepared in a 
similar manner to S. aureus except that the strains were grown in LB broth. All E. 
coli cultures were incubated at 37 -C. For long-term storage, E. coli strains and their 
plasmid-bearing derivatives were stored in LB broth plus 20 % (v/v) glycerol at -20 
oC and/or -70 oC. 
2.5.3 Plasmid and chromosomal DNA 
Purified plasmid or chromosomal DNA was stored in TE buffer at 4 OC (short-term 
storage) or -20 CC (long-term storage). 
2.6 Phage techniques 
2.6.1 Preparation of S. aureus phage lysates(Lindsay pers. comm. ) 
S. aureus donor strains were inoculated into TSB and incubated overnight at 37 oC 
with shaking (250 rpm). This overnight culture was used to inoculate (OD600 0.05) 
25 ml fresh TSB which was then incubated at 37 OC with shaking (250 rpm) for three 
, 
hours until mid-log phase. Culture (3 ml) was centrifuged (10,000 rpm, 5 min, RT) 
and resuspended in fresh TSB (5 ml). Phage buffer (5 ml) and approximately 30 gl of 
stock lysate (ý11 or 485 propagated on 8325-4) wasadded. A ratio of cells: phage of 
approximately 20: 1 is required. The mixture was incubated at RT for 10 minutes and 
then transferred to a slow shaker (approximately 50 rpm) at 30 oC for 2-3 hours. If 
the cells had not lysed by this time they were left overnight at 25 °C without shaking. 
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The resulting phage lysate contained approximately 107-1010 pfu/ml. The lysate was 
filter sterilised and stored at 4 oC. 
2.6.2 Phage transduction (Mani et al.. 1993) 
S. aureus 8325/4 (or SH106, as required) was inoculated into LK broth (50 ml) and 
incubated overnight at 37 °C with shaking (250 rpm). The culture was then 
centrifuged (10,000 rpm, 10 min, RT) and resuspended in LK broth (2.5 ml). 
Aliquots (0.5 ml) were mixed with LK broth (1 ml) containing 10 mM CaC12 and 
phage lysate (section 2.6.1) (0.5 ml) was added. The mixture was incubated for 25 
minutes at 37 °C without shaking and then for 15 minutes at 25 °C with shaking (250 
rpm). Ice-cold Na-citrate (1 ml, 0.02 M) was added and the mixture was centrifuged 
(10,000 rpm, 10 min, 4°C). The pellet was resuspended in ice-cold Na-citrate (1 ml, 
0.02 M) and kept on ice for 2 hours. The cells were then spread onto LK agar plates 
in 100 td aliquots and incubated at 37 °C for 2-3 hours until a sheen of growth could 
be seen. The plates were then overlaid with LK top agar (5 ml) containing 30 µg/ml 
erythromycin and incubated for up to 2 days at 37 °C. Any resulting colonies were 
putative phage transductants. 
2.7 Transformation 
2.7.1 Preparation of competent E. coli cells (Hanahan et al.. 1991) 
A scoop of cells from a fresh overnight plate was inoculated into SOB medium (1 ml) 
and mixed by vortexing. Cells were inoculated into pre-warmed (37 °C) SOB 
medium (100 ml) in a 11 flask and incubated at 37 OC with shaking (150 rpm) until 
cell density reached OD0 0.5. The culture was chilled on ice for 15 minutes and 
cells pelleted by centrifugation (3,000 rpm, 15 min, 4 oC). The supernatant was 
removed and the pellet was resuspended in frozen storage buffer (FSB, 33 ml) by 
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vortexing. The cells were held on ice for 10-15 minutes and centrifuged and drained 
as before. The pellet was resuspended in 1/12.5 of the original volume of FSB (8 ml) 
and DMSO (3.5 %) was added and the tube swirled for 5-10 seconds. The cells were 
stored on ice for 5 minutes, a second equal volume of DMSO was added, followed by 
further storage on ice for 10-15 minutes. Aliquots of cells (220 µl) were transferred 
to microfuge tubes and flash frozen using ethanol/dry ice. The tubes were either used 
immediately or stored at -70 °C. 
2.7.2 Transformation of E. coli strains DH5a or XLOLR 
A competent cell suspension (Hanahan et al., 1991) (200 µl) was transferred to a pre- 
chilled microcentrifuge tube and mixed with DNA (approximately 50 ng) in a volume 
of 20 µl. After 40 minutes storage on ice, the tube was transferred to 42 oC for 90 
seconds, and then immediately chilled on ice for 2 minutes. SOC (0.8 ml) was added 
to the cells, which were then incubated for 45 minutes at 37 oC to allow the 
expression of plasmid encoded antibiotic resistance markers. Dilutions of the 
transformed cells were plated on to LB agar containing ampicillin (50 gg/ml) and then 
incubated overnight at 37 °C until colonies were visible. 
2.7.3 Transformation of E. coli XL2-Blue MRF ultracomne tent 
cells (Stratagene) 
Ultracompetent cells were thawed on ice and gently mixed by hand. Cells were 
aliqubted (100 µl) into pre-chilled 20 ml sterile universals and ß-mercaptoethanol 
(Stratagene) (1.7 µl) added to givea final concentration of 25 mM. The contents Of 
the tube were mixed gently and held on ice for 10 minutes, swirling gently every 2 
minutes. DNA (50 ng) was added to the cells and swirled gently and the tubes were 
held on ice for 30 minutes. The tubes were heat shocked in a water bath at 42 oC. for 
30 seconds and then held on ice for 2 minutes. Preheated (42 0C) NZY broth (0.9 ml) 
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was added to the tubes and they were then incubated at 37 oC for 1 hour with shaking 
at 250 rpm. Transformed cells (200 µl aliquots) were plated onto LB agar containing 
ampicillin (50 µg/m1) and incubated overnight at 37 °C. 
2.7.4 Electroporation of S. aureus (Schenk and Ladag a. g 1992) 
2.7.4.1 Preparation of electro-competent cells 
Cells to be transformed (S. aureus strain RN4220) were grown overnight in B2 broth 
at 37 oC with shaking (250 rpm). An aliquot (1 ml) was used to inoculate 25 ml of 
fresh B2 broth and incubated at 37 °C, with shaking, until OD600 of 0.5 was reached. 
The culture was transferred to a sterile tube and centrifuged (5,000 rpm, 10 min, RT). 
The pellet was washed 3 times by resuspension and centrifugation (5,000 rpm, 10 
min, RT) with an equal volume (25 ml) of sterile H2O at RT, once in a fifth volume (5 
ml) of sterile glycerol (10 % v/v) and once in a one tenth volume (2.5 ml) of sterile 
glycerol (10 % v/v). Following final resuspension in 2.5 ml of sterile glycerol (10 % 
v/v), the cells were incubated at RT for 15 minutes without shaking. The cells were 
then harvested (5,000 rpm, 10 min, RT) and resuspended in glycerol (0.8 ml, 10 % 
v/v). Cells (70 µl) were then removed to a sterile microfuge tube containing dried 
DNA (1 µg) and mixed, or removed to a sterile microfuge tube, flash frozen and 
stored at -70 CC until required. 
2.7.4.2 Electroporation protocol 
For electroporation, 60 µl of each 70 µl aliquot with DNA was removed to a sterile 
electroporation cuvette (0.2 cm) and electroporated using a Gene Pulser (BioRad) at 
20 °C, 100 ohms resistance, 25 mF capacitance and 2.5 kV. Fresh B2 broth (1 ml) 
was added to the cuvette, mixed and transferred to a sterile universal. Erythromycin 
(0.05 gg/ml) was added, where appropriate, and cells were then incubated for 1 hour 
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at 37 °C to allow induction of antibiotic resistance. The cells were then plated in 100 
gl aliquots onto TSB agar containing appropriate antibiotics and incubated overnight 
at 37 °C. 
2.7.5 Transformation of S. aureus by protoplasting, (Novick. 1991) 
S. aureus strain RN4220 was inoculated into 2X BHI broth (50 ml) in an acid-washed 
Ehrlenmeyer flask (250 ml) and grown to mid-log phase (OD600 -2.5). The culture 
was then centrifuged (5,000 rpm, 10 min, RT), resuspended in 2X BHI (50 ml) and 
then centrifuged (5,000 rpm, 10 min, RT). The pellet was then resuspended in sterile 
SMM (10 ml). Lysostaphin was added (50 gg/ml) and the mixture was incubated for 
15-20 minutes at 37 °C without shaking. The protoplasts were centrifuged (1,200 
rpm, 7 min, RT) and resuspended in sterile SMM (5 ml). DNA (10 gg in 0.25 ml TE) 
was added to 2X SMM (0.25 ml) in a sterile universal and then the protoplasts (0.5 
ml) were added. PEG 8000 (1.5 ml, 40 % w/v) was added immediately and mixed by 
gentle inversion. After 2 minutes, SMMP (5 ml) was added and protoplasts were 
collected by centrifugation (1,200 rpm, 7 min, RT). The pellet was resuspended in 
SMMP (1 ml) containing chloramphenicol (0.15 µg/ml), where appropriate, and 
incubated at 32 °C with gentle shaking (100 rpm) for 2-3 hours. Aliquots (100 µl) 
were then plated onto DM3 agar containing appropriate antibiotics and incubated for 
up to 5 days at 37 oC. 
2.8 DNA purification techniques 
2.8.1 Small scale plasmid preparation from P. coli 
Plasmid-bearing cells were grown overnight at 37 oC in 15 ml LB containing 
ampicillin (50 pg/ml), inoculated from a single colony. The culture was then 
centrifuged (3,000 rpm, 10 min, RT) and the cells were resuspended in 100 gl of 
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plasmid preparation solution I in a microcentrifuge tube. Lysozyme (5 µl, 50. mg/ml 
in 10 mM Tris-HCl [pH 8]) was added, mixed briefly by vortexing and incubated at 
RT for 5 minutes. Plasmid preparation solution II (200 µl) was added, mixed by 
gentle inversion 5 times and incubated at RT for 5 minutes. Ice-cold plasmid 
preparation solution III (150 µl) was added and mixed thoroughly by inversion 5 
times to ensure dispersal of solution III through the lysate. Following storage on ice 
for 10 minutes, the white precipitated debris was pelleted by centrifugation (10,000 
rpm, 5 min, 4 oC), and the supernatant transferred to a fresh tube. The plasmid DNA 
was then precipitated by the addition of 100 % (v/v) ethanol (950 µl) and storage on 
ice for 2 minutes. The plasmid DNA was then pelleted by centrifugation (10,000 
rpm, 10 min, 4 °C). The supernatant was aspirated off and the pellet air dried and 
resuspended in TE (100 µl) containing RNase A (10 mg/ml). The plasmid DNA was 
incubated for 20 minutes at 37 °C and then cleaned using a Gene Clean kit (Anachem) 
(see 2.8.2). 
2.8.2 Gene Cleaning of plasmid DNA (Anachem) 
To plasmid DNA in a microfuge tube, Nal (3X volume, 6 M) was added, followed by 
10 µl glass milk suspension from the Gene Clean kit (Anachem). For purifying DNA 
from agarose gels, the agarose was dissolved in 3 volumes of the NaI stock solution 
(6 M) at 45-55 oC prior to addition of glass milk. The tube was stored on ice for 5 
minutes, mixing at 1 minute intervals and then centrifuged (10,000 rpm, 5 sec, RT). 
The supernatant was removed and the pellet washed 3 times in ice cold New Wash 
(Anachem) (0.5 ml), centrifuging between each wash (10,000 rpm, 5 sec, RT). After 
the final wash, TE was added (1-2X volume of glass milk used) and the tube heated at 
45-55 °C for 3 minutes. The glass milk was pelleted (10,000 rpm, 30 sec, RT) and the 
supernatant, containing purified plasmid DNA, was transferred to a clean tube. 
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2.8.3* Large scale plasmid preparation from E. coli (or S. aureus) 
Plasmid-containing cells were grown overnight at 37 oC, with shaking (250 rpm) in 
LB broth (or BHI for S. aureus) (500 ml) containing appropriate antibiotic and were 
harvested by centrifugation (10,000 rpm, 2 min, RT). The pelleted cells were 
resuspended in plasmid preparation solution I (18 ml). Freshly prepared lysozyme 
(0.4 ml, 50 mg/ml), (and lysostaphin (180 µl, 5 mg/ml) for S. aureus) was added and 
mixed briefly by vortexing. The preparation was incubated at RT for 10 minutes for 
E. coli (or at 37°C for 30 minutes for S. aureus). Freshly prepared plasmid 
preparation solution II (40 ml) was added, mixed thoroughly by gentle inversion 5 
times and then incubated at RT for 5 minutes. Plasmid preparation solution III (20 
ml) was added and the contents mixed by shaking several times. Following storage 
on ice for 10 minutes, the white precipitated debris was pelleted by centrifugation 
(4,000 rpm, 15 min, 4 oC). The supernatant was then filtered into a fresh tube through 
4 layers of cheesecloth. The plasmid DNA was precipitated by the addition of 
isopropanol (0.6 volume), and stored at RT for 10 minutes. The plasmid DNA was 
pelleted by centrifugation (5,000 rpm, 15 min, RT). The pellet was then rinsed with 
70 % (v/v) ethanol (5 ml) at RT and, following removal of ethanol, air dried and 
dissolved in 1 ml TE (pH 8.0) and split between 3 minifuge tubes. The plasmid DNA 
was then purified by precipitation with polyethylene glycol (PEG). 
2.8.4 Polyethylene Glycol (PEG) purification of DNA 
To plasmid DNA in a volume of 0.3 ml TE, half volume of ice cold LiCl (150 µl, 10 
M) was added. The samples were mixed well and, after centrifugation (10,000 rpm, 
10 min, 4 oC), supernatants were transferred to fresh microcentrifuge tubes. An equal 
volume of isopropanol was added and the DNA pelleted (10,000 rpm, 10 min, RT). 
The supernatant was discarded and the pellets washed with 70 % (v/v) ethanol at RT. 
The pellets were air dried and subsequently' combined into one microfuge tube, 
57 
dissolved in TE (0.5 ml) containing DNase-free RNase (10 mg/ml). The tube was 
then stored at RT for 30 minutes. NaCl (1.6 M) containing 13 % (w/v) PEG 8000 
(0.5 ml) was added and the solution mixed well. The plasmid DNA was recovered by 
centrifugation (12,000 rpm, 5 min, 4, C). The supernatant was aspirated and the 
pellet dissolved in TE (pH 8.0) (0.4 ml). The solution was extracted once with 
phenol, once with phenol/chloroform and once with chloroform (see section 2.8.5). 
2.8.5 Phenol/chloroform purification of DNA 
To DNA in TE, an equal volume of phenol was added and, after mixing by vortexing, 
was centrifuged (10,000 rpm, 10 min, RT). The mixture separated into an upper layer 
of aqueous DNA and a lower layer of phenol. The aqueous layer, containing plasmid 
DNA, was removed to a clean microfuge tube and one half volume of phenol and one 
half volume of chloroform/isoamylalcohol (24: 1) was added. After mixing by 
vortexing and centrifugation (12,000 rpm, 5 min, RT) the upper aqueous layer was 
again removed to a new microcentrifuge tube containing an equal volume of 
chloroform/isoamylalcohol and mixed gently. After centrifugation (12,000 rpm, 2 
min, RT) the top aqueous layer was removed to a fresh tube and the DNA 
precipitated with ethanol (see 2.8.6). 
2.8.6 Ethanol precipitation of DNA 
DNA was precipitated by the addition of 0.1 volume of 3M sodium acetate (adjusted 
to pH 4.6 with acetic acid), and 2-3 volumes of ice-cold absolute ethanol. The 
precipitated DNA was pelleted by centrifugation (10,000 rpm, 15 min, 4 oC), and the 
pellet was washed with ice-cold ethanol (70 % v/v). The supernatant was removed, 
the pellet air dried and then dissolved in TE. 
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2.8.7. Chromosomal DNA preparation 
Chromosomal DNA was isolated and purified using a QIAGEN 100/G kit according 
to the manufacturer's instructions, as follows. The S. aureus strain of interest was 
inoculated into 10 ml of TSB from a single colony and incubated overnight at 37 oC 
with shaking (250 rpm). The cells were pelleted (3,000 rpm, 10 min, RT) and 
resuspended in 3.5 ml of buffer 1 (QIAGEN) containing 200 gg/ml RNase A. After 
vigorous vortexing, lysostaphin (30 µl, 5 mg/ml) and pronase (100 µl, 20 mg/ml) were 
added and incubated for 30 minutes at 37 oC. To the clear suspension, buffer 2 
(QIAGEN) (1.2 ml) was added and briefly vortexed. The tube was then incubated at 
50 oC for 30 minutes. 
The cell lysate was applied to a QIAGEN 100/G tip equilibrated with buffer QBT 
(QIAGEN) (4 ml). Once the flow had stopped the tip was washed twice with buffer 
QC (QIAGEN) (7.5 ml). The genomic DNA was eluted into a sterile 50 ml tube by 
adding 5 ml of buffer QF (QIAGEN). 
Genomic DNA was precipitated by adding 3.5 ml of isopropanol and inverting the 
tube 20 times and then pelleted (5,000 rpm, 10 min, RT) and washed with 70 % (v/v) 
ice-cold ethanol. The supernatant was discarded and the pellet dried in a vacuum 
desiccator. The DNA was dissolved in 250 µl TE. 
2.9 In vitro DNA manipulation techniques 
2.9.1 DNA ligation 
All ligations were incubated at 14 oC overnight except for blunt-end ligations which 
were incubated at 4 °C for 48 hours. 
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2.9.1.1 Standard DNA ligation 
To linearised plasmid vector DNA in TE buffer, DNA insert was added to a ratio of 
1: 3. Sterile distilled H2O was added up to 8 µl and then T4 DNA ligase buffer (1 µl, 
10X) and 3 Weiss units (1 µl) of T4 DNA ligase were added. 
2.9.1.2 Self-ligation of Tn917 and flanking chromosomal DNA 
To 250 µl of digested DNA (1 µg) in TE buffer, 30 µl of lOX ligase buffer and 3 
Weiss units (1 µl) of T4 DNA ligase were added. The solution was then made up to 
300 µl with sterile distilled water and incubated overnight at 14 oC. 
2.9.2 Agarose gel electrophoresis 
DNA fragments were separated by horizontal gel electrophoresis using a Horizon 11- 
14 gel electrophoresis tank (Gibco BRL). An agarose gel (0.8 % w/v in 100 ml TBE) 
containing 0.2 mg/ml ethidium bromide, was submerged in TBE buffer (500 ml). 
DNA samples were mixed with one tenth their volume of lOX DNA loading buffer 
and loaded into wells in the gel. The gel was run at 100 V for approximately 1 hour 
(the exact time depending on the sizes of the fragments to be separated), and 
visualised by means of a U. V. transilluminator (2UV, UVP). DNA fragment sizes 
were estimated using 1 gg X DNA digested with either HindIII or double digested 
with HindIIUEcoRI, as size standards (Table 2.4). The sizes of known fragments 
(kilobase pairs) were plotted on a logarithmic scale against mobility Of fragments 
(mm) on a linear scale. A bestfit curve was drawn by eye and this curve was used to ' 
determine the size (in kb) of the DNA fragments in the experimental tracks. 
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Fragment sizes of digested ? (bp) 
Hindill HindIIIIEcoRI 
23130 21226 
9416 5148 
6557 4973 
4361 4268 
2322 3530 
2027 2027 
564 1904 
125 1584 
1375 
947 
831 
564 
125 
TABLE 2.4 
Sizes of resulting fragments following digestion of a. DNA with Hind II or 
Hindi IIEcoRI. 
61 
2.9.3 Pulsed field gel electrophoresis (Pattee et al.. 1990) 
2.9.3.1 Preparation of samples 
The S. aureus strain of interest was inoculated into 10 ml of TSB from a single 
colony and incubated overnight at 37 °C with shaking (250 rpm). The culture was 
used to inoculate (OD600 0.05) fresh TSB which was then incubated at 37 °C with 
shaking (250 rpm) until the OD6W reached 0.8. Chloramphenicol (180 µg/ml) was 
then added and the culture incubated for a further 10 minutes. Cells (2 x 108 cfu - 
approximately 0.5 ml at OD600 1.0 (see section 3.2.3) per plug) were pelleted (10,000 
rpm, 3 min, RT) and resuspended, in one half of the total volume of plugs to be 
made, of cell suspension buffer. The cell suspension was equilibrated to 50 0C, and 
lysostaphin was added to a final concentration of 100 µg/ml. An equal volume of 2% 
(w/v) CleanCut agarose (Sigma) in sterile H2O (equilibrated to 50 oC) was 
immediately added and mixed. The cell suspension was then aliquoted into plug 
moulds and allowed to solidify at 4 oC for 15 minutes. The set plugs were transferred 
to 50 ml tubes containing lysis buffer (5 ml) and incubated for 1 hour at 37 oC without 
shaking. The lysis buffer was removed and the plugs were rinsed with wash buffer 
(25 ml) and incubated at 50 oC overnight without shaking in Proteinase K Reaction 
Buffer (5 ml). The plugs were subsequently washed 4 times in 50 ml of wash buffer 
for 30 minutes at RT with gentle shaking. In the second and third washes PMSF 
(phenylmethylsulphonyl fluoride) was added to 1 mM. Plugs were either stored in 
wash buffer at 4 oC, or processed. 
2.9.3.2 Restriction digestion of DNA in situ 
The plugs were washed in 50 ml TE for 30 minutes and transferred to individual 
microcentrifuge tubes containing 1 ml of appropriate 1X restriction enzyme buffer. 
After incubation for 1 hour with gentle shaking the buffer was removed and 0.3 ml of 
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fresh 1X restriction buffer added. 50 units of SmaI were added and the plugs were 
incubated overnight at 30 oC. After digestion the buffer was removed and the plugs 
were washed in 1 ml of wash buffer for 30 minutes with gentle shaking. The plugs 
were loaded into either, the wells of Clamped Homogenous Electric Field (CHEF), 
or Field Inversion Gel Electrophoresis (FIGE) gels. 
2.9.3.3 Separation of DNA by PFGE 
DNA fragments were separated by using a CHEF-DR II system (BioRad) and a 
FILE Mapper system (BioRad). A 1.0 % (w/v) agarose CHEF or FILE gel was 
submerged in 0.5X TBE electrophoresis buffer. The CHEF gel was run at 6V cm-1 
for approximately 22 hours at 14 oC with 10-50 second switching times. The FIGE 
gel was run at RT for 16 hours. The forward and reverse voltages were 180 and 120 
respectively. The switch time ramps were 0.1-0.4 seconds and were linear in shape. 
All gels were washed in 0.5 mg/ml ethidium bromide in water to stain the DNA and 
visualised by means of a UV transilluminator (2UV, UVP). The sizes of DNA 
fragments were estimated using aX ladder (BioRad, 50-1000 kb), Saccharomyces 
cerevisiae DNA size standards (BioRad, 240-2200 kb) and DNA size standards of 8- 
48 kb (BioRad) (Table 2.5). The sizes (kilobase pairs) of known fragments were 
plotted on a logarithmic scale against mobility (mm) of fragments on a linear scale. 
A best fit curve was drawn by eye and this curve was used to determine the size (in 
kb) of the DNA fragments in the experimental tracks. 
2.9.4 Gel photography 
A permanent record of agarose gels was obtained by photographing the ethidium 
bromide stained gels illuminated with incident UV light. A Kodak 203 red-orange 
filter and Polaroid 667 (ASA 3000) film were used. 
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Size standards (kb) 
Saccharomyces cerevisiae Lambda ladder 8-48 kb size standards 
chromosomal fragments 
2200 970.0 48.5 
1600 921.5 38.4 
1125 873.0 35.5 
1020 824.5 29.9 
945 776.0 24.8 
825 727.5 22.6 
785 679.0 19.4 
750 630.5 17.1 
680 582.0 15.6 
610 533.5 12.2 
565 485.0 10.1 
450 436.5 8.6 
365 388.0 8.3 
285 339.5 
225 291.0 
242.5 
194.0 
145.4 
97.0 
48.5 
TABLE 2.5 
The sizes of standards used as size markers for pulsed field gel electrophoresis. 
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2.10 Quantification of DNA (Sambrook et al., 1989) 
Spectroscopic measurements at 260 nm were used to determine the concentration of 
DNA solutions. An absorbance of 1 corresponds to approximately 50 µg/ml for 
double stranded DNA. The concentration of DNA could be estimated independently 
by agarose gel electrophoresis, comparing the intensity of the ethidium bromide 
stained bands to bands containing known amounts of DNA. 
2.11 DNA hybridisation techniques 
2.11.1 Labelling of DNA probes with Digoxigenin 
The commercially available Digoxigenin (DIG) DNA labelling and detection kit from 
Boehringer Mannheim was used to generate DNA probes for hybridisation by a 
random priming labelling method. The DNA template (approximately 3 µg in 10 µl 
TE) was heat denatured in a boiling water bath for 10 minutes and immediately 
cooled in dry ice/ethanol for 30 seconds. To this denatured DNA, 2 µl each of lOX 
concentrated hexanucleotide mixture and lOX dNTP labelling mixture (comprising 
dATP, lmmol/l; dCTP, 1 mmol/l; dGTP, 1 mmol/l; Dig-dUTP, 0.35 mmol/1) (both 
supplied with the kit) were added. Klenow enzyme (1 µl of 2 U/µl stock), labelling 
grade, was added, and the volume of the reaction was made up to 20 µl with distilled 
water. The reaction was incubated overnight at 37 OC, and then the labelled DNA 
was purified using a Gene Clean kit (Anachem) (see section 2.7.1.1) and resuspended 
in 50 µl TE. 
Just prior to use, the probe was denatured by placing the tube in a boiling water bath 
for 10 minutes followed by immediate chilling on ice. 
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2.11.2 . Southern blotting 
Agarose gel electrophoresis was performed as described in section 2.9.2, and the gel 
was photographed prior to Southern blotting analysis. For all of the hybridisations 
described below, unless otherwise stated, Amersham Hybond-N+ extra (positively 
charged nylon membrane) was used. Prior to use, the membrane was cut to the same 
dimensions as the gel to be blotted. 
2.11.2.1 Transfer of DNA from an agarose gel - using a vacuum blotter 
(Appligene) 
Appropriately sized nylon membrane was placed on the vacuum blotter as per the 
manufacturer's instructions (Appligene). The membrane was wetted with distilled 
water and the gel placed on top and the vacuum blotter switched on to give a vacuum 
of approximately 50 mBar. Sufficient HCl (0.25 M) to cover the surface of the gel 
was added and left for 10 minutes. Excess HCl which remained on the surface of the 
gel was removed and denaturing solution was then added to the surface of the gel and 
left for 10 minutes. Following removal of any denaturing solution which remained on 
the surface of the gel, neutralising solution was added to the top of the gel and left for 
10 minutes. Any neutralising solution which remained on the gel was removed and 
replaced by lOX SSC and the gel left for 30 minutes. The vacuum was then turned 
off, the gel discarded and the membrane was stored (DNA-side up) on clean filter 
paper to air dry for approximately 15-30 minutes. The DNA was either, fixed to the 
membrane by baking in an oven at 80 oC for 2 hours, or fixed to the membrane by 
U. V. crosslinking (Amersham) (700 mJ, 15 sec). 
2.11.2.2 Colony blotting 
Colonies for screening were patched in duplicate onto LB agar plates containing 
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ampicillin and grown overnight at 37 °C. One plate was then stored at 4 OC as a stock 
plate and the other was used for colony blotting. 
Filter paper (Whatman 3MM) was cut into four pieces, each approximately 1 foot 
square, and placed on individual flat plastic trays. Each of the four pieces was 
saturated with either, SDS (10 % w/v), denaturing solution, neutralising solution, or 
2X SSC and any excess liquid removed. Round nitrocellulose (RN) filters 
(Whatman) were laid, briefly, on top of each agar plate so that each colony adhered to 
the RN filter. The RN filters were then removed from each plate and placed, colony 
side up, on top of the SDS impregnated filter paper and left for 3 minutes. Each RN 
filter was then removed and laid, briefly (10 sec), colony side up, on a clean paper 
towel to dry away any remaining SDS. Each RN filter was then laid onto the filter 
paper containing denaturing solution and left for 5 minutes. Following drying as 
described above, the RN filters were laid on the filter paper containing neutralising 
solution and left for 5 minutes. Following drying as described, each RN filter was 
then laid on the 2X SSC-impregnated filter paper and left for 5 minutes. The RN 
filters were then dried on paper towels for at least 30 minutes at RT and then baked at 
80 oC, in vacuo, for 2 hours to fix the DNA to the membrane. The impregnated 
square sheets of filter paper were discarded. 
The RN filters were then floated on the surface of 2X SSC until wetted from beneath 
and then submerged for 5 minutes. These filters were then transferred to a container 
of prewashing solution (200 ml of 5X SSC, SDS (0.5 % w/v) and EDTA (1 mM)), 
covered and incubated at 50 OC for 30 minutes. Any bacterial debris remaining on 
the surface of a filter was then removed gently by scraping with wet paper towels and 
the filters were processed as for a standard Southern blot (see section 2.11.3). 
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2.11.3 Prehybridisation and hybridisation 
Membranes to be probed with the DIG-labelled DNA were prehybridised for 1 hour 
at 68 ,C in prehybridisation solution (20 ml per 100 cm2 of membrane) in a 
hybridisation oven (Stuart Scientific). The membranes were then hybridised with the 
labelled probe overnight at 68 °C. The concentration of the probe used was 5-25 
ng/ml, diluted in prehybridisation fluid. Unbound probe was removed by washing the 
membranes twice in 2X SSC containing SDS (0.1 % w/v) for 5 minutes at RT and 
then washing twice in SSC (0.1 %) containing SDS (0.1 % w/v) for 15 minutes at 68 
oC in a hybridisation oven (Stuart Scientific). 
2.11.4 Detection of DIG-labelled DNA 
The hybridised and washed membranes were equilibrated with buffer 1 for 1 minute, 
and then blocked for 30 minutes with gentle rocking in buffer 2. The membranes 
were then transferred to buffer 1 containing a 1: 5,000 dilution of Anti-DIG-alkaline 
phosphatase antibody (Boehringer Mannheim DNA labelling and detection kit) and 
incubated for 30 minutes with gentle rocking. The membranes were then washed 
twice with buffer 1 for 15 minutes with gentle rocking and then equilibrated in buffer 
3. The membranes were transferred to buffer 3 (15 ml) containing 66 µl of nitroblue 
tetrazolium (NBT) (50 pg/ml in 70 % (v/v) dimethylformamide) and 33 of µl bromo- 
4-chloro-3-indolyl-phosphate (BCIP) (50 gg/ml in water) and incubated in the dark, 
without shaking, until a purple precipitate formed at the labelled DNA. The reaction 
was stopped by washing the filters in buffer 4. 
2.12 Assays 
2.12.1 Galactosidase assay 
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2.12.1.1 Using 4-methylumbelliferone-( a1g actopyranoside (MUG) as the 
substrate (Youngman. 1990) 
Samples (0.5 ml) of cultures of interest were pelleted (10,000 rpm, 5 min, RT) in a 
microcentrifuge tube. The supernatant was discarded and the pellet resuspended in 
AB buffer (0.5 ml) containing DNase (100 ng/ml) and lysostaphin (25 µg/ml). An 
aliquot (50 µl) was removed from each sample and added to 5 41 of MUG solution 
(0.4 mg/ml in dimethyl sulphoxide). After incubation for 100 minutes at RT, an 
aliquot of the sample (sufficient to achieve a measurable fluorescence) was added to 
Na2CO3 (2.5 ml, 0.2 M) in a fluorimeter cuvette. A calibration curve of the 
fluorescent product, 4-MU (4-methyl umbelliferone, 1 mm) was created with final 
concentrations of 0,10,20,50,100,150, and 200 nM in Na2CO3. Fluorescence was 
measured using a fluorimeter (Hoefer DynaQuant 200). For each sample the 
concentration of 4-MU was related to ß-galactosidase activity, using the following 
equation. 
pmol MUG = MUG units of ß-galactosidase activity 
VxTxOD600 
where V= volume of culture used (ml), T= time of assay (100 min) and OD6W 
reflects the cell density at the time the sample was removed from the culture. 1 MUG 
unit of ß-Galactosidase activity is defined as the activity that hydrolyses 1 pmol of 
MUG per min per ml per OD600 to 4-MU. 
2.12.1.2 Using o-nitrophenyl alg actopyranoside (ONPG) as the substrate 
Cells were grown to the required ODD and 1 ml samples were transferred to 
microcentrifuge tubes and immediately placed on ice. A suitable aliquot (starting 
with 100 µl) of each sample was transferred to a test tube and made up to 1 ml in 'Z' 
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buffer. Chloroform (100 µl) and SDS (40 µl, 0.1 % w/v) were added to lyre the cells 
and the samples vortexed for 10 seconds. The tubes were transferred to a water bath 
at 28 °C for 5 minutes. The reaction was started by adding freshly prepared ONPG 
(200 µl of 4 mg/ml in'Z' buffer) and the tubes were shaken for a few seconds. The 
tubes were held at 28 °C for 15 minutes and the reaction was stopped by the addition 
of Na2CO3 (0.5 ml, 1 M). Approximately 1.2 ml of each reaction mix was transferred 
to a fresh microfuge tube and centrifuged (10,000 rpm, 1 min, RT) to remove cell 
debris. The supernatant (1 ml) from each sample was decanted to a1 ml 
spectrophotometric cuvette and the OD420 determined. An OD420 reading of 0.6-0.9 
was required and assays were repeated as necessary, varying the amount of cell 
culture used. Units of ß-galactosidase activity were calculated in Miller units (Miller, 
1972) and are proportional to the increase in o-nitrophenol per minute per bacterium. 
OD420 x 1000 
VxTxOD600 
= Miller units (MU) 
where V= volume of culture used (in ml), T= time of the reaction (in minutes) and 
the ODD reflects the cell density at the time the sample was removed from the 
culture. 
2.12.2 cc-haemolysin assay 
Cells were grown to the required OD600 and 1 ml of culture was removed to a sterile 
microfuge tube and centrifuged (7,000 rpm, 2 min, RT). The supernatant was 
transferred to a fresh tube and either assayed immediately or stored at -20 oC. A 
suitable aliquot of the supernatant was transferred to a fresh microfuge tube (the 
amount assayed depended on the activity expected but generally the assay was started 
with a 100 µl sample). Each sample was made up to 1 ml with HA buffer and mixed 
by gentle inversion. Defibrinated rabbit blood (TCS Biologicals) (20 µl) was added, 
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mixed gently and the samples were incubated for 15 minutes at 37 oC. The tubes 
were then centrifuged (7,000 rpm, 30 sec, RT) and the supernatant was transferred to 
1 ml spectrophotometric cuvettes. The OD543 of each sample was read against a 
blank of HA buffer containing 20 µl rabbit blood, treated as above. An OD543 of 0.5- 
0.7 was optimum and the amount of sample used was adjusted, if required, to achieve 
this. Haemolysin units (HU) were calculated using the following equation: 
OD543 x 1000 = Haemolysin units (HU) 
VxTxODbpp 
where V= volume of culture used (ml), T= length of assay (min) and OD6oo reflects 
the cell density at the time the sample was removed from the culture. 
2.13 Transposon mutagenesis 
2.13.1 Transposon mutagenesis using n551 
Following transformation of the strain to be mutagenised (SH106) with plasmid 
(pRN3208), the strain was grown overnight at 30 °C in BHI (100 ml) containing Cm 
and CdC12. This overnight culture was used to inoculate BHI (100 ml) containing Cm 
and CdC12, to OD6M 0.05 and grown, at 30 OC, until the ODD reached 1.5 with 
shaking at 250 rpm. An aliquot of the culture (3 ml) was removed, centrifuged (3,000 
rpm, 10 min, RT) and resuspended in pre-warmed (43 °C) TSB (100 ml) containing 
erythromycin. This culture was maintained at 43 °C, with shaking at 250 rpm, and 
grown until the ODD reached 0.4-2.0. An aliquot (3 ml) was then removed to fresh 
pre-warmed (43 °C) TSB (100 ml) containing erythromycin and grown at 43 °C, with 
shaking, until the ODD reached 1.5. The culture was then centrifuged (8,000 rpm, 
10 min, RT), resuspended in 4 ml of BHI containing glycerol (10 % v/v) and flash 
frozen in ethanol-dry ice in 0.5 ml aliquots and stored at -20 °C until required. One 
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sample was immediately defrosted and used to determine the efficiency of 
transposition and purity of the library (see section 4.2.2). 
2.14 Cloning of chromosomal DNA flanking a transposon 
2.14.1 Cloning chromosomal DNA flanking Tn551 
This procedure is described in section 4.2.8. 
2.14.2 Cloning chromosomal DNA flanking TOP 
Chromosomal DNA (2-5 µg) of each transposon mutant was digested in a total 
volume of 20 µl with either EcoRI or XbaI, overnight at 37 -C. The digested DNA 
was cleaned by phenol/chloroform extraction and resuspended in TE (250 µl). The 
DNA was then self-ligated (see section 2.9.1.2) overnight and, following ethanol 
precipitation, resuspended in TE (20 µl). Circularised DNA was transformed into E. 
coli XLOLR or DH5a, selecting for ampicillin resistance. Only the fragment of DNA 
containing pLTV 1 can be transformed and maintained in E. coli so that any ampicillin 
resistant colonies should contain recircularised Tn917 plus some flanking 
chromosomal DNA. 
2.15 Polymerase Chain Reaction (PCR) 
PCR reactions were carried out in an Eppendorf 5330 Mastercycler using the 
following constituents in PCR reaction tubes. 
Template DNA 1 µg 
Primer (Forward) 100 pmoles 
Primer (Reverse) 100 pmoles 
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Reaction buffer (10X) 10111 
MgC12 3 mM 
dNTPs (1 mM stock) 10µl 
Taq polymerase (2.5U) 1 µl 
Distilled H2O to 100 µl 
Samples were equilibrated to 95 oC for 3 minutes to ensure DNA had melted and then 
the PCR reaction was performed using the cycle; heating to 95 oC for 1 minute to 
melt the DNA, cooling to 55 oC for 1 minute to anneal primers and template DNA 
and then heating to 72 oC for 2 minutes to allow extension of DNA. This cycle was 
repeated 30 times before the samples were cooled to, and then held at, 12 0C until 
required. 
2.16 Automated sequencing 
The sequencing reactions were performed using the Taq DyeDeoxy Terminator cycle 
sequencing kit supplied by Applied Biosystems. Plasmid DNA for sequencing was 
prepared by the large scale plasmid preparation method. A polymerase chain reaction 
(PCR) was carried out using 8 ttl of the Terminator ready reaction mix, 1 gg template 
DNA and 3.2 pmol sequencing primer, and the volume made up to 20 0 with distilled 
Hz0. 
The PCR reactions were performed in an Eppendorf 5330 Mastercycler. This was 
preheated to 96 oC, and then, once the tubes were inserted, a 25 cycle program was 
started. Each cycle consisted of a rapid thermal ramp to 96 OC which was held for 30 
seconds, a rapid thermal ramp to 50 0C for 15 seconds, and finally a rapid thermal 
ramp to 60 oC for 4 minutes. At the end of the cycles the tubes were ramped to 4 oC 
and held at that temperature until required. 
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The reaction products were precipitated by transferring the reaction to a clean tube 
containing 2 gl sodium acetate (3 M pH 4.6) and 50 µl 95 % (v/v) ethanol. The 
reaction products were pelleted by centrifugation (14,000 rpm, 30 min, RT), washed 
with 70 % (v/v) ethanol and dried in a vacuum dessicator. Samples were loaded onto 
an Applied Biosystems 373A DNA sequencer according to the manufacturer's 
instructions. 
2.17 Sequence analysis 
Automated sequence data from the ABI 373A DNA sequencer was edited and 
analysed using the FASTA program. The database library was accessed via the 
Genetics Computer Group at the Daresbury laboratory, Warrington, England. 
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CHAPTER 3 
Analysis of the role of environmental and physiological 
factors in the regulation of agr expression and activity 
7s 
3.1 Introduction 
Expression of virulence determinants in S. aureus is affected by many environmental 
conditions but how these stimuli are transduced is at present unknown. pH and glucose 
have been shown to affect agr expression (Regassa et al., 1992) but it is unclear whether 
this occurs directly or via other components. a-haemolysin is a virulence determinant 
whose expression is positively regulated by agr, via RNAIII, but it is also subject to 
control in other, as yet unidentified, ways. For example, it has been shown that a- 
haemolysin production is controlled temporally, occurring at the post-exponential phase 
of growth in batch culture (Vandenesch et al., 1991). Expression of a-haemolysin 
usually occurs two hours after RNAIII production, which becomes evident during mid- 
exponential growth. Experiments extending the exponential growth phase following 
induction of RNAIH demonstrated that a-haemolysin expression does not necessarily 
occur two hours after induction of RNAIII but, rather, at the beginning of post- 
exponential phase (which was some 4.5 hours later) (Vandenesch et al., 1991). 
Regulation of virulence determinant expression is thus likely to be a complex response to 
multiple overlapping stimuli. In order to understand more of the regulatory hierarchy it is 
essential to know which stimuli are transduced via agr. 
Other workers have measured the effect of environmental conditions on agr expression 
using Northern blots to measure RNA levels. Whilst this method is useful, it is complex, 
time consuming and can only measure RNA levels at a precise time point. A more 
simple assay was therefore needed so that the effects of multiple environmental and 
physiological conditions on agr expression could be examined. This has been achieved 
by the creation of a chromosomal transcriptional reporter gene fusion between hid, which 
measures expression of RNAIH from the P3 promoter (see Fig. 1.2), and lacZ. 
The variety of reporter gene fusions available and the way in which they work is 
discussed in section 1.9 but, briefly, transcriptional reporter gene fusions work by 
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inserting promoterless genes encoding a measurable gene product downstream of a 
promoter of interest. This means that, when the promoter is transcriptionally active, the 
reporter gene is transcribed and the resulting gene product can be assayed to give a 
quantitative measure of promoter activity. Of the many reporter gene systems available, 
the lac system is probably the most widely used and, as mentioned, is the system used in 
this work. 
A variety of directed reporter gene fusions have been developed in S. aureus in other 
laboratories but have mostly been plasmid based. For example, as detailed in section 1.9, 
the staphylococcal ß-lactamase gene (blaZ) has been used to create plasmid based 
transcriptional fusions to each of the three promoters of the agr locus in order to study 
their expression (Kornblum et al., 1990). The luciferase reporter system which was used 
in S. aureus to study the expression of TSST-1 was also plasmid based (Timmins et al., 
1995). Regulation of the epidermolytic toxin A (eta) gene of S. aureus has been 
examined by simultaneous use of two plasmid based fusions (Sheehan et al., 1992). 
These two fusions used the luciferase (luxAB) genes of Vibriofischeri or the catechol 
2,3-dioxygenase (xylE) gene from Pseudomonas putida as the reporter. Although the eta- 
luxAB fusion provided a measure of real-time changes in promoter activity it was not 
usable into stationary phase, during which time the eta-xylE fusion became necessary 
(Sheehan et al., 1992). Plasmid fusions suffer from several drawbacks, for example 
strains need to be maintained and grown in media containing appropriate antibiotics to 
ensure the plasmid is not lost. In addition, titration of regulatory elements can occur. A 
chromosomal reporter gene fusion was used in S. aureus to determine the expression of 
the major autolysin gene of S. aureus, ad (Foster, 1995). This involved the use of a 
suicide vector, pAZ106 (Kemp et al., 1991) (Fig. 3.1) which, lacking a replicon 
functional in S. aureus, can only confer antibiotic marker resistance by means of 
integration into the chromosome. This method avoided problems associated with multi- 
copy plasmids, but, in this case, resulted in insertional inactivation of the atl gene. 
77 
FIGURE 3.1 
Map of pAZ106 (Kemp et al., 1991). This plasmid contains an ampicillin resistance gene . (bla), an Em resistance gene (erin) and a promoterless lacZ gene. The restriction sites 
denoted are: Ba, BämHI; E, EcoRI; Ec, EcoRV; Sm, Smal; X, XbaI. 
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The reporter fusion created in this work has also been produced using the lacZ gene of 
pAZ106 (Fig. 3.1) but without causing insertional inactivation of any part of agr. This 
method provided a stable construct and allowed a convenient assay for expression of 
RNAIII by monitoring ß-galactosidase levels. Simultaneous measurement of a- 
haemolysin activity has allowed the identification of conditions which not only affect agr 
expression but also the expression of a virulence determinant under the positive 
transcriptional control of agr. 
79. 
3.2 Results 
3.2.1 Construction and verification of hld:: lacZ fusion 
The first step in creating the hid:: lacZ transcriptional fusion was to isolate a 677 bp 
PstlJEcoRV fragment spanning the P3 promoter of the agr locus of S. aureus (see Fig. 
1.2). This fragment was introduced into the similarly digested, dephosphorylated pUBS 1 
(Foster, 1995), to give appropriate flanking restriction sites for further subcloning. This 
insert was isolated from this construct (pHF21) (Fig. 3.2) as a 701 bp Xbal/EcoRV 
fragment and then subcloned into the suicide vector pAZ 106 (Fig. 3.1) (digested with 
Xbal/SmaI) upstream of the promoterless lacZ gene in the orientation such that a 
transcriptional fusion between hid and lacZ was created (pHF23) (Fig. 3.2). pAZ 106 has 
no functional replicon in S. aureus and so, following transformation with pHF23, 
erythromycin (Em) resistant clones occurred only as a result of plasmid integration by a 
single crossover between the 677 bp fragment of agr in the plasmid and homologous 
chromosomal DNA (Fig. 3.3). Hence a transcriptional lacZ fusion was created whereby 
the lacZ reporter gene is under the control of the P3 promoter of agr, in addition to an 
intact copy of agr (Fig. 3.3). S. aureus RN4220 was used as the host strain as it is able to 
accept foreign DNA. RN4220 containing integrated pHF23, designated SH100, had blue 
colonies when grown on BHI-erythromycin plates containing X-Gal, indicating ß- 
galactosidase activity, whereas the parental strain was white. Total genomic DNA from 
SH 100 was prepared and electroporated (Schenk and Ladagga, 1992) (1 µg) into S. 
aureus strain 8325-4. An Em resistant clone was recovered and called SH101. 
Transformation with naked DNA resulted in a double crossover event allowing stable Em 
resistance to be maintained. 
The correct insertional event was confirmed by Southern blot analysis (Fig. 3.4). 
Chromosomal DNA from 8325-4 and SH101 was digested with EcoRV and resulting 
fragments were probed with a digoxygenin labelled 677 kb EcoRV/PstI fragment of agr, 
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(a) 
(b) 
XP 
FIGURE 3.2 
(a) pHF21 comprising pUBSI (Foster, 1995) containing the 677 hp Pstl/EcoRV fragment 
of agr, spanning P3 promoter, within the multiple cloning site (MCS). 
(b) pHF23 consisting of XballSmal digested pAZ106 (Kemp et al., 1991) containing the 
701 bp Xbal/EcoRV fragment isolated from pHF21. 
The restriction enzymes denoted are: Ec, EcoRV; P, Pstl; X, Xbal 
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Construction of the hld:: lacZ transcriptional reporter gene fusion strain, SH 101. The 
extent of the agr locus is indicated by the symbol, II. The hybridising bands indicated 
resulted from digesting chromosomal DNA of strains 8325-4 (same restriction pattern as 
RN4220) and SH101 with EcoRV and correspond to bands on the Southern blot (see Fig. 
3.4). The extent of the probe (double headed arrow), comprising the digoxygenin 
labelled 677 bp PstUEcoRV fragment of agr r-spanning the P3 promoter; is shown. The 
restriction sites denoted are Ec, EcoRV and P, PstI. (This figure is not to scale). 
82 
123 
(bp) 
21226 - 
5148 
4973 
4268 
3530 - 
2027 
1904 
1584 
1375 
FIGURE 3.4 
40M rrv 
Southern blot to confirm the construction of strain SH101. Lane 1 shows EcoRI/Hindlll 
digested X marker, with the sizes of the fragments (bp) indicated on the left. Lanes 2 and 
3 show hybridising fragments of EcoRV digested chromosomal DNA of strains 8325-4 
and SH 101, respectively, probed with the digoxygenin labelled 677 bp EcoRV/Pstl 
fragment of agr. (The arrow on the right indicates a band in lane 3 which was apparent 
on the original Southern blot but has not reproduced well on the scanned image shown). 
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spanning the P3 promoter (see Fig. 1.2). One band of approximately 4.2 kb of EcoRV 
digested chromosomal DNA of 8325-4 hybridised with the probe (Fig. 3.4), comprising 
the number of bases between the EcoRV sites at positions 1474 and 5646 of agr (Fig. 
1.2). As predicted, two fragments of approximately 5.2 and 8 kb of EcoRV digested 
chromosomal DNA from strain SH 101 hybridised with the probe, representing the 
additional 9 kb of pAZ106 plus the insert (Fig. 3.4). The derivation of these fragments is 
shown in Fig. 3.3. The integration is stable and does not need to be maintained by the 
presence of antibiotics. In addition, it is important to note that an intact copy of RNAIII 
remains in strain SH101 and that this strain grows identically to the wild type, producing 
a-haemolysin at a comparable level to its parent, approximately 150 haemolysin units 
(HU) (see section 2.12.2) following overnight growth at 37 0C. In order to investigate 
agr expression, via the hld:: lacZ reporter gene fusion, under different environmental and 
physiological conditions, ß-galactosidase production was measured and calculated in 
Miller units (MU) (see section 2.12.1). Strain 8325-4, which was used as a control in all 
the following experiments, was not blue on X-Gal plates and produced negligible 
amounts of ß-galactosidase (approximately 2 MU after overnight growth). 
3.2.2 Development of a standard experimental procedure 
The level of expression of hld:: lacZ was found to be very dependent on the growth 
conditions of the culture prior to inoculation into the experimental flask (100 ml BHI in a 
250 ml flask). For example, inoculating cultures from plates >1 day old led to reduced 
galactosidase production, falling from an average of 100 MU to 35 MU in cultures 
inoculated from plates 2 or 3 days old. Similarly, inoculating from plates into BHI and 
growing overnight often resulted in lower levels of ß-galactosidase (-. 100 MU) compared 
to cultures inoculated from a broth (-140 MU). Smaller volume cultures (25 ml) grown 
in 250 ml flasks shaking at 250 rpm also produced less ß-galactosidase, possibly due to 
an aeration effect (see section 3.3). The most consistent expression of ß-galactosidase 
was found to be obtained by inoculating BHI (100 ml) from an overnight plate, growing 
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the culture to exponential phase (ODD of 1-2) (see Fig. 3.5) and then inoculating test 
and control flasks (250 ml) containing BHI (100 ml) to an OD600 of 0.05. Since it 
appeared that increasing the length of exponential growth encouraged maximal hld:: lacZ 
expression these standard conditions were strictly adhered to. Each experiment was 
repeated between 3-6 times and all the values given below represent the mean obtained 
for each sample for the number of experiments stated. 
3.2.3 Viable counts 
Viable counts were taken of cells grown in 1X and 0.25X BHI to ensure that the final 
OD600 showed a relatively constant relationship to final cell numbers even when growth 
conditions were altered. There was found to be a good correlation between final cell 
numbers and OD600 following overnight growth in BHI at 1X and 0.25X concentrations, 
reaching 3.2 x 109 cfu/ml in 1X at an OD600 of 10 and 1.2 x 109 cfu/ml at an OD600 of 3.5 
in 0.25X. This is equivalent to 3.2 x 108 cfu/ml or 3.4 x 108 cfu/ml at an OD6oo of 1.0 in 
1X or 0.25X BHI, respectively. 
3.2.4 hld:: lacZ expression during growth 
Production of ß-galactosidase by SH101 reflects hld:: lacZ expression and hence RNAIII 
production and was monitored during growth using ONPG as the substrate (Fig. 3.5) (see 
section 2.12.1.2). The expression of hld:: IacZ was very low during exponential phase 
(<10 MU) but began to rise sharply 5 hours into growth at an OD600 of 5.2 which 
corresponds to the transition between exponential and stationary phase. Thereafter, ß- 
galactosidase levels continued to rise rapidly for 6-8 hours to approximately 160 MU 
before falling slightly and stabilising at 140 MU. It was possible that the apparent low 
levels of hld:: lacZ transcription during exponential phase were due to the insensitivity of 
the assay and so the more sensitive substrate MUG was used (Youngman, 1990) (see 
section 2.12.1.1). Using this method, expression became apparent up to 30 minutes 
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earlier than with ONPG but the expression profile was unchanged (results not shown). 
Typically, 18 hours was chosen as the standard time for comparative samples to be taken 
in later experiments. a-haemolysin activity became apparent approximately 2 hours after 
the onset of hld:: lacZ expression and increased sharply giving a final activity of 
approximately 150 haemolysin units (HU) (Fig. 3.5). 
3.2.5 Effect of growth medium 
Strain SH101 was initially grown in BHI, Tryptic Soy Broth (TSB) and a Chemically 
Defined Medium (CDM) (Hussein et al., 1991) to evaluate the effect of different media 
on final OD600 and hld:: lacZ expression. Cultures grown in BHI produced the highest 
levels of hld:: lacZ expression, reaching an average of 144 MU after 18 hours, whilst ß- 
galactosidase levels in cultures grown in TSB or CDM reached an average of 85 MU or 
<10 MU, respectively. a-haemolysin levels were similarly reduced in the different 
media. A similar trend in the final OD600 of cultures was observed with growth in BHI 
reaching an average OD600 of 10.0, in TSB an OD600 of 7.0 and in CDM an OD600 of 
3.5. These values represent the average of 3 independent experiments and varied by less 
than 11 %. 
To give an indication as to whether expression of hld:: lacZ was related to cell density, 
the effect of medium concentration was examined. Decreasing the concentration of BHI 
to 0.5X and 0.25X normal strength (37 g/1) resulted in a marked reduction in ß- 
galactosidase levels to an average of 25 MU and 8 MU, respectively compared to an 
average of 138 MU in the control cultures (Fig. 3.6). The rate of growth was unaffected 
but the final OD600 was lower in 0.5X (OD600 of 5.5) and 0.25X (OD600 of 3.2) compared 
to 1X BHI (OD600 of 9.3). a-haemolysin activity was also affected, falling from an 
average of 154 HU in the control cultures to an average of 62 HU in 0.5X BHI (Fig. 3.6). 
There was no detectable activity in 0.25X BHI (Fig. 3.6). These values represent an. 
average of 5 independent experiments and varied by less than 15 %. 
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Expression of hld:: lacZ and a-haemolysin activity during growth. Strain SH101 was 
grown in BHI at 37 °C with shaking at 250 rpm. Growth, as absorbance at 600 nm (Q ), 
hld:: lacZ expression as ß-galactosidase activity (  Miller units) and a-haemolysin . activity (0 haemolysin units) were measured as described in Chapter 2. The dotted lines 
indicate the time during growth at which the ß-galactosidase level started to rise. 
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Effect of medium concentration on hld:: lacZ expression and a-haemolysin activity. 
Strain SH101 was grown in 1X, 0.5X or 0.25X BHI and p-galactosidase activity (  
Miller units) or a-haemolysin activity (® haemolysin units) were measured. The value 
för each sample represents the mean of 5 independent experiments which varied by <15 
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Addition of dried skimmed milk (0.1,1 or 10 % w/v) or bovine serum albumin (0.5 % 
w/v) to CDM did not lead to an increase in overnight growth yield. ß-galactosidase and 
a-haemolysin production were similarly unaffected. 
Subsequently, an alternative CDM (Holland et al., 1994) was tried and, although growth 
was good, reaching an average OD600 of 13 compared to 9.6 in BHI during 3 independent 
experiments, ß-galactosidase levels were an average of 27-fold less than in BHI (5 MU vs 
135 MU). 
3.2.6 Effect of homoserine or homoserine lactone 
Homoserine lactone (HL) is a density dependent signalling compound found in some 
Gram negatives (see section 1.5.3). To see whether the presence of HL in CDM (Hussein 
et al., 1991) might activate hld:: lacZ expression, two variants of HL (L or DL) (1 mM) 
were added and cells grown overnight. The final level of growth was slightly improved 
reaching an OD600 of 4.1 or 5.1 in L- or DL-HL respectively but no ß-galactosidase 
activity could be measured. 
In addition L-homoserine or homoserine lactone (L- or DL-) (1 mm) was added to cells 
grown in BHI during exponential phase (ODD of 2.0) to determine whether early 
induction of hld:: lacZ would occur. The rate of growth was not affected and there was 
no early induction of hld:: lacZ expression. 
3.2.7 Effect of osmolarity 
The effect of the osmolarity of the growth medium on hld:: lacZ expression was 
determined by adding NaCl or sucrose (up to 2 M) to BHI. As NaCl concentration 
increased above the 0.08 M level present in BHI, so ß-galactosidase levels rose giving an 
average 4- to 5-fold increase in 0.5 or 1M NaCl, respectively, compared to an average of 
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129 MU in the control samples (Fig. 3.7). Surprisingly, compared with the control (143 
HU), a-haemolysin levels decreased to 29 HU and 2 HU in 0.5 M and 1M NaCl 
respectively (Fig. 3.7). The lack of a-haemolysin activity was not due to a direct effect 
of salt on the protein as addition of equivalent concentrations of NaCl to a sample of 
known haemolytic activity did not inhibit haemolysis. At concentrations of NaCl above 1 
M hld:: lacZ expression sharply declined to 25 MU in 1.5 M NaCl and 2 MU in 2M 
NaCl. a-haemolysin activity could not be detected at either concentration of NaCl. The 
final ODD of the cultures was reduced from 10.0 in BHI to 8.3,7.1,6.9 or 5.8 in 0.5,1, 
1.5 or 2M NaCl, respectively. These values represent an average of 6 independent 
experiments and varied by less than 25 %. 
Supplementing BHI with 0.5 M and 1M sucrose caused a marked reduction in ß- 
galactosidase levels which, with 1M sucrose, fell to an average of 9 MU compared to the 
average of 129 MU obtained in the BHI control (Fig. 3.7). Growth of SH 101 was also 
affected, growing to an average ODD of 6.9 or 5.3 in 0.5 or 1M sucrose compared to an 
average ODD of 10.2 in the control. The bacteria proved unable to grow in sucrose 
concentrations at, or above, 1.5 M. No a-haemolysin activity could be detected, even at 
concentrations as low as 0.02 M sucrose which did not inhibit ß-galactosidase production 
(Fig. 3.7). These values, similarly, represent an average of 6 independent experiments 
that varied by less than 12 %. 
3.2.8 Effect of glucose 
The addition of 0.25 % (w/v) glucose to Bill led to an increase in ß-galactosidase levels 
from an average of 143 MU in the BHI control (which contains 0.25 % w/v glucose) to 
an average of 206 MU (Fig. 3.8). At 0.5 % or 1% (w/v) glucose, levels were markedly 
reduced to an average of 53 MU or 10 MU respectively. Growth was inhibited as glucose 
concentration increased, typically falling from an ODD of 10.0 in the control to an 
ODD of 8.4,7.2 or 6.4 in 0.25,0.5 or 1% (w/v) glucose. a-haemolysin activity was 
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Effect of NaCl and sucrose on hld:: lacZ expression and a-haemolysin activity. Strain 
SH101 was grown in BHI containing NaCl or sucrose, where stated. ß-galactosidase 
activity (  Miller units) or a-haemolysin activity (® haemolysin units) were measured. 
The value for each sample represents the mean of 6 independent experiments which 
varied by <25 % (sucrose) or <12 % (NaCI). 
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Effect of glucose on hld:: lacZ expression and a-haemolysin activity. Strain SH101 was 
grown in BHI containing glucose (0.25 %, 0.5 % or 1% w/v) and ß-galactosidase activity 
(  Miller units) or a-haemolysin activity (® haemolysin units) were measured. The 
value for each sample represents the mean of 4 independent experiments which varied by 
<17%. 
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reduced to an average of 14 HU, 13 HU or 0 HU at each respective concentration of 
glucose, compared to an average of 157 HU in the control samples (Fig. 3.8). These 
values represent an average of 4 independent experiments and varied by less than 17 %. 
3.2.9 Effect of calcium and magnesium levels 
Cultures grown in BHI supplemented with calcium chloride (5 mM) or magnesium 
chloride (up to 20 mM) did not have a significant effect either on ß-galactosidase activity, 
a-haemolysin levels or final OD600. However, whilst the addition of 0.5 mM ethylene 
glycol-bis(ß-aminoethylether)N, N, N', N'-tetraacetic acid (EGTA) to create a calcium- 
restricted environment (Chambers, 1993) did not affect cell growth, there was a 5-fold 
increase in hld:: lacZ activity (Fig. 3.9). This effect was reflected more markedly in a- 
haemolysin levels where there was an increase of up to 18-fold in the calcium restricted 
medium compared to the BHI control. Supplementing BHI containing EGTA with 5 mM 
calcium chloride restored both ß-galactosidase and a-haemolysin activities to 
approximately those found in BHI alone. The addition of 20 mM MgCl2 to media 
already containing EGTA also led to a reduction in ß-galactosidase or a-haemolysin 
levels, to approximately 585 MU or 1153 HU, respectively, compared to 740 MU or 
2415 HU in cultures grown in BHI containing only EGTA (Fig. 3.9). These values 
represent an average of 3 independent experiments and varied by less than 15 %. 
The above experiments were also carried out substituting 0.5 mM of 
ethylenediaminetetraacetic acid (EDTA) (Chambers, 1993) for EGTA. A similar trend 
was observed with ß-galactosidase and a-haemolysin levels, rising up to 5-fold and 10- 
fold, respectively whilst the final ODD decreased to an average of 6.2 from 9.3 upon 
addition of EDTA. However, addition of either MgC12 (20 mM) or CaC12 (5 mM) 
restored final growth levels to normal. ß-galactosidase activity also returned to control 
levels, as did a-haemolysin production in the presence of additional CaC12. Adding 
MgC12 to EDTA- treated cultures resulted in a-haemolysiri levels only 2-fold above that 
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FIGURE 3.9 
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+ MgCl2 
Effect of availability of divalent cations on hld:: lacZ expression and a-haemolysin 
activity. Strain SH101 was grown in BHI containing EGTA (0.5 mM) or EGTA ± CaC12 
(5 mM) or MgC12 (20 mM and p-galactosidase activity (  Miller units) or a-haemolysin 
activity (® haemolysin units) were measured. The value for each sample represents the 
mean of 3 independent experiments which varied by <15 %. 
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produced in BHI alone which showed an average of 155 HU. These values represent an 
average of 3 independent experiments and varied by less than 20 %. 
3.2.10 Effect of temperature 
Optimum hld:: lacZ expression occurred at 42 °C and was approximately twice that of the 
control which reached an average of 139 MU at 37 °C (Fig. 3.10). Cells grown at 30 °C 
exhibited an average of only 50 MU. The final growth level was relatively unaffected at 
30 °C (OD600 of 8.9) but was repressed at 42 °C (OD600 of 6.7). The most marked effect 
of temperature was the dramatic increase in a-haemolysin production at 42 °C, at which 
temperature levels of this toxin were up to 8-fold higher than the average of 150 HU 
obtained at 37 °C (Fig. 3.10). These values represent an average of 4 independent 
experiments and varied by less than 7 %. 
3.2.11 Effect of heat shock 
SH101 was grown to exponential phase (ODD of 1.0) at 37 OC, heat shocked for 5 or 10 
minutes at 47 °C or 53 OC and then returned to 37 OC for approximately 18 hours. This 
did not result in a significant alteration to the kinetics of growth or the final OD600 
reached. Levels of ß-galactosidase production were not markedly altered whilst a 
haemolysin activity was affected after heat shocking at 53 0C, falling to an average of 100 
HU compared to an average of 148 HU found in the control. Assaying samples at 30,60 
and 90 minutes immediately following heat shock showed that early expression of 
hld:: lacZ was not induced. These values represent an average of 3 independent 
experiments and varied by less than 22 %. 
3.2.12 Effect of alcohols 
Growth in the presence of isopropanol (1 or 2% v/v) in BHI resulted in a decrease in ß- 
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Effect of temperature on hld:: lacZ expression and a-haemolysin activity. Strain SH101 
was grown in BHI at 30 °C, 37 °C or 42 °C and p-galactosidase activity (  Miller units) 
or a-haemolysin activity (® haemolysin units) were measured. The value for each 
sample represents the mean of 4 independent experiments which varied by <7 % 
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galactosidase levels to an average of 48 MU or 20 MU, and a-haemolysin levels to 36 
HU or 2 HU, compared to the BHI control which showed an average of 150 MU or 157 
HU (Fig. 3.11). The addition of ethanol (1 or 2% v/v) enhanced hld:: lacZ expression to 
an average of 321 MU or 300 MU, respectively and altered a-haemolysin activity to an 
average of 273 HU or 31 HU at each respective concentration (Fig. 3.11). Final OD600 
was 10.0 in the control, 6.8 or 5.9 in 1 or 2% (v/v) ethanol and 9 or 8.9 in 1 or 2% (v/v) 
isopropanol respectively. These values represent an average of 5 independent 
experiments and varied by less than 21 %. 
3.2.13 Effect of glycerol monolaurate (GML) 
Cells grown in BHI containing GML (up to 0.2 mg/ml) did not show any marked change 
in ß-galactosidase activity, or final ODD (8.8), compared with cells grown in BHI alone 
which showed an average of 143 MU (Fig. 3.12). However, there was no a-haemolysin 
activity in the presence of 0.2 mg/ml GML (Fig. 3.12). This was not due to a direct effect 
of GML on a-haemolysin activity since adding GML (0.2 mg/ml) to a control sample of 
known haemolytic activity did not lead to any decrease in haemolysin units. These values 
represent an average of 3 independent experiments and varied by less than 8 %. 
3.2.14 Effect of sodium citrate 
When SH101 was grown in BHI supplemented with 0.1 to 0.25 % (w/v) sodium citrate 
there was a dramatic reduction in ß-galactosidase levels from an average of 132 MU 
obtained in BHI alone. Addition of 0.1 % or 0.25 % sodium citrate resulted in a 5-fold or 
20-fold reduction in ß-galactosidase activity respectively (Fig. 3.13). There was a 
corresponding loss of a-haemolysin activity (4-fold at 0.1 % and 25-fold at 0.25 %) (Fig. 
3.13) but final cell density remained relatively unaffected, reaching an average OD600 of 
9.4 or 8.2 in 0.1 or 0.25 % sodium citrate compared to an OD600 of 9.8 in BHI alone. 
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Effect of isopropanol or ethanol on hld:: lacZ expression and a-haemolysin activity. 
Strain SH101 was grown in BHI containing isopropanol (1 % or 2% v/v) or ethanol (1 % 
or 2% v/v) and ß-galactosidase activity (0 Miller units) or a-haemolysin activity ( haemolysin units) were measured. The value for each sample represents the mean of 5 
independent experiments which varied by Q1 %. 
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FIGURE 3.12 
GML 
(0.2 mg/ml) 
Effect of glycerol monolaurate (GML) on hld:: lacZ expression and a-haemolysin 
activity. Strain SH101 was grown in BHI containing GML (0.2 mg ml) and ß- 
galactosidase activity (  Miller units) or a-haemolysin activity ( haemolysin units) 
were measured. The value for each sample represents the mean of 3 independent 
experiments which varied by <8 %. 
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IMMOL55M 
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Na-citrate Na-citrate 
Additions to 13H1 
Effect of sodium citrate on hld:: lacZ expression and a-haemolysin activity. Strain 
SH101 was grown in BHI containing either 0.1 % or 0.25 % (w/v) sodium citrate and ß- 
galactosidase activity (  Miller units) or a-haemolysin activity (® haemolysin units) 
were measured. The value for each sample represents the mean of 3 independent 
experiments which varied by <6 %. 
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These values represent an average of 3 independent experiments and varied by less than 6 
%. 
3.2.15 Effect of oxygen availability 
Cultures were grown anaerobically in an anaerobic jar (BBL GasPak System) without 
shaking. Anaerobic growth resulted in a 15-fold or 20-fold reduction in hld:: lacZ 
expression or a-haemolysin activity, respectively when compared to aerobically grown 
cells which showed an average of 141 MU and 149 HU (Fig. 3.14). Final OD600 was 
severely reduced reaching an average of only 3.2 after 48 hours of anaerobic growth 
compared to an average ODD of 9.2 after 18 hours of aerobic growth. These values 
represent an average of 6 independent experiments and varied by less than 33 %. 
3.2.16 Effect of sodium bicarbonate 
Growing cells in BHI with either 0.2 % or 0.4 % NaHCO3 (w/v) did not result in any 
change in ß-galactosidase levels (Fig. 3.15). ODD was slightly affected reaching an 
average of 8.9 in the control and 8.2 or 7.5 in the presence of 0.2 % or 0.4 % (w/v) 
NaHCO3 respectively. a-haemolysin levels were most affected rising >2-fold in both 
concentrations of sodium bicarbonate from an average of 151 HU obtained in BHI alone 
(Fig. 3.15). These values represent an average of 4 independent experiments and varied 
by less than 15 %. 
3.2.17 Effect of altering multiple environmental conditions 
High levels of hld:: lacZ expression have been observed under conditions of reduced 
Cat+, 0.5 or 1M NaCI or at increased temperature, up to 42 OC. The effects on 
hld:: lacZ expression of altering combinations of two of these environmental conditions 
was studied. Growth of SH 101 in the presence of 0.5 mM EGTA at 42 OC did not 
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Effect of oxygen availability on hld:: lacZ expression and a-haemolysin activity. Strain 
SH101 was grown in BHI aerobically or anaerobically and ß-galactosidase activity (  
Miller units) or a-haemolysin activity (® haemolysin units) were measured. The value 
for each sample represents the mean of 6 independent experiments which varied by <33 
%. 
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FIGURE 3.15 
0.4 % Na- 
bicarbonate 
Effect of sodium bicarbonate (NaHCO3) on hld:: lacZ expression and a-haemolysin 
activity. Strain SH101 was grown in BHI containing either 0.2 % or 0.4 % (w/v) 
NaHCO3 and ß-galactosidase activity (  Miller units) or a-haemolysin activity 
haemolysin units) were measured. The value for each sample represents the mean of 4 
independent experiments which varied by <15 %. 
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lead to a significant increase or decrease in ß-galactosidase levels above that obtained in 
the presence of 0.5 mM EGTA alone. Similarly, combining the addition of NaC1(0.5 M 
or 1 M) and EGTA did not lead to an increase in ß-galactosidase production over and 
above that obtained in either EGTA or NaCl alone. There was an approximately 4-fold 
increase in cultures grown with combined NaCl and EGTA compared with the control, 
which reflects the increase in p-galactosidase levels found in BHI containing either NaCl 
or EGTA. Interestingly, it was found that the presence of EGTA in BHI somewhat 
counteracted the inhibitory effect of additional NaCl (0.5 M) on a-haemolysin 
production, with levels being restored to approximately 80% of those obtained in BHI 
with EGTA alone (see Fig. 3.9). 
3.2.18 Effect of addition of spent culture medium 
RAP (RNAIII activating protein) has been identified as an octapeptide produced by the 
agrD gene and is the signalling compound of a quorum sensing system (Balaban and 
Novick, 1995; Ji et al., 1995; Ji et al., 1997) (see section 1.6.1.1.2.2). RAP-containing 
spent culture medium was prepared by growing strain 8325-4 overnight in TSB at 37 °C, 
with shaking at 250 rpm. Spent medium and an equal volume of sterile TSB were then 
freeze-dried and each resuspended to a IOX concentration in sterile H2O. Adding RAP- 
containing concentrate to an early exponential culture of SH101 (OD6oo of 0.8) led to a 
slight, but consistent, increase in ß-galactosidase activity, two hours post-addition (ODD 
of 5.5) (Fig. 3.16). After three hours there was typically a 6-fold increase in ß- 
galactosidase compared with the background levels (3 MU) present in a control sample 
with no additions or a sample with IOX sterile TSB added. This experiment was repeated 
4 times and the values fluctuated by less than 7 %. The kinetics of growth of the cultures 
with spent medium added remained identical to cultures grown with sterile medium 
added. 
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FIGURE 3.16 
Effect of spent culture medium on hld:: lacZ expression. Strain SH101 was grown in BHI 
until the ODD reached 0.8. (a) Spent culture medium (10X), prepared as described in 
section 3.2.18, or (b) l OX sterile TSB was added at T=O. Growth, as absorbance at 600 
nm (ODD (a) O; (b) p) and hld:: lacZ expression as p-galactosidase activity (Miller units 
(a) "; (b)  ) were measured at 1,2 and 3h post-addition as described in Chapter 2. 
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3.3 Discussion 
The creation of a strain (SH101) containing a chromosomal hld:: lacZ transcriptional 
fusion has allowed the convenient assay of hld:: lacZ expression and hence RNAHI 
production. Construction of the fusion in single copy in the chromosome avoids 
problems due to titration of regulatory elements possibly associated with the use of 
multicopy plasmid based reporter systems. The fusion is stably maintained and does not 
require constant drug selection. In addition, an intact copy of hid remains in the 
chromosome to prevent the pleiotropic effects associated with an agr mutation. Using the 
reporter system, the effects of a wide range of environmental and physiological 
conditions on hld:: lacZ expression have been examined. The hla gene (which encodes (x- 
haemolysin) is positively regulated by RNAIII as well as other factors (Vandenesch et al., 
1991) and so by the study of a-haemolysin activity it has been possible to investigate the 
relationship between hld:: lacZ expression and a-haemolysin levels. 
The production of RNAIII has previously been shown to be growth phase regulated by 
the use of reporter fusion plasmids and transcript analysis (Kornblum et al., 1990; 
Vandenesch et al., 1991). In SH 101 both hld:: lacZ expression and a-haemolysin 
activity appear as the cells enter post-exponential phase. This is slightly later than that 
previously noted, when RNAHI expression is initiated during late exponential phase 
(Janzon et al., 1989; Vandenesch et al., 1991). a-haemolysin production did not occur 
until 2 hours after RNAIII transcription, which is consistent with previous observations 
(Vandenesch et al., 1991). Use of the more sensitive, fluorogenic substrate MUG in the 
hld:: lacZ fusion assays did not significantly alter the kinetics of ß-galactosidase 
expression. Overnight growth (18 h) provided a convenient time point for sample 
collection. The high levels of both a-haemolysin and ß-galactosidase in the overnight 
cultures may not be due to continued expression per se but more likely the stability of the 
respective proteins. 
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It has been proposed that expression of RNAIII is controlled as part of a density 
dependent signal transduction pathway via an extracellular octapeptide called RAP 
(Balaban and Novick, 1995; Ji et al., 1995; Ji et al., 1997). Thus, it would be expected 
that hld:: lacZ levels would show a correlation with culture density. The growth media 
results shown support this hypothesis, especially using dilutions of BHI. Half- and 
quarter-strength BHI affected the final average OD600 of cultures (5.5 and 3.6, 
respectively) but did not adversely affect the growth rate (results not shown). 
Significantly lower hld:: lacZ expression was apparent in both 0.5X (18 %) and 0.25X 
BHI (6 %) compared with the 1X control. In addition, different types of media have been 
shown to result in reduced final cell density with a concomitant fall in hld:: lacZ 
expression, although this could be due to the different media constituents. Cells grown in 
TSB or a CDM (Hussein et al., 1991) reach a lower ODD than those grown in BHI and 
as final cell density is decreased so hld:: lacZ expression falls. 
Attempts were made to identify components which might have led to increased growth 
and hld:: lacZ expression in CDM (Hussein et al., 1991). In particular, various solutions 
containing protein (milk or bovine serum albumin) were supplemented since CDM 
contains only amino acids whereas other media which support good growth contain 
proteins and peptides. However, cell growth, hld:: lacZ expression and a-haemolysin 
levels were not increased. Similarly, adding L- or DL-homoserine lactone (HL), a 
density-dependent signalling molecule of some Gram negative bacteria (see section 
1.5.3), did not activate hld:: lacZ expression. L-HL is the natural configuration of 
homoserine lactone, although DL-HL has also been shown to be active. Interestingly, 
later experiments on the effect of environmental conditions on hld:: lacZ expression 
revealed a number of situations where hld:: lacZ expression is deregulated from culture 
density. Addition of EGTA or 1M NaCl enhanced hld:: lacZ expression 5-fold. 
Conversely, 0.5 % (w/v) glucose, 0.25 % (w/v) sodium citrate and the CDM of Holland et 
al. (1994) reduced hld:: lacZ expression 3-, 20- and 27-fold respectively whilst having no 
significant effect on final cell density. It has been shown that S. aureus grown in defined 
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media containing 6,12 or 18 amino acids show comparable growth to cells grown in BHI, 
but haemolytic activity is negligible (Taylor and Holland, 1989a). Similarly, TSST-1 
production is negligible in a6 or 12 amino acid defined medium and only reaches 50 % 
that found in BHI in an 18 amino acid defined medium (Taylor and Holland, 1989a). 
Thus regulation of RNAIII, and control of production of some virulence determinants, is 
not a simple system but involves the transduction of many signals, including cell density. 
S. aureus is an extremely osmotolerant organism, a trait which undoubtedly contributes to 
its ability to grow in many foods (Troller, 1986). In media containing 1M NaCI S. 
aureus was found to grow well, with growth still considerable at 2M NaCl. High salt 
concentrations (up to 1 M) increased hld:: lacZ expression, although a-haemolysin levels 
were markedly decreased. This latter observation has recently been confirmed by 
showing that growing S. aureus in high NaCl (up to 1.2 M) results in repression of hla 
(Ohlsen et al., 1997). Regassa et al. (1992) have similarly noted that addition of NaCl to 
media, at a level as low as 0.05 M, slightly enhances RNAIII expression. Production of 
two of the enterotoxins (SEB and SEC), whose expression is positively regulated by agr, 
is also adversely affected by high salt concentrations (Genigeorgis and Sadler, 1966; 
Regassa and Betley, 1993). This additional regulation of SEC is believed to occur at the 
level of transcription or mRNA stability (Regassa and Betley, 1993). The effect of NaCl 
concentrations (2-16 % w/v) on SEB production has also been examined in parallel with 
pH (Genigeorgis and Sadler, 1966). At all pH levels examined, SEB production 
remained highest at the lowest NaCl concentrations. Production of epidermolytic toxin A 
(Eta), like a-haemolysin, is positively regulated by agr, and eta expression decreases 
dramatically as NaCl concentrations increase from 0M to 1M (Sheehan et al., 1992). 
Thus, regulation of several genes which require RNAIII for high level expression show a 
common response to high NaCl levels in a manner independent of RNAIII. It has been 
suggested that the agr-independent transcriptional regulation of eta may be mediated by 
salt induced changes in DNA topology (Sheehan et al., 1992). Other agr-independent 
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regulators of virulence determinant production are apparent as the temporal regulation of 
hla during growth occurs irrespective of RNAIH (Vandenesch et al., 1991). 
The NaCI-enhanced expression of hld:: lacZ and reduction in a-haemolysin activity 
cannot be accounted for by simply an effect of osmolarity, since 0.5 M sucrose strongly 
inhibits hld:: lacZ expression as well as a-haemolysin activity. Similarly, a-haemolysin 
activity is undetectable even at 20 mM sucrose, at which concentration hld:: lacZ 
expression is unaffected. This suggests that NaCl and, to an extent, sucrose are mediating 
their effect on a-haemolysin activity in an agr-independent manner. It should be noted, 
however, that S. aureus is able to utilise sucrose (Bergey, 1957) and thus the glucose 
constituent of sucrose is probably playing a part in the repression of a-haemolysin 
production and, to some extent, hld:: lacZ expression (see below). This is particularly so 
since 0.5 M sucrose is equivalent to 9% glucose which is far greater than the 
concentration which has been shown, in this work, to inhibit both hld:: lacZ expression 
and a-haemolysin production. Interestingly, eta expression is also greatly inhibited by 
the addition of sucrose to the growth medium (Sheehan et al., 1992). Conversely, NaCl 
(0.5 M) has been shown to stimulate secretion of a haemolysin of L. monocytogenes, 
listeriolysin 0 (LLO) (Dallmier and Martin, 1990). LLO production is also controlled by 
a global regulator, prfA. 
Experiments with sodium bicarbonate provide further evidence that a-haemolysin 
production is not controlled by agr alone. Addition of either 0.2 % or 0.4 % (w/v) 
NaHCO3 to BHI does not alter hld:: lacZ expression but causes a 2-3 fold increase in a- 
haemolysin activity. Bicarbonate is found in vivo, where it is in equilibrium with CO2 
and contributes to the buffering of extracellular fluids, at concentrations ranging from 15- 
40 mM (Dawson and Segal, 1975). In these experiments NaHCO3 concentration was 
either 24 or 48 mM, which is similar to that found in vivo and thus mimics the host 
environment. Bicarbonate has also been found to affect production of three co-ordinately 
regulated toxins in Bacillus anthraces (protective antigen, edema factor and lethal factor) 
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at the level of transcription (Sirard et al., 1994). The effect of bicarbonate is unlikely to 
be one of altered pH since B. anthracis cultures grown in the presence or absence of 
NaHCO3 reached approximately the same final pH (Sirard et al., 1994). 
The effects of glucose on growth and gene expression in bacteria is well documented. 
Glucose, as a rapidly metabolizable carbon source, results in a co-ordinated change of 
metabolic functions in many bacteria. This is achieved by changing the activity of 
several proteins which leads to the differential expression of operons encoding metabolic 
enzymes by a process known as carbon catabolite repression (Wagner et al., 1995). 
However, in S. aureus the effect of glucose is different from the catabolite repression 
seen in E. coli where it can be overcome by the addition of cyclic AMP (Ullmann and 
Danchin, 1983). The glucose repression of RNAIH synthesis under conditions of non- 
maintained pH, previously noted by Regassa et al. (1992), has been confirmed in this 
study at concentrations of 0.75 % (w/v) and above. a-haemolysin activity was severely 
repressed at all tested concentrations of glucose. However, under conditions of 
maintained pH (6.5), glucose has no effect on RNAIII levels although hla and sec 
expression and SEB production are greatly reduced (Jarvis et al., 1975; Regassa et al., 
1992). Expression of toxic shock syndrome toxin-1 (TSST-1), also positively regulated 
by agr, is similarly affected (Chan and Foster, submitted; Taylor and Holland, 1988). 
Glycerol monolaurate (GML) has also been shown to inhibit extracellular toxin 
production but not RNAIII expression (Holland et al., 1994; Projan et al., 1994; 
Schlievert et al., 1992). Glycerol monolaurate is a naturally occurring surfactant 
commonly used in the food and cosmetic industries as an emulsifier. In this study, 
hld:: lacZ expression was found to be unaltered by 0.2 mg/ml glycerol monolaurate but a- 
haemolysin activity was totally absent. Similarly, it has been reported that in a batch 
culture pulsed with 0.15 mg/ml GML just prior to onset of TSST-1 production, growth 
rate is reduced whilst TSST-1 levels are significantly delayed and reduced (Holland et al., 
1994). It has been reported that this reduction in TSST-1 production occurs only when 
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growth of S. aureus is affected (Holland et al., 1994). GML has previously been shown 
to inhibit the production of ß-lactamase, TSST-1 and a-haemolysin at a transcriptional 
level by interfering with signal transduction (Schlievert et al., 1992; Projan et al., 1994). 
In addition, production of protein A in an agr mutant, in which it is normally 
overproduced, is also inhibited in the presence of GML (Projan et al., 1994). However, 
inhibition of production of these extracellular factors is not achieved by interfering with 
agr activation but probably other signal transduction pathways involved in their 
expression (Projan et al., 1994). It has been suggested that a target in cell growth may be 
involved which in turn influences toxin production (Holland et al., 1994). This provides 
further evidence that, in addition to a-haemolysin production, TSST-1 may also require a 
post-exponential phase activation signal additional to agr. 
Of the many toxins produced by S. aureus, toxic shock syndrome toxin-1 (TSST-1) can 
be fatal and is a problem particularly in women where it is largely associated with the use 
of some types of tampon. The effect of divalent cations, in particular the presence of 
Mg2+ in tampons, has been well studied. Use of chemostat continuous culture to study 
the specific effects of Mg2+ concentration in a defined medium showed that Mg2+ limited 
conditions led to reduced production of TSST-1 (Taylor and Holland, 1989b). Toxin 
production increases approximately 23-fold with increased Mg2+ concentrations up to 0.4 
mM (Sarafian and Morse, 1987). In this work it has been shown that addition of Mg2+ 
(0.2,2 and 20 mM) to BHI did not significantly alter h1d:: lacZ expression or a- 
haemolysin activity. However, removing Mg2+ (0.5 mM EDTA) led to a 4-5-fold increase 
in hld:: lacZ expression and a 10-fold increase in haemolysin units. The effect on ß- 
galactosidase production was reversed when Mg2+ (20 mM) was present in addition to 
EDTA and a-haemolysin levels showed only a 2-fold increase. Thus, our studies suggest 
that the effect of Mg2+ on tst noted by other workers is probably specific and occurs 
independently of agr. 
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Addition of the calcium chelator EGTA results in a 5-fold increase in hld.: lacZ 
expression. This response is due mainly to Ca2+ as addition of excess Ca2+ in the 
presence of EGTA, reverses the effect. a-haemolysin activity is also enhanced up to 18- 
fold by a lack of Ca2+. The level of available Ca2+ may well be important in enabling S. 
aureus to inhabit certain environments, particularly the airways of cystic fibrosis (CF) 
sufferers (Kilbourn, 1984). Whilst S. aureus is infrequently found in the lower 
respiratory tract of healthy subjects, more than one-third of CF sufferers harbour this 
organism in their lower airways (Schwab et al., 1993). The mucus of these patients 
contains unusually high levels of calcium and it has been shown that the presence of Ca2+ 
enhances adhesion of the bacteria to mucin, a component of mucus (Kilbourn, 1984; 
Thomas et al., 1993). Calcium has also been shown to play a role in the production of 
fibronectin binding protein (FnBP), an important virulence factor which is negatively 
regulated by agr (Kornblum et al., 1990; Lindberg et al., 1990). In the presence of 
calcium, free extracellular FnBP is increased whereas this is suppressed when EGTA 
(6.25 mM) is added to the medium to chelate free Ca2+. In addition, the presence of 
EGTA leads to a sharp increase in cell wall-associated FnBP. The results obtained 
during this work suggest that these changes in FnBP production in response to Ca2+ 
availability are probably not mediated directly by agr. 
There are several examples in other organisms where changes in extracellular Ca2+ 
concentration have been shown to affect gene expression. For example, in Streptococcus 
pneumoniae, 0.15 mM Ca2+ is required for optimal growth but 1 mM triggers a 
differentiative state (Trombe et al., 1992). In contrast to the situation in S. aureus, the 
presence of free calcium in growth media has been shown to positively regulate gene 
expression in some serotypes of Actinobacillus (Haemophilus) pleuropneumoniae 
resulting in increased levels of haemolysin (Frey and Nicolet, 1988). In the presence of 
EGTA, a Ca2+ chelator, an almost complete loss of haemolytic activity is observed 
whereas free calcium concentrations above 3 mM cause a dramatic increase in activity. 
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Production of siderophores and haemolysins by S. aureus, as mechanisms for acquiring 
iron, is frequently regulated by iron availability, with increased expression occurring 
when iron is limited (Litwin and Calderwood, 1993; Stoebner and Payne, 1988; Trivier 
and Courcol, 1996; Waalwijk et al., 1983). In particular, this work has shown that 
addition of some chelators (EGTA and EDTA) does enhance both hld:: lacZ expression 
and a-haemolysin production. Iron-deprivation has also been shown to stimulate LLO 
secretion (Cowart and Foster, 1991). Citrate in particular chelates minerals, with a high 
equilibrium constant for iron. Citrate is naturally present in plant foods and is widely 
used as an antimicrobial agent in foods (Doores, 1993). The inhibitory effect of organic 
acids, such as citric acid, on microbial growth is attributed to damage caused by the 
hydrogen ion liberated inside the cell following permeation of the acid in its 
undissociated form. Acidification of the cytoplasm uncouples both substrate transport 
and oxidative phosphorylation from the electron transport system (Freese et al., 1973). In 
the Gram positive organism, L. monocytogenes, Listeriolysin 0 secretion is reportedly 
stimulated in the presence of citrate (4 % w/v optimum) (Kouassi and Shelef, 1995). This 
was thought to be possibly due to increased permeability of the cell membrane in the 
presence of the salt, thus facilitating the release of the haemolysin into the extracellular 
medium. Growth of S. aureus was found to be completely inhibited by 1% (w/v) Na- 
citrate and, although growth at 0.1 % (w/v) and 0.25 % (w/v) is relatively unaffected, 
there was very little detectable agr P3 promoter activity or a-haemolysin production at 
0.25 % (w/v). 
Temperature regulation of virulence determinant production is common amongst a 
number of bacterial pathogens as it allows for toxin production only when associated with 
the mammalian host (Datta and Kothary, 1993; Prugnola et al., 1995). Consistent with 
this was the -3-fold increase in hld:: IacZ expression observed at 37 °C compared to 30 
OC. More striking was the 8-fold increase in a-haemolysin activity at 42 °C compared to 
37 °C, whereas hld:: lacZ expression was only 2-fold higher. The finding that a- 
haemolysin levels are higher at 42 °C has recently been supported by experiments using 
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an hla:: lacZ fusion to measure hla expression at 37 °C and 42 °C (Ohlsen et al., 1997). 
In addition, Ohlsen et al. (1997) showed that increased temperature altered the temporal 
expression of hla from post-exponential to mid-exponential. This again suggests there 
are additional factors involved in the regulation of a-haemolysin activity independent of 
RNAIII. A similar pattern occurs with TSST-1 production which is significantly higher 
at 37 °C than 30 °C and 2-fold higher at 40 °C than 37 °C (Schlievert and Blomster, 
1983). Global regulators of toxin production in some other organisms are similarly 
affected. For example, transcription of virulence genes controlled by the bvg regulon of 
Bordetella pertussis is repressed at 25 °C and increases as temperatures rise to 37 °C 
(Prugnola et al., 1995). The secretion of listeriolysin 0 is similarly affected by 
temperature, showing a 64-fold increase as temperature rises from 26 °C to 37 °C (Datta 
and Kothary, 1993). 
Most bacteria show a dose-dependent inhibition of growth in ethanol over the range 1-10 
% (v/v) (Ingram and Buttke, 1984). Growth of S. aureus was reduced in the presence of 
both 1 and 2% (v/v) ethanol. The presence of alcohols, in particular ethanol, tends to 
increase membrane rigidity and it is the ability of cells to maintain the fluidity and 
integrity of membranes in this environment which leads to ethanol tolerance (Couto et al., 
1996). Cell membrane alterations affecting possible signal transduction mechanisms may 
account for the increase in hld:: lacZ expression and a-haemolysin activity in 1% (v/v) 
ethanol grown cells. However, isopropanol reduced hld:: lacZ expression approximately 
3-fold and a-haemolysin activity >4-fold at 1% (v/v), whilst having no marked effect on 
the final ODD. 
Oxygen availability is likely to be an important stimulus in vivo. It has been shown that 
S. aureus grown in batch culture, in flasks, has a reduced growth rate when the ratio of 
flask size to culture volume is <20: 1 (Taylor and Holland, 1988; Taylor and Holland, 
1989b). Growing strain SH101 in a flask to media volume of 10: 1 led to reduced ß- 
galactosidase activity compared to cells grown in a respective ratio of 2.5: 1. Anaerobic 
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growth led to a very much reduced final ODD, and almost no hld:: lacZ expression or a- 
haemolysin activity. It has recently been confirmed that expression of the hla gene itself 
is completely repressed under anaerobic conditions (Ohlsen et al., 1997). Due to the 
effect on growth it is difficult to determine if the lack of RNAHI is an effect of oxygen 
availability directly, or indirectly via cell density dependence of RNAIII expression. 
However, microaerophilic growth led to a large increase in both hld:: lacZ expression and 
a-haemolysin activity whilst ODD remained very low (P. F. Chan, pers. comm. ). 
Similarly, decreased oxygen availability has been shown to lead to increased TSST-1 
production but decreased cell yield (Sarafian and Morse, 1987) whilst anaerobic 
conditions have been shown to lead to a reduction in TSST-1 activity of between 4- and 
32-fold, depending on media and growth conditions (Sarafian and Morse, 1987; 
Schlievert and Blomster, 1983; Taylor and Holland, 1989b). 
This study has revealed that various environmental factors, such as high temperature (42 
°C), EGTA and 1M NaCl, each lead to increased hld:: lacZ expression. If these 
treatments are mediating their effects via independent mechanisms then an additive or 
even synergistic response to combinations of factors may be expected. No additive 
effects were seen with hld:: lacZ expression by this combined approach, but EGTA was 
able to reverse the inhibitory effect of 1M NaCl on a-haemolysin activity. Thus, there is 
some evidence of crosstalk between the regulatory mechanisms which control toxin 
biosynthesis. 
Production of virulence determinants by S. aureus is co-ordinately regulated in order that 
the organism may efficiently respond and adapt to changes in its internal and external 
environment. Central to this process is the agr locus which in itself is a complex 
regulatory element implicitly required for virulence. Part of the signal transduction 
process which elicits toxin production is a cell density dependent quorum sensing 
mechanism (Ji et al., 1995) (see section 1.6.1.1.2.2). The availability of the fusion strain 
produced in this work and the development of a suitable assay have allowed confirmation 
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of the existence of such a system in S. aureus. Although adding 'spent' media to cultures 
in early exponential phase caused only a slight increase in Miller units, this response 
occurred prior to when activity normally would have been expected and the findings were 
consistently reproducible. The cell density dependent signalling compound of some 
Gram negatives, homoserine lactone (see section 1.5.3) did not elicit an early increase in 
hld:: lacZ expression when added to an exponentially growing culture. Similarly, 
homoserine (which lacks the fatty acid chain of HL) had no effect. In E. coli the non- 
acylated form of homoserine lactone is thought to be an intracellular starvation signal that 
induces expression of the rpoS stationary phase specific sigma factor (Fuqua et al., 1996). 
Multiple environmental signals are being constantly monitored by the cells and responded 
to by both agr dependent and independent mechanisms. This work has revealed a 
number of the stimuli important in the control of toxin production. Of course, it is not 
possible to reproduce, in vitro, the environment that occurs in vivo since this is a complex 
and dynamic situation where many factors are interacting and changing, often rapidly. 
Some conditions that may reflect those found in vivo, including temperature, the 
availability of some cations or oxygen, or levels of sodium bicarbonate, have been 
examined in this work and found to affect hld:: lacZ expression or a-haemolysin 
production. However, it is not possible to extrapolate from the data obtained during these 
in vitro studies since the likelihood is that the effects in the body will be somewhat 
different. Thus, the conclusions that may be drawn from the data presented in this work 
must be treated with some caution before making parallels between the in vivo and in 
vitro behaviour of S. aureus and the way in which it regulates toxin production. 
Nevertheless, it is important to examine the way in which this organism deals with the 
many stresses it encounters when it infects a host, since the information obtained from 
this study can be used to predict possible targets for inhibiting toxin production, 
particularly in foods where levels of glucose or osmotic compounds, or temperature, can 
be carefully controlled. In particular, the results obtained in this work, and the work of 
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others, with glycerol monolaurate or sodium citrate may have implications for the food 
industry. 
It is likely that, although several global virulence determinant regulators have already 
been identified, such as agr, sar and sae (Cheung et al., 1992; Giraudo et al., 1994b; 
Kornblum et al., 1990), there are many signal response mechanisms, possibly specific to 
individual stimuli, still to be defined. These response mechanisms form part of a 
multilayered regulatory hierarchy with agr at its heart. agr itself probably does not 
respond to all the environmental signals directly, but is a conduit via which the response 
of other components is transduced. Fine control of expression of individual or subsets of 
virulence determinants is likely to be mediated independently of agr. Also more global 
regulatory mechanisms, including DNA topology (Sheehan et al., 1992) or alternative 
sigma factors (Wu et al., 1996), are likely to input into the ability of S. aureus to so deftly 
inhabit such a range of niches. 
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CHAPTER 4 
Isolation and characterisation of virulence 
determinant production mutants using Tn551 
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4.1 Introduction 
It is well known that agr is a major regulator of toxin production in S. aureus. 
However, it has been shown in this work and the work of others, that mechanisms 
other than agr are also involved in the control of production of at least some of the 
virulence factors (Cheung et al., 1992; Giraudo et al., 1994b; Sheehan et al., 1992; 
Vandenesch et al., 1991). In particular, several environmental conditions have been 
found to de-regulate production of some virulence factors from agr. Notably, high 
NaCl concentrations (0.5 and 1 M) led to a large increase in hld:: lacZ expression but 
cc-haemolysin activity was not detected (see section 3.2.7). Conversely, unavailability 
of divalent cations due to addition of EGTA or EDTA (0.5 mM) and growth in 
microaerophilic conditions (P. F. Chan, pers. comm. ) have led to a marked increase in 
a-haemolysin activity compared to a proportionally much smaller increase in 
hld:: lacZ expression (see section 3.2.9). In addition, a novel global regulator, 
staphylococcal accessory regulator (encoded by the sar locus) has been identified 
(Cheung et al., 1992). The protein product of the sarA gene, SarA, is thought to up- 
regulate expression from the P2 and P3 promoters of agr, possibly by interacting with 
AgrA (see section 1.6.1.2.1) (Cheung et al., 1997; Morfeldt et al., 1996b). The 
hld:: lacZ fusion reporter strain created during this work (see section 3.2.1) allows* an 
easy assay for expression from the P3 promoter of agr with transcription from this 
promoter being linked, via hid, to production of (3-galactosidase. Thus, strains 
bearing mutations in genes encoding components which affect hld:: lacZ expression 
would show altered ß-galactosidase activity. In order to identify regulators of agr 
transcription, a transposon library has been created in an hld:: IacZ reporter strain. 
Transposons are a valuable and common tool for creating insertional inactivation 
mutants and as the site of mutation is tagged by the insertion of the transposon it can 
be relatively easily identified. This technique has been used to characterise many loci 
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both in S. aureus and other organisms (Cheung et al., 1992; Giraudo et al., 1994b; 
Hart et al., 1993; Recsei et al., 1986). 
Transposons are DNA fragments which are inherently mobile and can generally insert 
at random into plasmids or bacterial chromosomes independently of a host cell 
recombination system. Such transposable elements were first detected in maize, and 
their behaviour characterised, by McClintock (1948,1951) before the structure of 
DNA was known. There is now good evidence that transposons can be found in all 
organisms. When transposons move into new genomic locations they may, or may 
not, significantly alter neighbouring gene expression and have profound mutagenic 
effects (Singer and Berg, 1991). For example, insertion of a mobile segment into a 
new genomic site is mutagenic if a coding or critical regulatory segment is disrupted 
and gene transcription is prevented. Transposons frequently include their own 
regulatory regions and, in such cases, expression of genes in the neighbourhood of the 
insertion site may be influenced in complex ways, including the imposition of new 
regulatory modes. Since transposons carry out initiation of RNA synthesis they 
sometimes activate previously dormant genes. 
Transposons have been exploited for many mutagenesis studies and specific delivery 
vectors have been created. For example, a streptococcal transposon, Tn917 (see 
chapter 5) has been used in S. aureus to identify the regulatory locus, sar. An 
engineered Tn917 has been produced (Camilli et al., 1990) which has several features 
that make it the method of choice for creating transposon mutants (see chapter 5). 
However, this vector, pLTV1(see Fig. 5.1) could not be used to create hld:: IacZ 
expression mutants since it contains 'a lacZ gene. As the basis of the proposed screen 
depends on altered hld:: lacZ expression this could be compromised. Also, 
recombination could occur between the two lacZ copies. Another transposon widely 
used in S. aureus, and in fact used to create hld:: lacZ expression mutants, is Tn551. 
Tn551 has facilitated the identification of several S. aureus global regulators, namely 
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agr, xpr and sae, all of which have pleiotropic effects on virulence characteristics (see 
chapter 1). It has also been used extensively as a mutagenic tool for chromosome 
and plasmid mapping in S. aureus (Murphy, 1988; Pattee et al., 1977). 
Tn551 is a 5.3 kb, staphylococcal Tn3-like transposon that is found on the 
penicillinase plasmid, p1258. This transposon specifies constitutive resistance to the 
macrolide-lincosamide-streptogramin B (MLS) antibiotics. The Tn3 family of 
transposons, which also includes Tn917, contain homologous short terminal inverted 
repeats, (in the case of Tn551 about 40 bp) and generate a5 bp duplication of the 
target DNA during transposition (Khan and Novick, 1980; Perkins and Youngman, 
1984). Tn551 has an almost identical restriction pattern to Tn917 (see Fig. 5.1) but 
despite their similarities, Tn551 preferentially transposes into the chromosome (Pattee 
et al., 1977) whilst Tn917 transposes to either chromosomal or plasmid sites with a 
preference for some plasmids (Weaver and Clewell, 1987). 
The delivery vector used in this work to introduce Tn551 into bacterial cells was 
plasmid pRN3208 (Fig. 4.1), which is derived from p1258 (Kornblum et al., 1986). 
pI258 carries the gene for resistance to cadmium (Cd) and a ß-lactamase gene (bla) 
and, within Tn551, there is an erythromycin (Em) resistance gene (erm). pRN3208 is 
temperature-sensitive so that it can only replicate up to a temperature of 
approximately 30 OC. Thus, by raising the growth temperature to 43 OC it is possible 
to select only for those bacteria which contain Tn551 within their chromosome 
(Kornblum et al., 1986) since resistance to Cd, which is carried on pRN3208, will be 
lost, whereas Em resistance, which is carried within Tri551, will remain. 
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FIGURE 4.1 
Approximate map of pRN3208. This plasmid contains an ampicillin resistance gene 
(bla), a cadmium resistance gene (Cd) and a temperature sensitive replicon (Ts). The 
extent of Tn551, which contains an Em resistance gene (erm), is indicated by the 
symbol, II. The restriction sites denoted are: Hd, HindIIl; K, Kpnl; X, Xbal. 
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4.2 Results 
4.2.1 Development of strains for transposon muta eg nesis 
As mentioned in section 4.1, Tn551 contains an Em resistance gene (Fig. 4.1). In 
order to avoid recombination between this Em resistance gene and that contained in 
the chromosome of the existing hld:: lacZ reporter strain, SH101 (see section 3.2.1), it 
was necessary to identify either an alternative transposon or construct a new hld:: lacZ 
reporter strain with an alternative resistance marker so that there would be a different 
selectable marker on the transposon compared to the hld:: lacZ reporter strain. Since 
all transposons suitable for use in S. aureus contain an Em resistance gene, it was 
necessary to create a new hld:: lacZ reporter strain with a novel resistance marker. 
Two approaches were adopted to create such a construct, although the method 
described in section 4.2.1.2 was ultimately used to make Tn551 insertion mutants. 
4.2.1.1 Switching of SH100 from Em resistance to spectinomycin (Sp) 
esistance 
Strain SH100 comprises RN4220 (an S. aureus strain which accepts foreign DNA) 
containing pHF23 integrated into the chromosome, to form an hld:: lacZ fusion (see 
chapter 3). In order to change the resistance of this strain from Em, two different 
switching vectors were used. These vectors contain either an Sp resistance gene 
(pEr:: Sp) (Fig. 4.2) or a chloramphenicol (Cm) resistance gene (pEr:: Cm) within an 
Em resistance gene (Steinmetz and Richter, 1994). Thus the Em resistance gene is 
present in both of these plasmids but is insertionally inactivated by the new respective 
resistance marker gene (Fig. 4.2). The principle behind this is that, upon introduction 
of either pEr:: Sp or pEr:: Cm into strain SH100, the fragments of the Em resistance 
gene at either end of the Cm or Sp gene would, by a double crossover event, replace 
the chromosomal Em resistance gene of SH100 resulting in loss of Em resistance and 
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FIGURE 4.2 
SH100 
-- 
Er 
SH107 
-- 
Schematic diagram to show the alteration of antibiotic resistance associated with a 
chromosomal insertion (modified from Steinmetz and Richter, 1994). Strain SH100, 
containing an Em resistance gene (Er) inserted into the chromosome, was transformed 
with linearised switching vector, pEr.: Sp. Plasmid pEr:: Sp contains an Em resistance 
gene disrupted by a gene conferring resistance to Sp. Due to a double crossover 
event, the Em resistance of strain SHIOO was converted to Sp resistance, to give strain 
SH107. 
124 
concomitant gain of Cm or Sp resistance (Fig. 4.2). Accordingly, electroporation 
(Schenk and Ladagga, 1992) with linearised (by EcoRI digestion) pEr:: Sp or pEr:: Cm 
(1 µg) into S. aureus strain SH 100 was attempted. Transformants were selected on 
agar containing the appropriate antibiotic (Cm or Sp) and subsequently tested to 
ensure they had lost Em resistance. This would indicate that the double crossover 
event had occurred between the inactivated Em resistance gene of the switching 
plasmid and the Em resistance gene in strain SH100. Following four such attempts, a 
transformant was isolated which was Sp resistant and Em sensitive (strain SH107). 
No Cm resistant/Em sensitive transformants were isolated. Strain SH107 was blue on 
agar plates in the presence of X-Gal, indicating that the hld:: lacZ fusion was intact. 
This strain was not characterised further due to the success of the approach described 
below. 
4.2.1.2 Creation of an hld:: lacZ fusion using pTKlac 
As an alternative to the above approach, attempts were made to create a new 
hld:: lacZ fusion using the suicide vector, pTKlac (Kenney and Moran, 1991) (Fig. 
4.3) which carries a Cm resistance marker. The 677 bp Pstl/EcoRV fragment 
spanning the P3 promoter of agr (see Fig. 1.2) used to create strain SH101 (see 
chapter 3) was isolated as a 701 bp BamHllHindHl fragment from pHF21 (see Fig. 
3.2). This 701 bp fragment was ligated into similarly cut pTKlac and transformed 
into E. coli XLOLR. Putative recombinant plasmids were digested with PstI/EcoRV, 
to confirm the presence of the 677 bp fragment. The correct construct, pHF24 (Fig.. 
4.4), was transformed by electroporation into S. aureus RN4220. However, after two 
attempts no recombinants resistant to Cm were recovered. Two attempts at 
transformation (Novick, 1991) by protoplasting RN4220 were also unsuccessful. 
Four further attempts by electroporation (Schenk and Laddaga, 1992) also failed to 
yield any recombinants. It has been reported that the efficiency of recombination 
depends on the length of homologous DNA in the suicide vector construct (Perego, 
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pBR322 
FIGURE 4.3 
Map of the suicide vector, pTKlac (modified from Kenney and Moran, 1991). This 
plasmid contains an ampicillin resistance gene (bla), a Cm resistance gene (cat) and a 
promoterless lacZ gene, with a spoVG ribosome binding site (rbs), encoding ß- 
galactosidase. Plasmid pBR322 backbone is also contained within pTKlac, together 
with the multiple cloning site from pUC 18 and the trpA terminator from E. coll. 
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P' 
b/a 
FIGURE 4.4 
Map of pHF24. A 701 hp BaniHI/HindIll fragment of agr spanning the P3 promoter 
was isolated from pHF21 (see Fig. 3.1) and ligated into similarly digested pTKlac. 
The restriction sites denoted are: Ba, BamHI; Ec, EcoRV; Hd, HindIII; P, Pstl. 
ItttttittttuuuWuupiBiRn2i2iuuupppiggtgpttttl 
IIIIIýýýýýI 
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1993), so that a plasmid containing a longer fragment of agr would probably stand 
more chance of recombination. 
Plasmid pEXO (Morfeldt et al., 1988) contains an insert of 4.5 kb which includes 3.8 
kb of the agr locus (Fig. 4.5). A 1.8 kb EcoRV/Asp700 (see Fig. 4.5) fragment of the 
agr locus was excised from pEXO and purified. The identity of the 1.8 kb band was 
confirmed by PstI digestion which results in two fragments of 1101 bp and 677 bp 
(Fig. 4.5). The 1.8 kb fragment (0.25 µg) was ligated into BamHUHindIII digested, 
end-filled, dephosphorylated pTKlac (0.1 µg) and transformed into E. coli XLOLR. 
Appropriate restriction analysis of recombinant plasmids revealed that no plasmids 
containing the insert has been obtained. Despite repetition and the screening of 85 
putative clones, the correct construct was not obtained. 
As an alternative, pTKlac was digested with Smal and, following ligation with the 1.8 
kb EcoRVIAsp7OO pEXO fragment, was transformed into E. coli XLOLR. Ten 
putative clones were screened by plasmid minipreps and restriction analysis. One of 
these, pHF25, contained the insert in the correct orientation to give an hld:: lacZ 
fusion (Fig. 4.6) and one, pHF26, contained the insert in the incorrect orientation 
(Fig. 4.6). This was confirmed by restriction analysis, digesting both these plasmids 
(and pTKlac) with SalIJEcoRI to release the 1.8 kb fragment, and with PstI to release 
the 683 bp fragment from pHF25 (Fig. 4.7). The PstI digest indicated that the 677 bp 
PstIlex EcoRV fragment spanning the P3 promoter was inserted just 6 bp upstream of 
the Pstl site of pTKlac and thus in the correct orientation for transcription from the P3 
promoter through hid and the lacZ gene-of pTKlac (Fig. 4.6). In pHF26, the fragment 
was in the opposite orientation so. would not produce an hld:: lacZ fusion (Fig. 4.6). 
Following plasmid preparation (500 ml of culture) pHF25 (2 µg) was transformed 
into RN4220 by electroporation (Schenk and Ladagga, 1992). Two transformants 
were selected which were chloramphenicol resistant and blue on plates in the 
128 
P Ba/B C Ec PA 
C' 
C Bg/Ba Hg 1188 1474 2153 3252 3480 E 
__ 
IIIK 
PROBE 
FIGURE 4.5 
Partial map of pEXO ( Morfeldt et al.. 1988). The single line represents 3.8 kb of 
chromosomal DNA including 3.5 kb of agr; the filled bar represents 770 bp of 
Tn551; the open bars represent pSP64. The double headed arrow indicates the origin 
of the 1.8 kb Asp700/EcoRV probe used during this work. Restriction sites denoted 
are: A, Asp700; Ba, BamHI, Bg, Bg1fl; C, C1aI; E, EcoRI; Ec, EcoRV; Hd, HindIII; P, 
Pstl; C*, a ClaJ site which is methylated in E. coll. 
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FIGURE 4.6 
0.7 kb 1.1 kb 
Maps of pHF25 and pHF26. A 1.8 kb EcoRV/Asp700 fragment of agr spanning the 
P3 promoter was isolated from pEXO (see Fig. 4.5) and ligated into Smal digested 
pTKlac (see Fig. 4.3). Insertion of the fragment in the correct orientation (pHF25) 
and incorrect orientation (pHF26) was confirmed by digestion with EcoRIISalI to 
release the 1.8 kb fragment and Pstl, to release the 689 bp fragment spanning the P3 
promoter from pHF25. Restriction sites denoted are: E, EcoRI; P, Pstl; S, Sall. 
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FIGURE 4.7 
Agarose gel to confirm the orientation of the 1.8 kb EcoRV/Asp700 fragment of agr 
isolated from pEXO (see Fig. 4.5) in pHF25 and pHF26. Lanes 1-3 show pHF26, 
pHF25 and pTKlae (see Fig. 4.3), respectively, digested with SaiIIEcoRl to confirm 
the presence of the pEXO fragment (where applicable). The 1800 bp fragment is 
indicated on the left. Lane 4 is HindIlIlEcoRI digested a, (sizes of fragments are 
shown in Table 2.4). Lanes 5-7 show pHF26, pHF25 and pTKlac digested with PstI 
to release the 689 bp or 1 100 bp fragment (indicated on the right) from pHF25 or 
pHF26, respectively. 
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presence of X-Gal. Five attempts were. made to transform chromosomal DNA from 
SH106 into the wild type strain, 8325-4. However, this did not prove possible and 
strain SH106 was used as the starting strain for transposon mutagenesis. Correct 
integration of pHF25 into RN4220 was confirmed by Southern blotting with Pal 
digested chromosomal DNA from two transformants and RN4220 probed with a 
digoxygenin labelled 1.8 kb EcoRV/Asp700 fragment isolated from pEXO (Fig. 4.8). 
Two bands of PstI digested chromosomal DNA from RN4220 hybridised with the 
probe since there is a PstI site within the region of agr covered by the 1.8 kb probe 
(see Fig. 4.5). Clones 1 and 2 have each of the above bands but also have two 
additional bands of 689 bp and approximately 3.5 kb indicating the correct insertion. 
Fig. 4.9 shows how these bands are derived. 
4.2.2 Creation of transposon libraries in strain SH106 
Three separate transposon libraries were created using the temperature-sensitive 
plasmid, pRN3208, containing the transposon Tn551 (Kornblum et al., 1986) (Fig. 
4.1). As explained in section 4.1, plasmid pRN3208 has a Cd resistance marker for 
plasmid selection and an Em resistance marker for the transposon. Thus cells 
carrying pRN3208 are resistant to Cd but, following insertion of Tn551 into the 
chromosome, Cd resistance will be lost and only Em resistance will remain. Creation 
of transposon libraries is described in detail in chapter 2 but, briefly, strain SH106, 
containing pRN3208, was grown overnight with shaking at 30 OC in TSB containing 
Cm and CdC12. This culture was used to inoculate fresh media containing identical 
additions which was then grown with shaking at 30 OC until the OD600 reached 1.0. 
An aliquot of this culture (3 nil) was removed, centrifuged (3,000 rpm, 10 min, RT) 
and resuspended in TSB, containing Em, pre-warmed to 43 °C. The culture was 
maintained at 43 OC with shaking for approximately 4 hours until an OD600 of 
between 0.4 and 1.0 was obtained. An aliquot of this culture (3 ml) was transferred to 
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FIGURE 4.8 
Southern blot confirming the integration of pHF25 into the chromosome of S. aureus 
RN4220 to give strain SH 106. Lanes 1 and 2 show RN4220 containing pHF25 and 
Lane 3 shows RN4220 digested with Pstl, probed with the digoxygenin labelled 1.8 
kb EcoRVIAsp700 fragment isolated from pEXO (see Fig. 4.5). The sizes of 
HindlUEcoRI digested X fragments are indicated on the left (bp). The sizes of 
hybridising fragments are indicated on the right (bp). 
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FIGURE 4.9 
Construction of the hld:: lacZ transcriptional reporter gene fusion strain, SH 106. The 
extent of the agr locus is indicated by the symbol, II. The hybridising bands indicated 
resulted from digesting chromosomal DNA of strains RN4220 and SH106 with Pal 
(P) and correspond to bands on the Southern blot (see Fig. 4.8). The extent of the 1.8 
kb EcoRVIAsp700 probe (double headed arrow) (see Fig. 4.5) is shown. (This figure 
is not to scale). 
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TSB, pre-warmed to 43 °C, containing Em, and grown at 43 °C until the ODD 
reached 1.5. Cells were centrifuged (8,000 rpm, 10 min, RT), resuspended in 
TSB/glycerol (10 % v/v) and aliquoted (0.5 ml) into sterile 1.5 ml microfuge tubes. 
The cells were then flash frozen and stored at -20 °C. One aliquot of each library was 
immediately defrosted and quantified as shown in Table 4.1. The three libraries 
contained between 6.5 x 106 and 3x 107 colony forming units (cfu) per ml. In order 
to confirm that the libraries were not contaminated, serial dilutions of each library 
were spotted (10 µl) onto plates with either no antibiotic or with Cm/Em. In addition, 
comparison between the number of cfu on plates containing Cm or Cm/CdC12 
revealed that <1 % of the cells were Cd resistant and thus still retained pRN3208. 
4.2.3 Isolation of hld:: lacZ expression mutants 
4.2.3.1 Optimisation of mutant selection conditions 
Expression of hld:: lacZ by strain SH106 was measured on plates using the substrate 
X-Gal. Different concentrations of X-Gal (from 50-150 µl of a 20 mg/ml stock) were 
either spread directly on to the surface of BHI plates using glass beads or added in an 
agar overlay (3 ml). Both methods, using 100 µl of 20 mg/ml X-Gal, gave 
comparable and adequate results so, for ease of experimentation, X-Gal was spread 
with glass beads and the plates dried prior to plating of bacteria. In order to ensure 
that the colour of individual colonies would. be easily discernible, serial dilutions of 
cells were plated out to determine an optimum number of colonies per plate. It was 
apparent that approximately 250 cfu per plate was the maximum that allowed easy 
differentiation between blue and white colonies. 
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cfu/ml 
Library: Cm/Em No Ab Cm/CdC12 
HF1 2.5x107 2.6x107 9.5x104 
HF2 3x 107 3x 107 5.5 x 104 
HF3 6.5 x 106 7x 106 3x 104 
TABLE 4.1 
Determination of the concentration of the transposon libraries (where N= cfu/ml of 
each library), the purity and efficiency. of transposition. (Ab denotes antibiotic). 
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4.2.3.2 Quantification of the spontaneous hld:: lacZ mutation rate 
In order to determine the likelihood of mutations affecting hld:: lacZ expression being 
due to Tn551, it was necessary to establish the rate at which spontaneous mutations 
affecting ß-galactosidase production occurred. Thus, approximately 30,000 colonies 
of strain SH106 (without the transposon) were screened on antibiotic-free BHI plates 
spread with X-Gal. 36 colonies appeared white and were plated onto BHI with 
chloramphenicol and X-Gal. Of these, 19 grew to a comparable colony size to 
SH106,13 grew very slightly and 3 did not grow at all. On rescreening of the 
colonies, only one of those able to grow well was consistently white. As agr mutants 
grow well, those colonies which showed diminished growth were deemed unlikely to 
bear mutations in regulators of agr but rather have gross growth defects. It was 
therefore concluded that 1 in 30,000 cells was naturally white, presumably due to a 
spontaneous mutation. Strain SH106 was also grown at 43 OC, the temperature used 
to create the transposon libraries, and it was found that growth at this higher 
temperature did not lead to an increase in the number of spontaneous white mutants. 
4.2.3.3 Isolation of mutants with altered hld:: lacZ expression 
Transposon mutants were selected by plating out approximately 250 
colonies per plate on antibiotic-free BHI agar spread with X-Gal. Forty seven 
mutants (designated Al-A6, B1-B2, C1-C25, D1-D4 and 2/1-2/10) were selected out 
of approximately 52,000 colonies screened. These mutants were consistently white 
and grew well on plates in the presence of Cm and Em. The frequency of possible 
hld:: lacZ expression mutants in the transposon libraries was therefore deemed to be ' 
approximately 1 per 1000 cells. 
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4.2.4 Phage transduction 
4.2.4.1 Transduction into parental strain SH106 
In order to determine that the alteration in hld:: lacZ expression was due to transposon 
insertion, transposons from all 47 mutants were phage transduced into the parental 
strain SH106 on two separate occasions using 085. SH106 is blue in the presence of 
X-Gal due to hid:: lacZ expression. Phage transduction using lysate from each mutant 
into SH106 and selection for Em resistant colonies allowed the co-transduction of the 
transposon and the hid expression defect to be assessed. If the transposon insertion 
had resulted in the alteration in hld:: lacZ expression then all the transductants should 
be white on BHI X-Gal plates. Transduction was not achieved with lysate prepared 
from 8 of the 47 mutants, namely A3, A4, B 1, C8, C10, C15,2/1 and 2/8. However, 
transductants containing each of the remaining mutations were grown on BHI with X- 
Gal and Cm/Em, and all colonies remained blue indicating that the transposon had not 
inserted into a locus affecting hld:: lacZ expression in any of the mutants. The total 
number of transductants tested for each mutant is shown in Table 4.2. 
4.2.4.2 Transduction into wild type strain 8325-4 
Transposon mutations were also transduced into strain 8325-4 and selected as Em 
resistant colonies. Initially, transductants were inoculated as a single stab onto sheep 
blood agar plates to measure production of ß-haemolysin, and compared visually with 
8325-4 (Table 4.2). Several transductants showed variable but reduced levels of ß-' 
haemolysin activity, evidenced by approximately a 0-5 mm radius of clearing around 
the stab compared to approximately 7 mm around strain 8325-4 (Table 4.2). 
Transductants from five mutants (C2, C4, C5, C 11 and C25) showed ß-haemolysis 
reduced to consistently low levels (approximately a2 mm radius of complete 
clearing) (Table 4.2). All transductants"showed an additional, but faint, area of 
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Strain 
No. of transductants 
in SH 106 
No. of transductants 
in 8325-4 
Average (± SD) radius 
of ß-haemolysis (mm) 
8325-4 7+1.0 
Al 11 31 7±1.2 
A2 11 60 4±1.1 
A5 34 37 3+1.0 
A6 6 43 5+1.1 
B2 22 16 4±0.7 
C1 31 25 4+0.5 
C2 33 22 2+0.3 
C4 11 32 2+0.3 
C5 50 43 2±0.1 
C7 70 56 3.5 + 0.6 
C9 18 44 4± 1.9 
C11 33 23 2+0.2 
C13 16 14 5.5 + 1.3 
C14 6 32 6+0.5 
C16 49 28 5.5 + 1.0 
C 17 15 37 3+1.5 
C20 12 54 5+1.0 
C23 14 32 4+1.8 
C24 22 35 6+1.0 
C25 -- 23 2+0.4 
2/4 38 45 4.5 + 0.8 
2/5 15 22 3.5 + 1.5 
2/6 46 31 7+1.0 
2/7 -- 28 7+1.1 
2/10 40 25 7+2.0 
D1 52 47 5+1.0 
D2 27 0 --- 
D4 141 0 
TABLE a. 2 
Phage transduction of putative regulatory mutants. ß-haemolysis was measured using 
transductants in the 8325-4 background. 
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clearing up to .3 mm around each colony. 
The intensity of lysis in this outer halo was 
greatly reduced compared to the wild type. One transductant of each mutant (suffixed 
. 1) was selected 
for further study as necessary. 
4.2.5 Physical mapping of the transposon insertions 
One method for mapping transposon insertions utilises a technique known as pulsed 
field gel electrophoresis (PFGE) (see section 2.9.3) Chromosomal DNA is first 
digested with an enzyme which has rarely occurring restriction sites, for example, 
SmaI is used in S. aureus. Smal digestion of total chromosomal DNA of S. aureus 
8325 results in sixteen fragments ranging from 9-670 kb (Pattee et al., 1990) which 
can be resolved by PFGE. Strains 8325-4 and RN4220 differ from 8325 in that they 
are cured of three resident prophages, 0 11,0 12 and 0 13. Prophage 0 12 is in Smal 
fragment A (670 kb) whilst both 0 11 and 0 13 are in Smal fragment F (205 kb). The 
PFGE profile of strains 8325-4 and RN4220 thus differs from 8325 in that fragment 
A is reduced to 630 kb and fragment F decreases to 135 kb so that it appears in the 
same position as fragment H (Pattee et al., 1990). 
Digested chromosomal DNA can be separated by two types of pulsed field gel - 
clamped homogenous electric field electrophoresis (CHEF) and field inversion gel 
electrophoresis (FIGE). Under the conditions used in this work, separation of DNA 
by CHEF results in resolution of fragments ranging from 60-1000 kb and by FIGE 
from 9-250 kb. This technique allows the separation of such large fragments because, 
unlike standard gel electrophoresis, the direction of the current is constantly switched. 
In standard gel electrophoresis, pore size in the-agarose matrix alone retards 
fragments according to their size. In PFGE the switching current means that 
fragments of DNA passing through the gel have to constantly reorientate themselves. 
Smaller fragments reorientate themselves much more quickly and progress further 
through the gel matrix. 
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In order to physically map the Tn551 insertion site in the chromosome of each 
mutant, chromosomal DNA from 12 mutants (Al, A2, A5, B2, Cl, C2, C5, C7, C11, 
C17,2/4 and 2/8) together with a randomly selected blue transposon mutant (DB33) 
from a Tn551 library in SH106 as a positive control, and strain RN4220, was digested 
with Smal and examined by PFGE (see section 2.9.3). Briefly, the preparation of 
samples for PFGE involved setting whole cells (2 x 108) of each strain into a plug of 
agarose and then lysing, washing and digesting etc. in situ. Each plug containing the 
restricted DNA was then inserted into a well of a TBE agarose gel and the fragments 
separated by clamped homogenous electric field electrophoresis (CHEF). Under the 
conditions used (see section 2.9.3.3) eleven Smal fragments (from 76-630 kb) from 
each S. aureus strain examined were observed, designated A-K (Fig. 4.10). Since 
Tn551 has a high level of homology with Tn917 (Giraudo et al, 1994b) a 
digoxygenin labelled 5 kb Xbal fragment of Tn917, isolated from pLTV3 (Camilli et 
al., 1990) (see Fig. 5.1) was used to probe a Southern blot of the CHEF gel. Mutant 
Al did not show clear evidence of hybridisation with the probe (Fig. 4.11) although it 
can be seen from the pulsed field gel that strain Al has a typical S. aureus profile 
when compared with the RN4220 control (Fig. 4.10). This probably indicates that the 
transposon is in a fragment smaller than those resolved on a CHEF gel. Mutants A2, 
A5, B2, Cl, C2, C5, CI I and 2/4 all contained a transposon within Smal fragment A 
(630 kb) whilst strains C7 and C17 contained Tn551 in Smal fragment C (324 kb) 
(Fig. 4.11). Strain 2/8 did not have an S. aureus profile (Fig. 4.10) indicating that this 
was a contaminant and consequently did not contain Tn551 (Fig. 4.11). 
Chromosomal DNA of strain DB33 (Tn551 control) showed slight hybridisation with 
the probe at SmaI fragment A but a very strong reaction at the site of Smal fragment 
G (175 kb) (Fig: 4.11). Subsequent CHEF PFGE revealed that strains B1 and 2/1 
were not S. aureus as their SmaI profiles were not related to the RN4220 control 
(results not shown). This explains why it was not possible to phage transduce 
mutations from these strains, or strain 2/8 (see section 4.2.4). 
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FIGURE 4.10 
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Snual fragments 
(kb) 
A (63O) 
B(361) 
C (324) 
D (262) 
E (257) 
C(175) 
H (135) 
I (117) 
J (KO) 
K (76) 
CHEF pulsed field gel to map Tn551 insertion sites. Lanes 1 through 14 contain 
Smal digests of total chromosomal DNA of strains Al, A2, A5, B2, Cl, C2, C5, C7, 
Cl 1, C17,2/4,2/8, DB33 and RN4220. The corresponding DNA fragments of 
RN4220 are shown on the right with their sizes (kb). The gel was calibrated using the 
standards (not shown) listed in Table 2.5. 
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FIGURE 4.11 
Southern blot of a CHEF pulsed field gel to map Tn551 insertions (see Fig. 4.10). 
Lanes 1 through 13 contain Smal digests of total chromosomal DNA of strains A 1, 
A2, A5, B2, Cl, C2, C5, C7, C11, C17,2/4,2/8 and DB33 probed with a digoxygenin 
labelled 5 kb Xbal fragment of Tn917 (see Fig. 5.1). The corresponding DNA 
fragments of RN4220 are shown on the right with their sizes (kb). Hybridising bands 
are highlighted on the left. 
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Each selected transductant (see section 4.2.4.2) of a mutant that contained Tn551 in 
Smal fragment A or C was also examined using PFGE. This confirmed that the 
transposon mutations had transduced to the same fragments in strain 8325-4. 
4.2.6 Fine physical mapping of Tn551 insertions 
In order to further map the Tn551 insertion sites in each mutant, and to determine 
their relationship with each other, a series of restriction digests and hybridisation 
studies were carried out. Initially, chromosomal DNA (5 µg) of the Smal fragment A 
mutants was separated on TBE agarose gels following restriction digestion with 
EcoRI, Pstl or Xbal. Southern blots of these gels (Fig. 4.12) were probed with a 
digoxygenin labelled 5 kb Xbal fragment of Tn917 from pLTV 1 (Camilli et al., 1990) 
(see Fig. 5.1). XbaI cuts at the same position within Tn551 so that by using a 
similarly digested probe only one of the XbaI digest fragments covered by the probe 
will hybridise. From the resulting fragment sizes (Table 4.3) it can be seen that all of 
the mutants show a different hybridisation pattern indicating that none are siblings. 
Therefore, the transposon insertions may either be in different loci or at altered 
positions within the same locus. 
Many of the hybridising fragments were fairly large (Table 4.3) so chromosomal 
DNA (5 µg) of each Smal fragment A mutant, together with Smal fragment C 
mutants, was digested with KpnI, KpnIlEcoRI, EcoRIIPstI or SaII to identify smaller 
fragments suitable for subcloning. Tn551, in common with Tn917, contains both a 
KpnI and a Sail restriction site downstream of the Em resistance (erm) gene (see Fig. 
5.1). Southern blots of these gels (Figs. 4.13-4.16) were probed with ä digoxygenin 
labelled 3 kb KpnIlXbal fragment of Tn917-LTV3 (see Fig. 5.1). This probe 
excludes the Em resistance gene of Tn551. Consequently, when chromosomal DNA 
was digested with KpnI or KpnIlEcoRI the probe hybridised to chromosomal DNA 
flanking only the distal end of Tn551, i. e. excluding the Em resistance gene. This 
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FIGURE 4.12 
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Southern blots to map Tn551 insertion sites. (a) Lanes 1 through 8 show EcoRI 
digested chromosomal DNA of strains A2.1, A5.1, B2.1, C 1.1, C2.1, C5.1, C11.1 and 
2/4.1 and lanes 9 through 12 show Pstl digested chromosomal DNA of strains A2.1, 
A5.1, C 1.1 and C2.1, (b, overleaf) Lanes 1 through 8 show Xhal digested 
chromosomal DNA of strains A2.1, A5.1, B2.1, C 1.1, C2.1, C5.1, Cl 1.1 and 2/4.1 
and lanes 9 through 11 show Pstl digested chromosomal DNA of strains C5.1, C11.1 
and 2/4.1. DNA was probed with the digoxygenin labelled 5 kb Xbal fragment of 
Tn917 (see Fig. 5.1). The sizes of the bands of Hindlll digested k are shown on the 
left (bp). 
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Size of fragment containing Tn551 (kb) 
Mutant 
EcoRI PstI Xbal 
A2.1 >23.0 21.0 6.0 
A5.1 12.0 23.0 5.5 
B2.1 23.0 - 17.0 
CIA 12.0 23.0 12.0 
C2.1 23.0 20.0 12.0 
C5.1 23.0 9.5 12.0 
C11.1 15.0 20.0 18.0 
2/4.1 >23.0 20.0 12.0 
TABLE 4.3 
Physical mapping of Tn551 insertion sites. The sizes of the fragments of 
chromosomal DNA of each mutant, listed above, which hybridised with the 
digoxygenin labelled 5 kb Xbal fragment of Tn917 (see Fig. 5.1) are given. 
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Southern blot to map Tn551 insertion sites. Lanes 1 through 10 show strains A2.1, 
A5.1, B2.1, C1.1, C2.1, C5.1, C7.1, C11.1, C17.1, and 2/4.1 digested with Kpnl and 
probed with the digoxygenin labelled 3 kb XbaI/Kpnl digested fragment of Tn917 
(see Fig. 5.1). The sizes of the bands of HindHI digested ? are shown on the left (bp). 
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" Ai 
Southern blot to map Tn55/ insertion sites. Lanes 1 through 10 show strains A2.1, 
A5.1, B2.1, C1.1, C2.1, C5.1, C7.1, C11.1, C17.1, and 2/4.1 digested with 
KpnIlEcoRI and probed with the digoxygenin labelled 3 kb Xbal/Kpnl digested 
fragment of Tn917 (see Fig. 5.1). The sizes of the bands of Hindlll digested A. are 
shown on the left (bp). 
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Southern blot to map Tn551 insertion sites. Lanes 1 through 10 show strains A2.1, 
A5.1, B2.1, C1.1, C2.1, C5.1, C7.1, C11.1, C17.1, and 2/4.1 digested with EcOR1/Ystl 
and probed with the digoxygenin labelled 3 kb XbaUKpnI digested fragment of Tn917 
(see Fig. 5.1). The sizes of the bands of Hindu1 digested a, are shown on the left (bp). 
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Southern blot to map Tn551 insertion sites. Lanes 1 through 10 show strains A2.1, 
A5.1, B2.1, Cl.!, C2.1, C5.1, C7.1, C11.1, C17.1, and 2/4.1 digested with Sall and 
probed with the digoxygenin labelled 3 kb Xbal/Kpnl digested fragment of Tn917 
(see Fig. 5.1). The sizes of the bands of HindIII digested ? are shown on the left (bp). 
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strategy was adopted since constitutive expression of the Em resistance gene may be 
toxic to E. coli and thus attempting to clone a fragment of DNA containing an Em 
resistance gene would have been detrimental. In fact, when Morfeldt et al. (1988) 
first identified exp (agr) by a Tn551 insertion it proved necessary to clone DNA 
flanking only the distal end of Tn551, excluding the Em resistance gene. 
Again all the mutants showed different restriction profiles (Table 4.4). The Sall 
restriction digest of the chromosomal DNA of each mutant resulted in two bands 
hybridising with the probe since a Sall site occurs within the region of Tn551 covered 
by the probe (Table 4.4). Two fragments of PstI/EcoRI digested DNA of strains 
C2.1, C5.1 and Cu.! 7also hybridised with the probe. However, at least in the case of 
strains C2.1 and C5.1 it is likely that the larger fragments (23 kb) represent DNA 
which has digested only with EcoRI (see Table 4.3). Strain C17.1 was not previously 
digested with EcoRI or PstI individually so it is impossible to be certain that the extra 
band is due to partially digested DNA, although this seems likely. 
4.2.7 Cloning of transposon insertion sites 
In order to clone chromosomal DNA flanking Tn551 it is necessary to identify a 
fragment of DNA containing the transposon which is a suitable size (up to 10 kb) to 
ligate into a plasmid capable of being maintained in E. coli. Chromosomal DNA (25 
µg) of strains A2.1, A5.1, B2.1, Cl.!, C2.1, C5.1, C7.1, Cl!.!, Cu.!, 7and 2/4.1 was 
therefore digested with KpnI or KpnIlEcoRI since these enzymes gave Tn551- 
containing fragments which were 10 kb or less (Table 4.4). In order to confirm the 
exact sizes of the fragments of chromosomal DNA which contained the transposon, 
KpnI or KpnIlEcoRI digested DNA (5 µg) was again separated on TBE agarose gels 
and Southern blots of each gel (results not shown) were probed as above. 
Chromosomal DNA (20 gg) from strains A5.1, C2.1, C17.1 and 2/4.1, digested with 
KpnI and from strains C11.1 and C7.1 digested with KpnI/EcoRI was separated on a 
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Sizes of hybridising fragments (kb) 
Strain 
K pnl K nUEcoRI EcoRUPsll Sall 
A2.1 4.2 4.2 12.0 16.0+9.4 
A5.1 4.0 4.0 9.2 15.0 + >23.0 
B2.1 9.3 9.3 9.0 20.0+19.0 
Cl.! 9.3 4.4 8.8 17.0+20.0 
C2.1 9.3 9.3 6.0+23.0 16.0+19.0 
C5.1 9.3 7.5 6.5+23.0 16.0+ 19.0 
C11.1 7.5 3.2 15.0 12.0+18.0 
2/4.1 4.1 4.4 >23.0 3.8+4.2 
C7.1 9.3 3.4 9.2 18.0+20.0 
C 17.1 3.8 3.8 18.0 + >23.0 18.0 + >23.0 
TABLE 4.4 
Physical mapping of Tn551 insertion sites. The sizes of the fragments of 
chromosomal DNA of each mutant, listed above, which hybridised with the 
digoxygenin labelled 3 kb KpnllXbal fragment of Tn917 (see Fig. 5.1) are given. 
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TAE agarose gel. For each mutant, fragments in the region spanning 2 kb above and 
below the appropriate size were excised and purified from the gel. Each sample 
therefore contained many fragments of Kpnl or KpnUEcoRI digested chromosomal 
DNA. The fragments were then ligated into similarly digested, dephosphorylated 
pUBS 1 (Foster, 1995) and transformed into E. coli XLOLR by electroporation 
(Schenk and Laddaga, 1992) or into ultra-competent E. coli XL2-Blue MRF' 
(Stratagene). Putative transformants were then probed, by colony blotting, with a5 
kb Xbal fragment of Tn917-LTV3 to identify clones containing Tn551. However, 
after probing approximately 100 colonies of each mutant it was not possible to isolate 
any positive clones. 
4.2.8 Phenotypic characterisation of five Tn551 mutants 
The five strains (C2.1, C4.1, C5.1, C 11.1 and C25.1) which showed consistently low 
levels of ß-haemolysin activity, along with 8325-4 (WT) and the agr- strain, WA250 
(Morfeldt et al., 1988) for comparison, were examined for the production of several 
virulence associated characteristics. Cultures of each strain were grown overnight in 
BHI and diluted in phosphate buffered saline (PBS) (I ml) to give an ODW) of 0.5. 
This was assumed to be approximately 108 cells per ml (see section 3.2.3). Serial 
dilutions (from 106 to 102 cfu/ml) in PBS were spotted (10 µl) onto antibiotic-free 
plates as appropriate and phenotypic characteristics compared. The results are 
summarised in Table 4.5. 
4.2.8.1 -haemolysin assay 
Strains were plated onto sheep blood agar (see appendix A, section A 1.4. I) where 
strain 8325-4 showed an average 7 mm radius of clearing around single colonies and 
strain WA250 was p-haemolysin negative (Fig. 4.17). All five mutants showed 
approximately a2 mm radius of complete clearing around single colonies. However, 
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Strain ß-haem. a-haem. Protease Lipase DNase 
Hyaluronate 
lyase 
8325-4 +++ +++ +++ +++ +++ +++ 
WA250 - - -/+ +++ + + 
C2. I + ++/+++ ++ ++ ++/+++ ++ 
C4.1 + ++/+++ + +++ +++ ++ 
C5.1 + ++ + +++ ++ ++ 
C11.1 + ++ ++ +++ +++ ++ 
C25.1 + ++/+++ ++/+++ ++ +++ ++ 
TABLE 4.5 
Phenotypic characteristics of five Tn551 mutants compared with strains 8325-4 (WT) 
and WA250 (agr). 
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(a) 
8325-4 
(b) 
8325-4 
cl l. l 
FIGURE 4.17 
l3-Haemolysin plate assay. Strains 8325-4 (WT), WA2S0 (agr) and strains (a) C5.1 
and (b) C11.1 were serially diluted and spotted (10 ftl) onto sheep blood agar prior to 
incubation overnight at 37°C. 
Serial dilutions (where N= 106 cfu/ml) were plated in the order shown in the key 
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extending a further 2-3 mm was an area of lysis which was much fainter than that 
found in 8325-4. Strains C5.1 and C11.1 show the limited range of variation in 
haemolytic activity of these mutants (Fig. 4.17). 
4.2.8.2 9c-haemolysin assay 
This assay consisted of plating dilutions of cultures on rabbit blood agar (see 
appendix A, section A1.4.2) and, following growth overnight at 37 °C, measuring 
zones of clearing around each colony. Strain 8325-4 showed a halo of clearing 
radiating approximately 1 cm from a colony and WA250 was a-haemolysin negative 
(Fig. 4.18). Strains C2.1, C4.1 and C25.1 all showed a slight reduction in intensity of 
clearing which extended approximately 8 mm, 8 mm and 9 mm respectively. Strains 
C5.1 and C 11.1 also showed a reduced radius of clearing which extended 
approximately 6 mm around single colonies (Fig. 4.18). However, strain C 11.1 
showed a much less intense halo of clearing (Fig. 4.18). 
4.2.8.3 Lipase assay 
This assay used egg yolk (10 %) in an overlay (5 ml) on TPEY agar plates (see 
appendix A, section A 1.4.4) to test for lipase activity. Plates were incubated for 48 
hours at 37 OC and a positive result was evidenced by a white precipitate around 
colonies (see section 4.3). Strains WA250 and 8325-4 appeared equally lipase 
positive, characterised by approximately a3 mm precipitate around single colonies 
(Fig. 4.19). Strains C4.1, C5.1 and C11.1 showed lipase activity comparable to the 
wild type but strains C2.1 and C25.1 showed reduced activity resulting in a precipitate 
extending approximately 2 mm around single colonies (Fig. 4.19). 
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(a) 
8325-4 
WA250 
C5.1 
(b) 
8325-4 
C11.1 
FIGURE 4.18 
ca-Haemolysin plate assay. Strains C5.1 (a) and C11.1 (b), together with 8325-4 
(WT) and strain WA250 (agr) were grown for 24 h at 37°1C on rabbit blood agar and 
the zones of (x-haemolysis measured and compared. The key for the dilutions plated 
is as in Fig. 4.17. 
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(a) 
8325-4 
C2.1 
(b) 
8325-4 
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FIGURE 4.19 
WA250 
WA250 
Lipase plate assay. Strains C2.1 (a) and C25.1 (b) together with 8325-4 (WT) and 
WA250 (agr) were grown for 48 hat 37°C on egg yolk agar (10%). Lipase 
production is evident as a white zone of precipitation around the colonies. The key 
for the dilutions plated is as in Fig. 4.17. 
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4.2.8.4 Protease assay 
Strains were plated on BHI agar plates containing dried skimmed milk (1.5 % w/v) 
(see appendix A, section A 1.4.5) for 24 hours at 37 OC and protease activity was 
evident as a halo of clearing in the opaque background (see section 4.3). All five 
mutants appeared to have reduced protease activity compared to strain 8325-4 which 
gave an area of clearing radiating approximately 3 mm around single colonies (Fig. 
4.20). A halo of protease activity was apparent in strain WA250 around large clusters 
of colonies but not around single colonies (Fig. 4.20). Strains C2.1 and C11.1 gave a 
halo radiating approximately 2 mm, C5.1 showed approximately 1.5 mm of clearing 
around single colonies (Fig. 4.20) and strain C25.1 approximately 2-3 mm. All 
mutants showed an area of clearing which was less intense than that observed in the 
wild type. Strain C4.1 showed the greatest reduction with a very faint halo of 
clearing extending approximately 1.5 mm from single colonies (Fig. 4.20). 
4.2.8.5 DNase assay 
Strains were grown overnight at 37 OC on DNase agar plates and then overlaid with 
0.5X DNase agar (5 ml) containing methyl green (0.5 mg/ml) (see appendix A, 
section A 1.4.3) and incubated at 37 OC for a further 1-2 hours. DNase positive 
colonies are characterised by a zone of clearing against the blue/green of the plates 
(see section 4.3). Strain 8325-4 was DNase positive, evidenced by approximately a1 
cm radius of clearing around colonies and strain WA250 was slightly DNase positive 
with faint clearing extending approximately 3 mm (Fig. 4.21). Mutants C4.1, C11.1 
and C25.1 all showed identical levels of DNase activity to 8325-4. The zone of 
clearing around colonies of C2.1 tended to appear smaller (approximately 8 mm) and 
less intense. However, mutant C5.1 had a5 mm halo of clearing around colonies and 
this halo was less intense (Fig. 4.21). 
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(a) 
8325-4 
C4.1 
(b) 
8325-4 
C5.1 
FIGURE 4.20 
Protease plate assay. Strains C4. I (a) and C5.1 (b), together with 8325-4 (WT) and 
WA250 (agr) were grown on BHI agar containing dried skimmed milk (1.5% w/v). 
Protease production can be seen as a zone of clearing in the opaque background. The 
key to the dilutions plated is shown in Fig. 4.17. 
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8325-4 
C5.1 
FIGURE 4.21 
pNase plate assay. Strains C5.1,8.325-4 (WT) and WA250 (agr) were grown for 24 
h at 37°C on DNase agar then overlaid with dimethyl green (0.5 mg/ml) in DNase 
agar (0.5X, 5 ml) and incubated for 1-2 hat 37°C. Zones of clearing were measured 
to compare production of DNase. Key to dilutions plated is as for Fig. 4.17. 
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4.2.8.6 Hyaluronate lyase assay 
Cells were incubated overnight at 37 OC on BHI agar plates containing BSA (1 % 
w/v) and sodium hyaluronate (0.04 % w/v) and then flooded with acetic acid (2 M) at 
room temperature (Farrell et al., 1995; Smith and Willett, 1968) (see appendix A, 
section A 1.4.6). Undegraded hyaluronate precipitates as a conjugate with albumin in 
the presence of the acetic acid (Farrell et al., 1995) (see section 4.3). Hyaluronate 
lyase activity was observed as a clear zone against a background precipitate. Zones 
of clearing around strain 8325-4 extended approximately 7 mm around single 
colonies and, around strain WA250, approximately 4 mm (Fig. 4.22). All the 
mutants, including C5.1 and C25.1 showed approximately a 5-6 mm halo of clearing 
(Fig. 4.22). 
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clearing. The key to dilutions plated is as for Fig. 4.17. 
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4.3 Discussion 
In order to identify possible agr regulatory loci, it was proposed to isolate mutants 
with altered hld:: lacZ expression. Mutants were created using the staphylococcal 
transposon Tn551 (which contains an Em resistance gene) in an hld:: lacZ reporter 
strain. Since the hld:: lacZ reporter strain, SH101 (see chapter 3), contains the Em 
resistance gene of pAZ106 (Kemp et al., 1991) a new fusion strain with a different 
selective marker was required. This avoids the likelihood of the Em resistance gene 
of Tn551 recombining with the chromosomal Em resistance gene. Thus, the second 
reporter gene fusion produced in this work, strain SH106, although essentially the 
same as strain SH101, utilised an alternative suicide vector, pTKlac which carries a 
Cm resistance gene instead of an Em resistance gene. This fusion is stable, does not 
need to be maintained with antibiotics and leaves an intact single copy of agr. The 
lacZ expression is dependent on the activity of the P3 promoter of agr. Thus, 
hld:: lacZ expression, measured by ß-galactosidase activity, is a reporter of the levels 
of transcription generated by P3 of the agr locus. Tn551 mutagenesis was thus used 
to try to isolate mutants with altered hld:: lacZ expression as evidenced by a change in 
the blue colour of colonies. Spontaneous mutants arose at a frequency approximately 
30 times less than the recovered rate of transposon mutants. Transposon insertion 
could result in less hld:: lacZ expression either by insertion in agr itself, or perhaps 
another gene affecting agr activity. 
Forty seven putative hld:: lacZ expression mutants were recovered as white colonies 
on plates containing X-Gal. Phage transduction of these mutations into the parental 
strain, should have rendered the transductants white also. However, all transductants 
remained blue. Following phage transduction into the wild type strain, 8325-4, 
several mutants were identified which showed altered patterns of p-haemolysis. This 
haemolysin is positively regulated by agr and so mutations affecting agr activity 
might be expected to affect levels of p-haemolysin. 
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Haemolysins are cytolytic toxins which can lyse not only erythrocytes but often other 
cell types as well (Rowe and Welch, 1994). ß-haemolysin production is measured on 
sheep blood agar plates on which a-haemolysin production is inhibited (Peng et al., 
1988). Four mutants (A5.1, C7.1, C17.1 and 2/4.1) showed variable levels of 
reduction in ß-haemolysin activity (approximately 0-5 mm radius of clearing) 
compared with strain 8325-4 (approximately 7 mm). Five further mutants (C2.1, 
C4.1, C5.1, C11.1 and C25.1) showed consistently low levels of (3-haemolysis 
(approximately 2 mm radius of clearing). 
All these mutants (excluding C4.1 and C25.1) together with a further five mutants 
(Al.!, A2.1, B2.1, C1.1 and 2/8.1) were examined using CHEF PFGE. Eight 
mutants were shown to contain the transposon Tn551 in SmaI fragment A and two in 
fragment C. These initial results suggested that none of the mutants contained the 
transposon within either the ß-haemolysin gene or agr since these loci are in Smal 
fragment F which co-runs with fragment H in 8325-4 and RN4220 (Pattee et al., 
1990; Smeltzer et al., 1992)). Similarly, these are not sar mutants since the sar locus 
has been mapped to SmaI fragment D (Cheung and Ying, 1994). 
The location of the transposon within the chromosome of each mutant was mapped 
more finely by restriction digest to identify whether Tn551 was inserting into the 
same locus in each mutant. The restriction data suggested that none of the mutants 
were identical to each other. Furthermore, following additional characterisation of 
five mutants (C2.1, C4.1, C5.1, C11.1 and C25.1) it was found that they all showed 
different profiles of virulence determinant production. This indicates that the 
transposon in each of these five strains has probably not inserted at different positions 
within the same gene, but rather that multiple loci may have been affected. 
a-haemolysin activity was measured using rabbit erythrocytes as the substrate. This 
haemolysin forms pores in target cell membranes (see section 1.4.2.1) and is 
extremely active against rabbit erythrocytes, which is the accepted medium for 
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quantifying activity. All five mutants showed reduced levels of a-haemolysin 
compared to wild type strain 8325-4. Strains C2.1 and C4.1 showed similar levels of 
a-haemolysin but the other three mutants (C5.1, C11.1 and C25.1) were different to 
each other. None of these mutants contain Tn551 in the hla structural gene since this 
has been mapped to Smal fragment B (Pattee et al., 1990). 
The method employed in this work for assaying lipase activity used a simple plate 
assay consisting of TPEY agar containing enriched egg yolk (10 % v/v) which gives a 
cloudy emulsion. Lipase activity is evidenced by a white precipitate around a colony. 
Only two of the mutants (C2.1 and 25.1) displayed reduced lipase activity compared 
to the wild type 8325-4. It was also seen that the agr strain WA250 showed no 
`reduction in lipase activity, equalling the levels produced by 8325-4. The lipase 
activity of S. aureus is discussed in section 1.4.6.1. Also as suggested in section 
1.4.6.1, other substrates provide more definitive tests for lipase activity than egg-yolk 
and it has been shown that some strains displaying lipase negative phenotypes on 
egg-yolk agar are, in fact, lipase positive when tested on the long chain fatty acid 
triacylglycerol, triolein (Farrell et al., 1990). In addition, a strain of S. aureus 
containing a transposon in agr, used by Smeltzer et al. (1992), has been reported as 
showing a decrease in lipase activity compared to an agr+ strain, using tributyrin as 
the substrate. This finding does not correlate with the results shown above for the 
agr strain, WA250. However, it should be noted that the egg yolk assay used in this 
work has been used as a qualitative rather than quantitative assay and the conflicting 
result may be due to the choice of substrate. 
Two mutants (C2.1 and C5.1) showed reduced DNase activity. The assay used in this 
work was based on a method described by Langlois et al. (1989) and differs from 
methods used by some other workers in that it uses methyl green to detect the extent 
of DNase activity (Smith et al., 1969). Methyl green combines solely with DNA 
which is highly polymerised and thus nuclease activity can be seen as a zone of 
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clearing in the dye around nuclease-producing colonies. It is possible to use toluidine 
blue-DNA-agar (Lachica et al., 1970) or acridine orange (40 gg/ml)-DNA-agar which 
intercalates with the DNA in the agar and fluoresces under UV light with DNase 
positive colonies evidenced by a non-fluorescent zone. The disadvantage of using 
acridine orange is that it is toxic and plates can only be viewed under UV light. The 
nuclease of S. aureus is discussed in section 1.4.6.3. 
All five mutants showed reduced protease activity with clearing radiating 
approximately 1.5 mm around single colonies of each mutant compared to 
approximately 3 mm in strain 8325-4. In addition, the halo of clearing was less 
intense in all mutants than in strain 8325-4. In this assay, protease activity degrades 
the casein present in dry skimmed milk changing the milky appearance of the plates 
to a zone of clearing. The proteases of S. aureus are discussed in section 1.4.6.2. 
All five mutants also showed reduced hyaluronate lyase activity compared to 8325-4. 
In this assay the undegraded substrate (hyaluronate), in the presence of 2M acetic 
acid, precipitates as a conjugate with the bovine serum albumin leaving a clear zone 
around those colonies that produce soluble enzymes (hyaluronate lyase) that attack 
the hyaluronate (Smith and Willett, 1968). Hyaluronate lyase is discussed in section 
1.4.8. 
As discussed in section 4.1, transposons provide a straightforward way of creating 
mutants that can be identified by a particular phenotype. Transposon mutagenesis is 
also a good way of identifying mutants with pleiotropic alterations to virulence 
characteristics when the transposon is inserted into a regulatory locus. For example, 
the agr locus was originally identified by the insertion of Tn551 into what was 
thought to be the a-haemolysin (hla) gene (Mallonee et al., 1982) (see section 
1.6.1.1.1). Similarly, in 1992 Smeltzer et al. described a Tn551 chromosomal 
insertion in an S. aureus strain which caused an almost complete reduction of 
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expression of extracellular lipase. It was subsequently found that this insertion, 
designated xpr (extracellular protein regulator) affected the expression of several 
exoproteins at the mRNA level and that xpr and agr are probably interactive at the 
genetic level (Hart et al., 1993) (see section 1.6.1.4). 
Tn551 was also used to identify another class of pleiotropic mutant defective in the 
production of several exoproteins, this locus was designated sae (S. aureus exoprotein 
expression) (Giraudo et al., 1994b) (see section 1.6.1.3). 
Transposons can be used to create mutants which can then be selected as displaying a 
particular phenotype, as in the work described in this thesis where transposon mutants 
were selected as white colonies with reduced levels of ß-haemolysin. Another 
regulator of exoprotein expression in S. aureus, designated sar (staphylococcal 
accessory regulator), has also been identified in this way (Cheung et al., 1992). Here, 
a streptococcal transposon, Tn917 was used to create mutants which were initially 
isolated as fibrinogen binding protein negative and subsequently found to be affected 
in production of several virulence determinants (see section 1.6.1.2). 
In addition, transposons can be used to isolate mutants of a specific phenotype which 
has been identified by other means which do not allow cloning. An example of this 
occurred when Björklind and Arvidson (1980) found that protease I negative mutants 
rapidly accumulated during growth in a chemostat. Further analysis showed that they 
had identified a class of pleiotropic mutant, originally designated Exp- and 
subsequently identified as the same locus as agr (see section 1.6.1.1.1). 
It is possible to identify novel potentially regulatory loci in bacteria by other means 
and some of these methods are discussed in Chapter 6. 
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The mutants described in this thesis are distinct from one another yet share some 
similarities. More data needs to be acquired before it can be hypothesised that any of 
the mutants contain Tn551 within a novel regulatory locus. For example, measuring 
a- and ß-haemolysin in liquid cultures would give a less subjective measure of 
haemolysin production. In addition production of other virulence factors could also 
be measured, in particular, ß-lactamase, &-haemolysin and both extracellular and cell 
bound protein A. 
In the meantime, it seems likely that some of these mutants are regulatory mutants 
since levels of several different virulence determinants are reduced. In addition, at 
least some of the genes for these virulence determinants are in different Smal 
fragments to each other and to the fragments in which Tn551 lies in each mutant. 
Also, none of the exoproteins examined so far are completely negative, which mirrors 
the situation found in sar mutants, though not agr mutants. It may be possible that in 
some of the mutants, the transposon is in a locus which is resulting in the selection of 
suppressors in agr. In spite of several attempts it has not proved possible to clone 
chromosomal DNA flanking the Tn551 insertion sites from any of these mutants. 
However, following further phenotypic characterisation, this must be the next step on 
the road to molecular analysis of the novel loci. 
170 
CHAPTER 5 
Isolation and characterisation of virulence 
determinant production mutants using 
Tn917 insertional mutagenesis 
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5.1 Introduction 
As discussed in chapter 4, transposon mutagenesis provides a good tool for allowing 
identification of genes involved in global regulation of production of virulence 
determinants. Previously, Tn551 was used to create mutants in an hld:: lacZ fusion 
strain of RN4220 in order to try to isolate genes directly affecting agr expression (see 
chapter 4). 
Another approach is to use the streptococcal transposon, Tn91 7 to create random 
mutations in a population of bacteria and then select for one particular phenotype. 
Mutants can then be tested for pleiotropic effects on several virulence determinants, 
such as a-haemolysin, lipase, protease and hyaluronate lyase. This method, selecting 
for fibrinogen binding protein mutants, was used to identify the sar locus of S. aureus. 
A 20.6 kb plasmid, pLTV 1, containing Tn917 has been specifically constructed to 
carry out efficient insertional mutagenesis and to facilitate the characterisation of 
disrupted genes (Camilli et al., 1990) (Fig. 5.1). Plasmid pLTV1 carries a highly 
temperature-sensitive replicon derivative of vector pE194Ts, so that a temperature 
shift (from 30 OC to 43 °C) during growth of cells containing pLTV 1 will result in 
loss of the plasmid and concomitant loss of tetracycline (Tet) resistance. This, then, 
allows the selection of cells with a transposon inserted in the chromosome, not only 
by the loss of Tet resistance, but by continued erythromycin (Em) and 
chloramphenicol (Cm) resistance since the erm and cat genes respectively are carried 
within the transposon (Camilli et al., 1990). Another feature of pLTV1 is that it 
carries a promoterless lacZ gene at one end of the transposable element. Thus, 
provided the transposon inserts into the chromosome downstream of an active 
promoter and in the correct orientation, a lacZ transcriptional reporter gene fusion will 
be created allowing measurement of promoter activity. A major benefit of using 
Tn917-LTV 1 is that it allows rapid cloning of chromosomal DNA flanking the 
insertion site (Camilli et al., 1990). This transposon also contains a ColEI replicon 
and a bla gene encoding an ampicillin resistance determinant (Fig. 5.1), both of which 
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(a) Map of pLTV 1. The multiple cloning site (MCS) contains sites for 9 restriction 
enzymes (clockwise) Sp. Sphl; P, Pstl: S, Sall-, X, Xbal; Ba, BamHI; Sm, Smal; K, 
Kpnl; Ss, Sstl; E, EcoRI. Other restriction sites indicated are: Bg, Bg=III; Hd, Hindlll; 
Hp, Hpal; Xh, Xhol. The extent of the Tn917 transposable element is indicated by 
the symbol, II. 
(b) Simplified linear representation of transposable element of pLTV I indicating 
fragments used in this work to create probes (double headed arrows). 
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are functional in E. coll. This means that by digestion of transposon mutant 
chromosomal DNA with a suitable enzyme (e. g. XbaI or EcoRI), and subsequent 
ligation, a plasmid comprising part of Tn917, together with some flanking 
chromosomal DNA, is created (Fig. 5.2) which can be transformed into, and 
maintained in, E. coli. 
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FIGURE 5.2 
Method of cloning chromosomal DNA flanking the Tn917 insertion site. Mutant 
chromosomal DNA containing the transposon was digested with an enzyme that 
restricts the DNA within the multiple cloning site of the transposable element, for 
example EcoRI (E) or Xbal (X) and somewhere in the chromosomal DNA (heavy 
line). This generates a DNA fragment containing one end of the transposon plus 
some flanking chromosomal DNA. Ligation of the ends of this fragment generates a 
plasmid containing a ColE I origin of replication and an ampicillin resistance gene 
(bla). This plasmid can be recovered by transformation into E. coli and selection for 
ampicillin resistant colonies. 
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5.2.1 Creation of a transposon library in strain 8325-4 
A transposon library was created by Dr SJ Foster using Tn91 7-LTV 1 in wild type 
strain 8325-4. By screening 26,000 colonies of this library, another worker identified 
nine transposon mutants which showed no ß-haemolysin activity on sheep blood agar 
plates. These nine transposon mutants were screened for p-galactosidase activity on 
BHI plates containing X-Gal (80 gl of 20 mg/ml). However, none of these mutants 
were blue indicating that the Tn917-LTV 1 lacZ gene was not transcribed to a high 
level. 
5.2.2 Phage transduction into wild type strain 8325-4 
In order to ensure that the observed decrease in ß-haemolysin production was due to 
the transposon, transduction of each mutation into wild type strain 8325-4 was carried 
out. Phage lysates of the nine mutants were prepared (J. Lindsay, pers. comm. ) using 
phage o 11. It was not possible to transduce with phage lysate of three mutants (12, 
43 or 1B - Table 5.1) but the remainder were transduced and transductants identified 
as Em resistant, indicating that Tn917-LTV 1 had been transferred. Transductants, 
together with 8325-4, were plated on to sheep blood agar and production of V 
haemolysin was measured and compared (Table 5.1). Transductants of three original 
mutants (42,132 and 11A) all showed equal ß-haemolysis to 8325-4 (approximately a 
7 mm radius of clearing), but the remaining three (10,5B and 113) showed greatly 
reduced levels of ß-haemolysis (0-2 mm radius of clearing). In fact, 96 %, '97 % and 
100 % of 10,5B and 113 transductants, respectively, were completely non 0- 
haemolytic. These data indicated that, in strains 10,5B and 113, loss of 0-haemolytic 
activity was associated with the transposon. One transductant of 10,5B and 113 
(suffixed . 1) was selected and used for further studies. 
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Strain/mutant No. of transductants Radius of ß-haemolysis 
8325-4 7 mm 
10 79 0-2 mm 
12 - - 
42 17 7 mm 
43 - - 
113 14 O mm 
132 25 7 mm 
IIA 15 7 mm 
1B - - 
5B 80 0-2 mm 
TABLE 5.1 
Number of transductants and average extent of 0-haemolysis, using the sheep blood 
plate assay, following phage transduction into wild type strain, 8325-4 with phage 
lysate prepared from nine Tn917 mutants. 
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5.2.3 Physical mapping of transposon insertions 
In order to begin determination of the location of the transposon in the S. aureus 
chromosome in each mutant, pulsed field gel electrophoresis was carried out (see 
section 4.2.5). Thus, the transposon in 10.1,5B. 1 and 113.1 could be mapped to one 
of the sixteen fragments resulting from a Smal digest of S. aureus chromosomal DNA 
(see section 4.2.5). Digested chromosomal DNA of each strain was prepared as 
described in section 2.9.3 and separated using CHEF electrophoresis (Fig. 5.3) which, 
under the conditions used, resolves approximately eleven SmaI fragments ranging 
from 76-630 kb in 8325-4. The Southern blot of the resulting gel was probed using a 
digoxygenin labelled 5 kb XbaI fragment of Tn917 from pLTV3 (Camilli et al., 1990) 
(Fig. 5.4). This fragment is identical to that contained in Tn917-LTV 1 and comprises 
the DNA between the multiple cloning site and the distal end of Tn917 (Fig. 5.1). 
Digested chromosomal DNA of the agr- strain, WA250, and two random blue Tn917 
transposon mutants (BHC1 and BHC2), was also separated on the gel. WA250 
contains Tn551 within agr at approximately position 3750 of the published sequence 
(Morfeldt et al., 1988) (see Fig. 1.2). Tn551 is 5.3 kb and, since it does not contain a 
SmaI site, does not significantly alter the profile of Smal digested WA250 
chromosomal DNA which remains identical to 8325-4 (see section 4.2.5). In 
addition, Tn551 has very good homology to Tn917 and thus hybridises with the 
Tn917-based probe. It has been reported that the agr locus is in SmaI fragment F of 
strain 8325 which, in 8325-4 and its derivatives, co-runs with SmaI fragment H 
(Smeltzer et al., 1992; Pattee et al., 1990). This is due to the loss of prophages 4)11 
and 0 13 in 8325-4 which, in strain 8325, lie in Smal fragment F, and thus their 
absence reduces the size of fragment F to apprbximately'the 135 kb of fragment H 
(see section 4.2.5). However, it can be seen from the Southern blot (Fig. 5.4) and the 
corresponding gel (Fig. -5.3), that WA250 contained Tn551 within fragment G (175 
kb). Tn917-LTV1 contains a Smal site (Fig. 5.1) so it would be expected that, 
following digestion with Smal, the fragment of chromosomal DNA containing this 
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FIGURE 5.3 
CHEF pulsed field gel to map Tn917 insertion sites. Lanes 1 through 6 contain Smul 
digests of total chromosomal DNA of two controls, BHC 1 and BHC2, WA250 (agr), 
10.1,5B. 1 and 113.1. The corresponding DNA fragments of WA250 are shown on 
the right with their sizes (kb). The gel was calibrated using the standards (not shown) 
listed in Table 2.5. 
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Southern blot of a CHEF pulsed field gel (see Fig. 5.3) to map Tn917 insertions. 
Lanes 1 through 6 contain SmaI digests of total chromosomal DNA of two controls, 
BHC 1 and BHC2, WA250 (agr), 10.1,5B. 1 and 113.1 probed with a digoxygenin 
labelled 5 kb Xbal fragment of Tn917 (see Fig. 5.1). The corresponding fragments of 
WA250 are shown on the right with their sizes (kb). Hybridising bands are 
highlighted on the left. 
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transposon would disappear and two smaller, novel bands would appear. The probe 
comprises the Tn917 end of Tn917-LTV 1 (see Fig. 5.1) and thus, only one of these 
novel fragments of chromosomal DNA will hybridise and be apparent by Southern 
blotting, representing the region of chromosomal DNA that contains this part of the 
transposable element. The two Tn917 controls, BHC1 and 2 contained the part of the 
transposon covered by the probe in fragments which co-ran with Smal fragments G 
and H, respectively. Both strains 10.1 and 5B. 1 appeared to contain Tn917 within a 
fragment that co-ran with SmaI fragment I (117 kb) (Fig. 5.4). However, it was not 
possible to identify, from the gel (Fig. 5.3), either the band which disappeared or the 
second novel, smaller bands of 10.1 or 5B. 1 chromosomal DNA following digestion 
with Smal. This may have been due to the transposon having inserted towards the 
end of an existing SmaI fragment and thus only a small fragment of DNA would have 
been cleaved on Smal digestion. Any loss would also have been partly compensated 
by the addition of part of Tn917-LTV1. Strain 113.1 did not contain a fragment 
which hybridised with the Tn917 probe (Fig. 5.4). 
In order to resolve the smaller SmaI fragments more clearly, field inversion gel 
electrophoresis (FIGE) was used (see section 2.9.3). This works on the same basis as 
CHEF electrophoresis but separates fragments of 9-250 kb. Total chromosomal DNA 
of all three strains was digested with Smal and separated on a FIGE gel (Fig. 5.5). 
From this gel it can be seen that either Smal fragment F or H of both 10.1 and 5B. 1 
has disappeared (Fig. 5.5). Since fragment F co-runs with fragment H in 8325-4 it is 
not possible to determine which fragment remains, indicating that the transposon 
originated in either SmaI fragment F or H. The expected appearance of two new 
fragments can also be confirmed by this gel with Smal digested chromosomal DNA 
of 10.1 resulting in one novel fragment which co-runs with fragment I (117 kb) and 
the other between fragments M and N at approximately 20 kb (Fig. 5.5). In strain 
5B. 1 only one novel SmaI fragment can be seen, below fragment I at approximately 
110 kb (Fig. 5.5). A Southern blot of this gel, probed as above, confirmed that, in 
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FIGURE 5.5 
FIGE pulsed field gel to map Tn917 insertion sites. Lanes 1 through 4 contain Smal 
digests of total chromosomal DNA of strains 10.1,5B. 1,113.1 and 8325-4 (WT). 
The boxes in lane 1 highlight the missing Smal fragment F or H in strain 10.1 and two 
novel fragments, compared with 8325-4, of approximately 117 kb and 20 kb. The 
boxes in lane 2 highlight the missing Smal fragment F or H in strain 5B. 1 and one 
novel fragment of approximately 110 kb. The corresponding DNA fragments of 
8325-4 are shown on the right with their sizes (kb). The gel was calibrated using the 
standards (not shown) listed in Table 2.5. 
182 
strain 10.1, the part of the transposon covered by the probe was within a novel 
fragment that co-ran with SmaI fragment I (Fig. 5.6). Strain 5B. 1 appeared to contain 
this part of the transposon in a band which was slightly smaller than Smal fragment I 
(Fig. 5.6). The result for strain 113.1 was again not clear (Fig. 5.6). In several 
subsequent Southern blots of FIGE and CHEF gels it did not prove possible to map 
113.1 satisfactorily so it was considered prudent not to continue to study this mutant. 
The transposon in agr in strain WA250 mapped to fragment G (see Fig. 5.4), which 
did not correlate with the previously mentioned findings of Smeltzer et al. (1992). 
However, since the transposon in strains 10.1 or 5B. 1 did not originate in the same 
Smal fragment as Tn551 in strain WA250, it was thought likely that neither of these 
mutants contained Tn917 within the agr locus. Accordingly, these two transductants 
were characterised further. 
5.2.4 Phenotypic characterisation of transductants 5B. 1 and 10.1 
Cultures of strains 10.1 and 5B. 1 were serially diluted in PBS and spotted (as 
described in section 4.2.8), except where indicated, onto different types of agar plates 
to measure production of various determinants associated with pathogenicity. 
Activity in the mutant strains was compared visually with strain 8325-4 (WT) and 
strain WA250 (agr-). 
5.2.4.1 haemolysin assay 
This assay is as described in section 4.2.8.1. Strains 10.1,5B. 1 and WA250 were 
haemolysin negative whilst strain 8325-4 showed an approximately. 7 mm radius of. 
clearing (Fig. 5.7). 
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FIGURE 5.6 
Southern blot of FIGE pulsed field gel (Fig. 5.5) to map Tn917 insertion sites. Lanes 
1 through 3 contain fragments of Smal digests of total chromosomal DNA of strains 
10.1,5B. 1,113.1 that hybridised with the digoxygenin labelled 5 kb XbaI fragment of 
Tn917 (see Fig. 5.1). The corresponding DNA fragments of 8325-4 (WT) are shown 
on the right with their sizes (kb). The arrow on the left indicates the hybridising 
fragments in lanes I and 2. 
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Serial dilutions (10 td) were plated in the order shown in Fig. 4.17. 
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5.2.4.2 haemolysin assay 
The basis of this assay is as described in section 4.2.8.2. Strain WA250 was 
haemolysin negative whilst strain 8325-4 had an approximately 1 cm radius of 
clearing around colonies (Fig. 5.8a). Strains 10.1 (Fig. 5.8a) and 5B. 1 were both a- 
haemolysin negative. 
5.2.4.3 Lipase assay 
Following this assay, described in section 4.2.8.3, strain WA250 was lipase negative 
following 48 hours incubation at 37 °C (Fig. 5.8b) although growth was poor. 
Strain 8325-4 and both mutant strains were lipase positive showing a white precipitate 
extending approximately 3 mm from colonies (Fig. 5.8b). 
5.2.4.4 DNase assay 
The basis of this assay is described in section 4.2.8.5. Both strains 10.1 and 5B. 1 
(Fig. 5.9a) showed less DNase activity (approximately 4 mm radius of clearing) than 
8325-4 (approximately 6 mm radius of clearing) but more than strain WA250 
(approximately 2 mm radius of clearing). 
5.2.4.5 Protease assay 
This assay is described in section 4.2.8.4. Both strains 10.1 and 5B. 1 (Fig. 5.9b) 
showed the same level of protease activity compared to strainWA250, with no 
clearing evident around single colonies (Fig. 5.9b). Strain 8325-4 showed an 
approximately 3 mm radius of clearing around colonies (Fig. 5.9b). 
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(a) 
5B. 1 
(b) 
FIGURE 5.8 
(a) a-haemolysin plate assay. Strains were serially diluted and spotted onto rabbit 
blood agar prior to overnight incubation at 37°C. Zones of (x-haemolysin activity of 
strains 5B. 1,8325-4 (WT) and WA250 (agr) were measured and compared. 
(b) Lipase plate assay. Strains 5B. 1,10.1,8325-4 (WT) and WA250 (agr) were 
streaked onto 10% (w/v) egg yolk agar plates and incubated for 48 h at 37°C. Lipase 
production is evident as a white zone of precipitation around the colonies. 
Key for dilutions is shown in Fig. 4.17. 
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(a) 
5B. 1 
(b) 
10.1 
FIGURE 5.9 
(a) DNase plate assay. Strains 5B. 1,8325-4 (WT) and WA250 (agr) were 
grown for 24 hours at 37°C on DNase agar then overlaid with dimethyl green (0.5 
mg /ml) in DNAse agar (0.5X, 5 ml) and incubated for 1-2 h at 37°C. Zones of 
clearing were measured to compare production of DNase. 
(b) Protease plate assay. Strains 10.1,8325-4 (WT) and WA250 (agr) were 
incubated overnight at 37°C on BH1 agar containing 1.5% (w/v) dried skimmed milk. 
Protease production can be seen as a zone of clearing in the opaque background. 
Key to dilutions is shown in Fig. 4.17. 
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5.2.4.6 Hyaluronate lyase assay 
This assay is described in section 4.2.8.6. Both mutant strains, 10.1 and 5B. 1 showed 
the same, or slightly greater level of hyaluronate lyase activity compared to WA250 
(approximately 4-5 mm radius of clearing around colonies) (Fig. 5.10). Strain 8325-4 
showed slightly more activity with an approximately 8 mm radius of clearing (Fig. 
5.10). 
5.2.5 Identification of the chromosomal sites of Tn917 insertion 
In order to further analyse the putative components involved in the regulation of 
virulence determinant production, it was important to identify the locus into which the 
transposon had inserted in each mutant. From the data obtained it was thought likely 
that neither of these mutants contained Tn917 within agr. In particular, both strains 
10.1 and 5B. 1 were lipase positive which differed from the phenotype observed by 
Smeltzer et al. (1992) for an agr mutant. In addition, the lipase negative phenotype of 
the agr strain, WA250 correlated with the findings of Smeltzer et al. (1992), 
although this differed from earlier results where WA250 appeared lipase positive (see 
section 4.2.8.3). However, as previously suggested, the anomalous behaviour of 
WA250 was thought to be due to the choice of egg-yolk as the substrate for the lipase 
assay (see section 4.3). The data obtained from the pulsed field gels also suggested 
that these were not agr mutants since the transposon in agr of strain WA250 mapped 
to Smal fragment G whereas the transposon in each transductant originated in either 
Smal fragment F or H (see section 5.2.3). In order to determine the exact site at 
which T n917 had inserted in each mutant, chromosomal DNA flanking the transposon 
insertion needed to be cloned and sequenced. This method is described in section 
2.14.2, but briefly, chromosomal DNA (5 µg) of each mutant strain was digested with 
Xbal or EcoRI which cut at the multiple cloning site within Tn917-LTV 1 and 
somewhere in the chromosome (see Fig. 5.2). Digested DNA was then ligated, 
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(a) 
WA250 
8325-4 
10.1 
(b) 
8325-4 
5B. 1 
FIGURE 5.10 
yyaluronate lyase plate assay. (a) Strains 10.1,8325-4 (WT) and WA250 (agr) and 
(b) strains 5B. 1,8325-4 (WT) and WA250 (agr) were incubated overnight at 37°C 
on hyaluronate agar (see Appendix A, section A 1.4.6) then flooded with 2M acetic acid 
at RT. Zones of clearing in the opaque background were measured after 30 mills to 
compare production of hyaluronate lyase. 
Key to dilutions is shown in Fig. 4.17. 
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concentrated by ethanol precipitation and used to transform E. coli strains XLOLR, 
DH5a or ultra-competent E. coli strain, XL2-Blue MRF (Stratagene), selecting for 
ampicillin resistance. This procedure was repeated for each mutant three times, 
without success, using the various hosts. Plasmids up to 66 kb can be efficiently 
transformed into DH5 strains of E. coli, but transformation frequency declines 
linearly with increased size (Hanahan et al., 1991). In order to ensure that XbaI or 
EcoRI digestion did not result in plasmids which were too large for successful 
transformation, chromosomal DNA (5 µg) of each mutant was digested singly with 
XbaI, EcoRI or additionally, Sall since it was known from the restriction map of 
pLTV 1 that this should result in a transposon fragment of approximately 7 kb. This 
fragment comprises the 7 kb between the Sall site in the multiple cloning site (MCS) 
and the Sall site at the end of the lacZ gene (see Fig. 5.1). Digested DNA was 
separated on a TBE agarose gel and a subsequent Southern blot was probed with a 
digoxygenin labelled 7 kb fragment of EcoRIISall cut pLTV 1 covering the multiple 
cloning site to the distal end of the lacZgene (see Fig. 5.1). The resulting 
hybridisation pattern can be seen in Fig. 5.11. The sizes of fragments for each strain 
which hybridised with the probe and thus contained the transposon are shown in 
Table 5.2. 
It was clear that digesting the mutants with these enzymes was appropriate since the 
resulting fragments did not exceed approximately 11.5 kb. In addition, these data 
showed that the mutants were not siblings as the restriction pattern for each strain was 
different. It can be seen from Fig. 5.11 and Table 5.2 that the hybridising Sal! 
fragment of both transductants was approximately 3 kb instead of the expected 7 kb 
(see Fig. 5.1). Thus, it was clear that a deletion of part of the 7 kb Sall fragment-had - 
occurred. To determine whether this had happened during phage transduction, 
chromosomal DNA (5 µg) from the original mutants, 10 and 5B was also digested 
with Xbal, EcoRI or Sall and a subsequent Southern blot similarly probed. The 
parental strains were identical to the transductants indicating that the deletion had 
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1 
(hp) 
2313() - 
9416 - 
6557 - 
4361 - 
ý'ký. y' N: /n ý. 
..... 
2322 - 
2027 - 
FIGURE 5.11 
-. ý.. 
Southern blot to mal)'l'n917 chronwsonial insertion sites. (S'hronºosonºaI I )NA oI 
strains 10.1 and 5ß. I was digested with Xbal (lanes I and 2), E'colll , (lanes, 
ý and 4) 
or Sall (lanes 5 and 6), and probed with a digoxygenin labelled 7 kb L'eoRI/Sail 
fragment of pLTV I (see Fig. 5.1). The corresponding fragments of //indlll digested x 
are shown on the left with their sixes (hp). 
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Strain 
Sizes of hybridising fragments (kb) 
XbaI EcoRI Sall 
10.1 7.5 7.0 3 
5B. 1 9.5 11.5 3 
TABLE 5.2 
Physical mapping of Tn917 insertion sites. The fragment sizes of Xbal, EcoRI or Sall 
digested chromosomal DNA of strains 10.1 or 5B. I that hybridised with the 
digoxygenin labelled 7 kb EcoRIISalI fragment of Tn917 are given. 
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probably occurred during transposition (results not shown). Thus it was likely that 
the reason the chromosomal DNA flanking the transposon insertion site could not be 
rescued directly by cloning was that the ColE1 replicon and/or the bla gene, 
necessary for maintenance and selection in E. coli, had been deleted. It was therefore 
necessary to clone flanking chromosomal DNA in the same way as that attempted for 
Tn551 mutants (see section 4.2.7). In order to identify a fragment of chromosomal 
DNA containing Tn917 which was a suitable size for cloning into a plasmid, 
chromosomal DNA (3 µg) of strains 10.1 and 5B. 1 was digested with XIioI or Sall. 
Following separation of DNA on a TBE agarose gel, a Southern blot was probed with 
a digoxygenin labelled 5 kb XbaI fragment of pLTV3. Both Sall digested 
chromosomal DNA of strains 10.1 and 5B. 1 resulted in two bands of approximately 9 
kb and 2 kb (Fig. 5.12 and Table 5.3). The 2 kb band comprised an internal fragment 
of Tn917-LTV1 (Fig. 5.1), and the other fragment in each strain includes the distal 
end of Tn917 and some chromosomal DNA. XhoI digested chromosomal DNA of 
10.1 resulted in two bands of approximately 7.5 and 8.5 kb and of 5B. 1 resulted in 
two bands which co-resolved at approximately 8 kb (Fig. 5.12). 
In order to clone part of the transposon and flanking DNA, chromosomal DNA (25 
µg) of both mutants was digested with XhoI and separated on a TAE agarose gel. The 
fragments in the region spanning 2 kb above and below the expected size were 
excised and purified from the gel. In addition, pUBS 1 (5 µg) was digested with XIzoI, 
dephosphorylated and then ligated (1 µg) with the gel purified DNA of 10.1 or 5B. 1 
(5 µg). The ligation mixtures were transformed into ultra-competent E. coli strain, 
XL2-Blue MRF' (Stratagene) and resulting colonies containing plasmids with inserts 
(>100 for each mutant) were picked onto LB agar plates containing ampicillin'(50 
µg/ml). Colony blots were performed (see section 2.11.2.2) and probed with the 
digoxygenin labelled 5 kb Xbal fragment of pLTV3. No positives were obtained 
when compared to the control (pLTV3). Further ligations and transformations did not 
provide any positive transformants. 
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2027 - ... .. ý 
F1(: IJRE 5.12 
Southern blot of chronmosoni al DNA of strains 10.1 (lanes I and 3) and U. I (lane. ' 2 
and 4) digested with Sall (lanes I and 2) or Xhol (lanes 3 and 4), probed with the 
digoxygenin labelled 5 kb Xbal fragment of'1'n9/7 isolated from pIA'V; (sec Fig. 
5.1). The corresponding fragments of //indlll digested X are shown on the left with 
their sizes (hp). 
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Strain 
Sires of hybridising fragments (kb) 
Sall Xhol 
10.1 2.0+9.0 S. 5+7.5 
513.1 2.0+9.0 8.0 (x 2) 
TABLE 5.3 
Physical mapping of Tny17 insertion sites. The sizes of fragments of 'Sall of Xhol 
digested chromosomal DNA of strains 10. I or 513.1 that hybridised with the 
digoxygenin labelled 5 kb Xhnl fragment of'I'ný1/7 are given. 
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Since some of the data obtained in this work was variable it was considered prudent to 
determine conclusively that the transposon in each mutant was not within agr by 
physical mapping of this area by restriction digest. In particular, the lipase activity in 
the agr strain, WA250 was variable and thus, although both mutants appeared 
consistently lipase positive, which suggested that they were not displaying an agr- 
phenotype in this respect (Smeltzer et al., 1992) it was considered that the lipase data 
may be somewhat unreliable due to the use of egg-yolk as the assay substrate. Also 
the transposon in both strains 10.1 and 5B. 1 originated in SmaI fragment F or H. This 
again was found to be different from the agr mutant, WA250 which appeared to 
contain Tn551 within SmaI fragment G. However, as discussed previously, the agr 
locus is in Smal fragment F in strain 8325 and is in a fragment which co-runs with 
Smal fragment H in strain 8325-4 (Smeltzer et al., 1992; Pattee et al., 1990). 
5.2.6 Fine physical mapping of Tn917 insertions 
To clarify whether Tn91 7 had inserted into the agr locus in either 10.1 or 5B. 1, 
chromosomal DNA of each mutant and 8325-4 was digested, separated by TBE 
agarose gel electrophoresis, blotted and probed with a fragment of the agr locus. 
Thus, any change in the size of hybridising fragments in the mutants, compared to 
8325-4 (WT), would indicate the presence of additional DNA, almost certainly 
comprising the transposon. Initially, chromosomal DNA from 10.1,5B. 1,8325-4 and 
WA250 was digested with Pvul. This enzyme has restriction sites towards either end 
of the agr locus (positions 332 and 4152) ( see Fig. 5.14). A Southern blot of 
digested DNA was probed with a digoxygenin labelled 1.8 kb Asp700/EcoRV 
fragment of agr (see Fig. 1.2). One fragment of 3.8 -kb of PvuII digested 
chromosomal DNA of 8325-4 hybridised with the probe, which represented the 
number of bases between the two PvuII sites of agr (Fig. 5.13 and Table 5.4). 
WA250 contains Tn551 (within agr) which does not contain any PvuII sites, so that 
the PvuII digestion of strain WA250 chromosomal DNA resulted in hybridisation 
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(bp) 
wswý 
Norge 
FIGURE 5.13 
23130 
9416 
6557 
4361 
2322 
2027 
Southern blot of chromosomal DNA of strains 8325-4 (WT) (lane 1), WA250 (agr) 
(lane 2), 10.1 (lane 3) and 5B. 1 (lane 4) digested with PvuII and probed with the 
digoxygenin labelled 1.8 kb Asp700/EcoRV fragment of agr (see Fig. 1.2). The 
corresponding fragments of HindIII digested X are shown on the right with their sizes 
(bp). 
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Sizes of fragments (kb) 
Strain 
PvuII PvuIUPstI HinclI/EcoRV 
8325-4 3.8 1.8 3.1 
2.0 
WA250 9.1 1.8 6.5t 
9. Ot 
3.5t 
10.1 3.8 1.8 11 
2.0 
5B. 1 9.0 2.0 11 
2.8 8.0 
0.8 
t These fragment sizes are anomalous see sections 5.2.6 and 5.3 
TABLE 5.4 
Sizes of agr hybridising fragments. Chromosomal DNA was digested with PvuII, 
PyüJUPstI or Hincl lEcoRV and the sizes of fragments that hybridised with the 
digoxygenin labelled 1.8 kb Asp700IEcoRV fragment of agr (see Fig. 1.2) were 
calculated from Southern blots (Figs. 5.13 and 5.15). 
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with the probe at a single band of approximately 9.1 kb comprising 3.8 kb (agr) and 
5.3 kb (Tn551) (Fig. 5.13). Digested chromosomal DNA of 10.1 gave a hybridising 
fragment of 3.8 kb (the same as 8325-4) indicating that this transductant possibly did 
not contain Tn917 within agr (Fig. 5.13). Two fragments of PvuII digested 
chromosomal DNA of strain 5B. 1 hybridised with the probe, one of 9 kb and one of 
2.8 kb. This suggested that Tn917 had inserted in agr in strain 5B. 1 and also that 
Tn917-LTV 1 contains a restriction site for PvuII (Fig. 5.13). This initial analysis 
could not, however, pinpoint the Tn917 insertion site. The derivation of fragments 
following digestion of DNA with PvuII is shown in Fig. 5.14. 
To identify more accurately the location of Tn917 in strain 5B. 1, chromosomal DNA 
of all four strains was digested with PvuII and PstI, which cuts at position 2149 
within agr (Fig. 5.14). In addition, chromosomal DNA of each strain was digested 
with HincIl and EcoRV (which cut within agr at positions 4548 and 1474 
respectively, see Fig. 5.14) to further narrow the location of Tn917 in strain 5B. 1 and 
also to ensure that Tn917 was not in the remaining 373 bases of agrA in strain 10.1. 
A Southern blot of these digests was probed with the digoxygenin labelled 1.8 kb 
Asp700/EcoRV fragment as above. Chromosomal DNA of strain 8325-4, digested 
with PvuII/Pstl, hybridised with the probe at two bands of 1.8 and 2 kb (Fig. 5.15 and 
Table 5.4). Three fragments of PvuIIIPstI digested chromosomal DNA of strain 
WA250 hybridised with the probe, one of 1.8 kb, one of approximately 9 kb and one 
of 3.5 kb (Fig 5.15). It seemed likely from these results that the 9 kb band arose from 
DNA which had been only partially digested and represented the PvuII fragment. 
There is no PstI site within Tn551 and it would therefore have been expected that the 
3.5 kb band would approximate 7.3 kb (2 kb chromosomal DNA plus 5.3 kb T n551). 
Digested chromosomal DNA of strain 10.1 hybridised with the probe at the same 
sized fragments as the wild type (Fig. 5.15) since it has already been shown that 
Tn917 does not occur within the Pvul sites of this mutant (Fig. 5.13). Strain 5B. 1 
contained Tn917 somewhere between the PvuJ sites of agr so that, by digesting 
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8325-4 and 10.1 
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P2 P3 
Hr 
WA250 
P1 
C 
H Pv P Ec Pv 
4548 4152 2149 1474 330 
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P1 
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I ----- 
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4152 330 
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5B. 1 
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FIGURE 5.14 
Physical map of the agr region showing the derivation of bands depicted on the 
Southern blot (Fig. 5.13) of Pvull digested chromosomal DNA of strains 8325-4 
(WT), WA250 (agr), 10.1 and 5B. 1, probed (double headed arrow) with the 
digoxygenin labelled 1.8 kb AsplOOIEcoRV fragment of agr (see Fig. 1.2). The 
restriction sites denoted are: Ec, EcoRV; H, HincII; P, PstI; Pv, Pvul. (This figure is 
not to scale). 
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- 4361 
-9416 
- 23130 
- 2322 
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FIGURE 5.15 
Southern blot of chromosomal DNA of strains 8325-4 (WT), WA250 (agr), 10.1 and 
5B. 1 digested with Pvull (lanes 1 through 4), PvuII/Pstl, (lanes 5 through 8) or 
HinclI/EcoRV (lanes 9 and 12) and probed with the digoxygenin labelled 1.8 kb 
Asp700/EcoRV fragment of agr (see Fig. 1.2). The corresponding fragments of 
Hindlll digested X are shown on the right with their sizes (bp). The arrow in lane 11 
indicates a band which was apparent on the original Southern blot but has not 
reproduced well on the scanned image shown. 
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simultaneously with Pal, the transposon could be located to one of two fragments of 
agr. Three hybridising bands resulted from this digest, one of approximately, 800 bp, 
one of 2 kb and the third of approximately 8 kb (Fig. 5.15). It has already been 
established that Tn917-LTV1 contains a PvuII restriction site. This site almost 
certainly occurs at the lacZ proximal end since Tn917 itself does not contain a PvuII 
site (Shaw and Clewell, 1985). From this information it could be seen that the 
transposon had inserted with the lacZ end of the transposable element just upstream of 
the Pal restriction site of agr (Fig. 5.16). In addition, the PvuII restriction site must 
be less than 800 bp into the transposon and, by the same token, must occur less than 
800 bp upstream of the Pstl site of agr (Fig. 5.16). 
Following digestion of chromosomal DNA of strain 8325-4 with HinclllEcoRV, a 
fragment of 3.1 kb hybridised with the probe (Fig. 5.15). The hybridising fragment of 
strain WA250 chromosomal DNA was again anomalous at 6.5 kb, rather than the 
expected size of 8.4 kb, arising from 3.1 kb of chromosomal DNA plus the 5.3 kb of 
Tn551(Fig. 5.15). Of similarly digested chromosomal DNA of strain 10.1, a 
fragment of 11 kb hybridised with the probe (Fig. 5.15) indicating that this strain was 
also an agr mutant with Tn917 lying in the 396 bases between the Hincll and PvuII 
sites (Fig. 5.14). Of HincIUEcoRV digested chromosomal DNA of strain 5B. 1, a 
fragment of 11 kb hybridised with the probe, indicating that Tn917 was downstream 
of the EcoRV site and thus in the 677 bp between the PstI and EcoRV restriction sites 
(Fig. 5.15). The derivation of fragments resulting from digestion of chromosomal 
DNA with HincIUEcoRV is shown in Figure 5.17. 
To locate the transposons exactly within agr, the area of the Tn91 7 insertion site in 
each mutant needed to be amplified and sequenced. 
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Physical map of the agr region showing the derivation of hands depicted on the 
Southern blot (Fig. 5.15) of PvulUPstI digested chromosomal DNA of strains 8325-4 
(WT), WA250 (agr), 10.1 and 5B. 1, probed (double headed arrow) with the 
digoxygenin labelled 1.8 kb Asp700/EcoRV fragment of agr (see Fig. 1.2). The 
restriction sites denoted are: P, Pstl; Pv, PvuII. (This figure is not to scale). 
*This fragment, which was calculated as 3.5 kb on the Southern blot (Fig. 5.15) 
should have been 7.3 kb, comprising 2 kb of chromosomal DNA and the 5.3 kb of 
Tn551. 
-r- 
Pv 
4152 
204 
8325-4 
PROBE 
P1 P2 P3 
ACB hld 
H Ec 
4548 1474 
11 
3.1 kb 
WA250 
k-TE 
H 
4152 
_ 
PROBE 
P1 P2 P3 
AC Tn551_ CD8 hld 
Ec 
1474 
i ------ ý 6.5 kb* 
10.1 and 5B. 1 
ý 
P1 P2 P3 
AC ID Br 
0Zl- 5B. 
Tn9 7, 1 
H Pv - P45484152 
2149 1474 
PROBE 
ý---------- 
-- 
i 
11.1 kb 
FIGURE 5.17 
Physical map of the agr region showing the derivation of bands depicted on the 
Southern blot (Fig. 5.15) of HinclI/EcoRV digested chromosomal DNA of strains 
8325-4 (WT), WA250 (agr), 10.1 and 5B. 1, probed (double headed arrow) with the 
digoxygenin labelled 1.8 kb Asp700/EcoRV fragment of agr (see Fig. 1.2). The 
restriction sites denoted are: Ec, EcoRV; H, Hincll; P, Pst!; Pv, PvuII. (This figure is 
not to scale). 
* This fragment, which was calculated as 6.5 kb on the Southern blot (Fig. 5.15), 
should have been 8.4 kb, comprising 3.1 kb of chromosomal DNA and the 5.3 kb of 
Tn551. 
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5.2.7 Amplification of chromosomal DNA flankin Tg n917 
insertion sites 
DNA can be amplified by a technique known as the polymerase chain reaction (PCR). 
Any region of a DNA molecule can be amplified provided the sequences of DNA at 
the borders of the region are known. However, PCR reactions extending over 10 kb 
of DNA tend to be less efficient. Short oligonucleotides comprising part of the 
sequences bordering the areas which are to be amplified are used as primers. 
Amplification is carried out by the method described in section 2.15. Briefly, the 
DNA template is melted to single strands at 95 °C and, on cooling to 55 °C, primers 
are annealed. The enzyme, Taq polymerase is present in the PCR reaction mix and, 
during incubation at 72 °C, it synthesises new strands complementary to the template 
DNA. The reaction mixture is then heated again to 95 °C so that the newly 
synthesised strands detach from the template. After cooling to 55 °C, more primers 
anneal to the chromosomal DNA template and also to the respective positions on the 
newly synthesised strands. Taq polymerase is an extremely thermostable enzyme and 
can thus carry out repeated rounds of DNA synthesis. Under the conditions used 
here, this cycling was repeated 30 times with DNA amplification proceeding 
exponentially (Saiki, 1990). Care must be taken with the design of primers as this is 
crucial to the efficacy of the PCR reaction. 
5.2.7.1 Design of primers for PCR of Tn917 insertion sites 
At each end of a primer sequence it is preferable to include four sequential bases from 
the vector into which the PCR products will be cloned, in this case pUBS 1. These 
bases comprise the sequence of pUBS 1 just up- or down-stream of an elected 
restriction sequence (in this case EcoRI) within the multiple cloning site. Thus, in the 
forward direction GCAG and in the reverse direction, TATC (Fig. 5.18) were used. 
Next in the primer sequence the selected restriction enzyme site (EcoRl - sequence 
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10. 
GCAGGAATTC 
CTTAAG CT AT 
4- 
FIGURE 5.18 
Partial sequence of the pUBS 1 multiple cloning site (MCS) showing the bases used in 
the creation of PCR primers. 
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GAATTC) is needed in order to allow the PCR product to be cloned easily into 
pUBS1. Following the EcoRI site, 25 bases of DNA homologous to the chromosomal 
DNA to be amplified is included in the primer sequence. There should be no more 
than 3 consecutive A and/or T bases or 2 consecutive G and/or C bases in this 
complete sequence of 25 bases and the total of G and/or C bases should not exceed 8- 
10. These last two conditions are necessary to avoid the formation of primer dimers, 
or the primer forming hairpin loops within itself. 
In the case of the Tn917 mutants, it was not possible to amplify the whole of the 
region containing Tn917 since the transposon alone is approximately 8 kb and thus 
the PCR reaction would not be very efficient. For each mutant it was therefore 
necessary to use four primers, two to extend out from Tn917 and two to extend in 
from flanking chromosomal regions. The two Tn917 based primers consisted of 
sequence approximately 800 bases into Tn917 from the end distal to the lacZ gene. 
5.2.7.1.1 PCR primers for strain 10.1 insertion site amplification 
Because the transposon in strain 10.1 was known to be between the Pvul site at 
position 4150 and the Hind site at position 4546 (see Fig. 5.17), the first suitable 
sequence of DNA upstream or downstream of these sites was used for primers. In the 
forward direction, upstream of PvuII, primer HF1 (Fig. 5.19) was used (Fig. 5.20) 
comprising bases 4071 to 4096 of agr (Fig. 5.21). In the reverse direction, 
downstream of HincIl, primer HF2 (Fig. 5.19) was used (Fig. 5.20) comprising bases 
4616 to 4592 (Fig. 5.21). 
5.2.7.1.2 PCR primers for strain 5B. 1 insertion site amplification 
The transposon in this mutant was between the EcoRV site at position 1479 and the 
Pstl site at position 2149 (see Fig. 5.17). Consequently, bases 1417 to 1441 (Fig. 
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PRIMER SEQUENCE 
HF1-10.1 GCAGGAATTCGTTACGAGTCACAGTGAACTTACCT 
HF2-10.1 TATCGAATTCCAGCTATACAGTGCATTTGCTAGTT 
HF3 - 5B. 1 GCAGGAATTCGAAT'M'GTTCACTGTGTCGATAATC 
HF4-5B. 1 TATCGAATTCCTCTTTGATGATAAGTGTGATAATG 
HF5-Tn917 GCAGGAATTCCAGATCTAGATATTGAGGAACATTT 
HF6-Tn917 TATCGAATTCGTCTAGATCTATAACTCCTTGTAAA 
FIGURE 5.19 
The sequence of primers used to amplify the transposon insertion sites in strains 10.1 
(HF1 and HF2) (see Fig. 5.21) and 5B. 1 (HF3 and HF4) (see Fig. 5.21). Primers HF5 
and HF6 include sequence occurring at the end of Tn917 distal to the lacZ gene. 
209 
Tn917 
/0 %-,, 
Pv H 
4152 4548 
agrA 
Orientation 1 
Pv Av x 
4152 5340 4560 
Primer HF1 Ii 
chromosome Tn917 
Primer HF6 
(Tn9 l 7seq. 
from base 
4555-4579) 
Orientation 2 
Primer HF5 
(Tn 917seq. 
from base 
4555-45799)) 
X Av H 
4560 5340 4548 
1II 
Tn9i7 
I 
chromosome 
Primer HF2 
FIGURE 5.20 
PCR reactions for the amplification of the transposon insertion site in strain 10.1. The 
orientation of primers is indicated, allowing for Tn917 to have inserted in the 
chromosome in either possible orientation between the HincII and PvuII restriction 
sites within the agr locus. The restriction sites denoted are: Av, AvaI; H, HincII; Pv, 
PvuII; X, Xbal. 
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Primer HF3 
ý 
14 01 TCATCTTATT TTTTAGTGAA TTTGTTCACT GTGTCGATAA TC CATTTTAC 
14 51 TAAGTCACCG ATTGTTGAAA TGATATCTTG TGCCATTGAA ATCACTCCTT 
Ec 
1501 CCTTAATTAA GATAAAAATT CTTAAAATTA AACAACTCAT CAACTATTTT 
1551 CCATCACATC TCTGTGATCT AGTTATATTA AAACATGCTA AAAGCATTTA 
1601 TTTTCCAATT TTTCTTAACT AGTCGT TTTT TATTCTTAAC TGTAAATTTT 
1651 TTTATGTTAA AATATTAAAT ACAAAT TACA TTTAACAGTT AAGTATTTAT 
1701 TTCCTACAGT TAGGCAATAT AATGATAAAA GATTGTACTA AATCGTATAA 
SD ORF-4 (agrB ) 
1751 TGACAGTGAG GAGAGTGGTG TAAAATTGAA TTATTTTGAT AATAAAATTG 
1801 ACCAGTTTGC CACGTATCTT CAAAAGAGAA ATAACTTAGA TCATATTCAA 
1851 TTTTTGCAAG TACGATTAGG GATGCAGGTC TTAGCTAAAA ATATAGGTAA 
1901 ATTAATTGTT ATGTATACTA TTGCCTATAT TTTAAACATT TTTCTGTTTA 
1951 CGTTAATTAC GAATTTAACA TTTTAT TTAA TAAGAAGACA TGCACATGGT 
2001 GCACATGCAC CTTCTTCTTT TTGGTG TTAT GTAGAAAGTA TTATACTATT 
2051 TATACTTTTA CCTTTAGTAA TAGTAAATTT TCATATTAAC TTTTTAATTA 
2101 TGATTATTTT AACAGTTATT TCTTTAGGTG TAATCTCAGT ATATGCTCCT 
P 
2151 GCAGCAACTA AAAAGAAGCC CATTCCTGTG CGACTTATTA AACGAAAAAA 
. Primer HF4 
2201 ATATTATGCG ATTATTGTTA GTTTAACCCT TTTCATTATC ACACTTATCA 
4 
2251 TCAAAGAGCC ATTTGCCCAA TTCATTCAAT TAGGCATCAT AATAGAAGCT 
FIGURE 5.21 
Partial sequence of the agr locus indicating the area of DNA used to create PCR 
primers (see Fig. 5.18) for (a) strain 5B. 1 and, overleaf, (b) strain 10.1. Relevant 
ORFs are indicated. The restriction sites denoted are: Ec, EcoRV; H, HincH; P, Pstl; 
Pv, PvuIl. 
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agrA gene 
---º - 
4001 AACTGATATT AATGGTATCA AATTAMCAG TGAAATTCGT AAGCATGACC 
Primer HF1 
4051 CAGTTGGTAA CATTATTTTC GTTACGAGTC ACAGTGAACT TACCTATTTA 
4101 ACATTTGTCT ACAAAGTTGC AGCGAZGGAT TTTATTTTTA AAGATGATCC 
Pv 
4151 AGCTGAATTA AGAACTCGAA TTATAGACTG TTTAGAAACT GCACATACAC 
4201 GCTTACAATT GTTGTCTAAA GATAATAGCG TTGAAACGAT TGAATTAAAA 
4251 CGTGGCAGTA ATTCAGTGTA TGTTCAATAT GATGATATTA TGTTTTTTGA 
4301 ATCATCAACA AAATCTCACA GACTCATTGC CCATTTAGAT AACCGTCAAA 
4351 TTGAATTTTA TGGTAATTTA AAAGAACTGA GTCAATTAGA TGATCGTTTC 
4401 TTTAGATGTC ATAATAGCTT TGTCGTCAAT CGCCATAATA TTGAATCTAT 
4451 AGATTCGAAA GAGCGAATTG TCTATTTTAA AAATAAAGAA CACTGCTATG 
End of agrA gene --- -H 
4501 CATCGGTGAG AAACGTTAAA AAAATAT T AAGATAATAA AGTCAGTTAA 
Primer HF2 
4 
4551 CGACGTATTC AATTGTAAAT CTTGTZGGAT TTTAACAAGA TAACTAGCAA 
4601 ATGCACTGTA TAGCTGGCTT TTTAATTTTA TTAACAAAAT TAAATATGAC 
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5.21) were used for primer HF3 (Fig. 5.19), upstream of EcoRV and bases 2258 to 
2235 (Fig. 5.21) were used for primer HF4 (Fig. 5.19), downstream of the PstI site. 
5.2.7.1.3 PCR primers internal to Tn917 
Since the orientation of Tn917 within the chromosome of each mutant was unknown, 
two internal primers were designed (Fig. 5.20). Both primers extended out from the 
same IacZ distal end of Tn917, thus bases 4555 to 4579 of Tn91 7 were used to create 
primers HF5 and HF6 (Fig. 5.19). These primers were set back approximately 800 bp 
from the end of Tn917. 
5.2.7.2 PCR amplification of Tn917 insertion sites 
The PCR reactions were completed as described in section 2.15. Reactions were 
carried out using primer pairs listed in Table 5.5. It was expected that only one 
reaction for each mutant would result in a PCR product depending on the orientation 
of the transposon. An agarose gel of the PCR products revealed that mutant 5B. 1 had 
one band, resulting from the primers HF3 and HF6 (Fig. 5.19), of approximately 1500 
bases (Table 5.5). Strain 10.1 had one band resulting from the primers HF2 and HF5 
(Fig. 5.19) of 1200 bp (Table 5.5). The PCR products of each mutant were separated 
on a TAE agarose gel, gel purified and ligated into EcoRI digested, dephosphorylated 
pUBS 1. Ligation mixes were transformed into ultra-competent E. coli (Stratagene) 
and transformants selected on LB plates as white, ampicillin resistant colonies. 
Approximately 100 colonies were obtained from each transformation and, following a 
mini-prep of two of each, it was confirmed by digestion with EcoRI that pUBS 1 
contained the correct inserts. The plasmids were designated pHF30 and pHF31 for 
the derivatives from 10.1 and 5B. 1 respectively. 
213 
Tn917 primers 
Mutant primers 
HF5 HF6 
HF1-10.1 - NP 
HF2-10.1 1.2 kb - 
HF3-5B. 1 - 1.5 kb 
HF4-5B. 1 NP - 
TABLE 5.5 
Primers used in PCR reactions to amplify chromosomal DNA flanking Tn917 
insertion sites in strains 10.1 and 5B. 1. The sizes of PCR products are given where 
applicable (kb). NP denotes no PCR product obtained. 
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5.2.8 DNA sequencing of plasmids VHF30 and 1HF31 
Sequencing of the PCR derived inserts in pHF30 and pHF31 was used to verify the 
position of Tn917 within agr in each mutant. Sequencing primers consisted of 17 bp 
oligonucleotides which comprised either the T3 or 77 promoter sequence in pUBS 1 
(Fig. 5.22). Thus, it was possible to sequence in from either end of the inserted 
chromosomal and/or transposon DNA since it was not known in which orientation the 
PCR products had been ligated into pUBS 1 (Fig. 5.22). Following these reactions the 
extension products were purified by ethanol precipitation and pellets dried under 
vacuum. Automated sequencing was carried out as described in section 2.16. 
5.2.8.1 DNA sequence of pHF30 
Database analysis (FASTA) of the DNA sequence generated from the T3 primer 
showed that Tn917 had inserted after base 4458 of agr in strain 10.1 (Fig. 5.23 and 
Fig. 5.21). The sequence, extending from the T3 promoter region of pUBS 1, includes 
part of the pUBS 1 multiple cloning site upstream of the EcoRI restriction site, then 
the EcoRI site and the agr primer from the PCR reaction, comprising bases 4616 to 
4592. The complementary sequence of agr then continues from base 4591 to base 
4458. The transposon has inserted at base 4458 since, at this point, the sequence of 
Tn91 7 begins from its last base, 5353 (Fig. 5.24). 
5.2.8.2 DNA sequence of pHF31 
Database analysis (FASTA) of the DNA sequence generated using the T7 primer is 
shown in Fig. 5.25. The sequence shows that this end of the insert is Tn917 derived. 
The T3 primer generated. sequence includes part of the pUBS 1 multiple cloning site 
upstream of the EcoRI restriction site, then the EcoRI site and the agr primer from the 
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T7 promoter/primer 
ATTAACCCTCACTAAAG 
mcs 
.......... 
EcdR I.......... 
GATATCACTCAGCATAA 
PRNEJi 
A*- 
t 
FIGURE 5.22 
hromosomal and/or Tn917 sequence T7 
promoter 
Position and sequence of the T3 and T7 sequencing primers in pUBS 1. 
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ATAAGCTTGATATCGAA=AGCTATACAGTGCAGTTGCTAGTTATCT 
TGTTAAAATCCAACAAGATTTACTATTGAATACGCCGTTAACTGACTTT 
ATTATCTTATTATATTTTTTTAACGT'M'CTCACCGATGCATAGCAGTGT 
TCTTTATTTTTAAAATAGACAATTCGCTCTTTOGGGGGCCCGAGCGCCG 
ACGAGGAA'I"M'GTATCGATAAGAAATAGATTTAAAAATGTCGCTGTTAT 
TI'rI'GTACATTTAACTTGACGGTGACATCTCTCTATTGTGAGTTATTAGT 
GGTACAGZ"II"I'CAACCGTTZ"rAATTATAAAAAAGTGGTGCATTT'1'TAAA 
TIGGCACAAACAAGTAACNGTTATTGCAGCAGGTGTATTTCTTATCTAT 
GGGTTTAACATGGATTT'I'ATCATTAAAATCATGAGTATTGT 
FIGURE 5.23 
DNA sequence of pHF30 using the T3 primer of pUBS 1. 
Key: italics denotes the MCS of pUBS 1; underlining denotes primer HF2; bold type 
denotes the sequence of the agr locus from base 4591 to base 4458; plain text 
denotes Tn917 sequence from base 5353. The point of Tn917 insertion is denoted by 
the symbol, A. 
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H PV AP Ec 
4546 4150 3252 2149 1472 
I 
----t 
agrA agrC 
-e 41 y 
P1 P2 P3 
FIGURE 5.24 
Approximate insertion site of Tn917 within the agr locus of strain 10.1. The 
restriction sites denoted are: A; Asp700; Ec, EcoRV; H, Hind ; P, Pstl; Pv, PvuII. 
(This figure is not to scale). 
--- -ý 
-1 C Tn9 17 trm LTVI - -l 
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CCCGC'ýGCTGCAGGAAZ"I'CCAGATCTAGATATTGAGGAACATTTCACTGA 
TACAAATGGC'TATTCTGATCAGGTGýTGACCGCATTACTAGGC 
TTTGATTTTGAACCTCGCATCAGAAATATýTCACAATTATTTT 
CTACAATCACCTTCCTACTACCCTAACTTATCAGAAGATATAAGCGGAA 
AAATCAATGTAAAAAATTATTGAAGAAAACTATGATGAAATTAAACGAA 
TCGCCTATTCGATTCAAACAGGAAAAGTATCTAGTTCTTTACTATTAGG 
AAAGCTAGGCTCATACGCACGTAAGAATAGAGTAGCTCTTGCACTGAGA 
GAACTAGGTCGCAT GCATTT'I'TATGATAGATTATATTACAG 
ATAGTGAGCTACGGCGAAGGATC 
FIGURE 5.25 
DNA sequence of pHF31 using Ti primer of pUBS 1. 
Key: italics denotes the MCS of pUBS 1; underlining denotes primer HF5; bold type 
denotes the Tn977 sequence from base 4580 to base 4951. 
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PCR reaction, comprising bases 1417 to 1441 (Fig. 5.26). The agr sequence then 
continues to base 1753. At this point there are 17 bases missing and then the 
sequence of agr resumes from base 1771 to base 1796. At this point, the complement 
of the sequence of the end of Tn917 starts, from base 5353 to base 5272. Therefore, 
Tn917 has inserted into agr following base 1796 (Fig. 5.27 and Fig. 5.21). 
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ATAAGCI'TGATATCGAAT'I'CGAATr! "I'GTTCACTGTGTCGATAATGCATT 
TTACTAAGTCACCGATTGTTGAAATGATATCTTGTGCCATTGAAATCTC 
TCCTTCCTTAATTAAGATAAAAATTCTTAAAATTAAACAACTCATCAAC 
TATTTTCCATCACATCTCTGTGATCTAGTTATATTAAAACATGCTAAAA 
GCATTTAT'I'TTCCAATTT'M'CTTAACTAGTCGTTTTTTATTCTTAACTG 
TAAATTTTTTTATGTTAAAATATTAAATACAAATTACATTTAACAGTTA 
AGTATTTATTTCCTACAGTTAGGCNATATAATGA*TAAAAGATTGTACT 
AAATCGTATAATOGGGGTCCCGAGCGCNTAGGGGAATN'I'GTATCGATAA 
GGGGTACAAATTCCCACTAAACCAATGTTTCAAGGGCTATTTATTT 
FIGURE 5.26 
DNA sequence of pHF31 using the T3 primer of pUBS 1. 
Key: italics denotes the MCS of pUBS 1; underlining denotes primer HF3; bold type 
denotes the sequence of the agr locus from base 1442 to base 1796; plain text 
denotes Tn917 sequence from base 5353 to base 5272. - The symbol, * indicates the 
site of a 17 bp deletion in the agr sequence. The point of Tn91 7 insertion is denoted 
by the symbol, A. 
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H Pv 
4546 4150 
ayrA 
FIGURE 5.27 
AP Ec 
3252 2149 1472 
I- -- 
agrc HEIK agrB I lacZ t-ý- 
D 
r 
Pt P2 P3 
Approximate insertion site of Tn917 within the agr locus of strain 5B. 1. The 
restriction sites denoted are: A, Asp700; Ec, EcoRV; H, HincII; P, Pstl; Pv, Pvul. 
(This figure is not to scale). 
Ec Pv 
492 330 
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5.3 Discussion 
A number of putative Tn917 mutants were isolated on the basis of a reduction in ß- 
haemolysin production. Following phage transduction and pulse field gel 
electrophoresis, two mutants were chosen for further analysis. Following Smal 
digestion, the mutations in both these strains (10.1 or 5B. 1) mapped to a novel 
fragment that co-ran with SmaI fragment I (117 kb) or a novel fragment of 
approximately 110 kb, respectively. 
Two random controls, BHCI and BHC2 contained Tn917 in novel fragments that co- 
ran with Smal fragments G and H, respectively. Strain WA250 (containing Tn551 in 
agr) was also examined to identify which fragment contained agr and it was found 
that hybridisation with the Tn917 probe occurred in SmaI fragment G. This was 
somewhat surprising since agr originates in SmaI fragment F in strain 8325 which has 
been reported to co-run with fragment H in 8325-4 (Pattee et al., 1990; Smeltzer et 
al., 1992). However, repeated PFGE of chromosomal DNA of strain WA250 
confirmed that Tn551, and thus presumably agr, was located in fragment G (results 
not shown). These results suggested that, either Tn917 in the newly isolated mutants 
was not located in agr, or that the data acquired for strain WA250 was anomalous. 
In addition, the phenotypes of strains 10.1 and 5B. 1, being lipase positive, were found 
to be different to an agr mutant examined by Smeltzer et at. (1992) who reported that 
lipase activity in an agr strain was markedly reduced. ' The*agr mutant strain, WA250 
also appeared, in these particular experiments, to be lipase negative, although this was 
contrary to the results obtained earlier (see section 4.2.8.3). The production of all 
other virulence determinants was as for strain WA250 and was typical of an agr 
mutant. 
As discussed in section 5.2.5, the transposon used to create these mutants, Tn917- 
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LTV J was specifically designed for straightforward cloning without the need for an 
additional intermediate vector. Following digestion with an appropriate enzyme 
(XbaI or EcoRl), it should be possible to religate Tn917-LTV 1 and some flanking 
chromosomal DNA and transform and maintain stable plasmids in E. coll. However, 
this did not prove possible and it was established, by SaII digestion, that this was due 
to a deletion of approximately 4 kb from the lacZ proximal end of the Tn91 7-LTV 1 
fragment. This deleted fragment could have contained the ColEI replicon and thus 
prevented maintenance in E. coli, and probably contained some of the lacZ gene, 
which would explain why the transductants were white in the presence of X-Gal. An 
alternative method for cloning the chromosomal DNA flanking the transposon 
insertion was to identify a fragment of chromosomal DNA containing Tn917 of <10 
kb and ligate this fragment into a plasmid suitable for replication in E. coli. 
However, no transformants containing a recombinant plasmid for either mutant were 
isolated. 
To test whether the mutations were actually in agr, chromosomal DNA was subjected 
to Southern blot analysis using an agr probe. If the transposons were in agr then the 
restriction profiles would have differed from the wild type strain, 8325-4 and 
hybridising bands would have increased by the size of Tn917-LTV1, i. e. 
approximately 8 kb. Chromosomal DNA from all four strains strains was initially 
digested with PvuII which cuts towards each end of agr (see Fig. 1.2). Strain 10.1 did 
not contain Tn917 between these two restriction sites since the resulting hybridising 
fragment was 3.8 kb which was the same as for 8325-4. Strain 5B. 1 did contain 
Tn917 within agr resulting in two hybridising fragments of 9 kb and 2.8 kb. 
Digestion of chromosomal DNA of all four strains with PvuH and PstI, which cuts 
within the 3.8 kb PvuII fragment, showed that in strain 5B. 1, Tn917 lay 
approximately 800 bp upstream of the PstI restriction site. The further digestion of 
SB. 1 chromosomal DNA with Hind (which cuts 396 bases downstream of PvuII) 
and EcoRV gave confirmation of just how close to the PstI site Tn917 lay. The 
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transposon was found to be downstream of the EcoRV site and thus somewhere in the 
677 bp between the EcoRV and PstI restriction sites (see Fig. 5.14). Digestion of 
strain 10.1 chromosomal DNA using Hincll and EcoRV revealed that Tn917 was 
located somewhere in these 396 bases. Digestion of chromosomal DNA of 8325-4 
with HincII/EcoRV resulted in a hybridising fragment of 3.1 kb representing the 
number of bases between these two restriction sites within agr. The confirmation that 
both mutants contained Tn917 within the agr locus highlighted the fact that a lipase 
assay using egg-yolk as the substrate must be regarded as somewhat unreliable. 
The results for strain WA250 were somewhat anomalous, although digestion with 
PvuII confirmed the presence of Tn551 with a 5.3 kb increase in the size of the 
hybridising fragment compared with strain 8325-4. However, following PvuIllPstI 
digestion, this extra 5.3 kb did not map to the expected 2 kb fragment downstream of 
the Pal site of agr (see Fig. 5.16). Instead, a hybridising fragment of 3.5 kb was 
apparent. This could indicate that there is a Pstl site within Tn551, although in this 
case there should have been an additional fragment hybridising with the probe of 3.8 
kb, comprising the remainder of Tn551. In addition, there is very good homology 
between Tn551 and Tn917 (Giraudo et al., 1994b) and Tn917 does not contain a PstI 
site (Shaw and Clewell, 1985). Following digestion with HinclI/EcoRV a fragment 
of 8.4 kb of chromosomal DNA of strain WA250 should have hybridised with the 
probe but, in fact, a fragment of 6.5 kb hybridised with the probe. Since the 
restriction data acquired for strain WA250 was not as expected and the lipase activity 
was variable it seemed possible that the strain of WA250 used in some of these 
experiments had undergone some changes at the genetic level during laboratory use. 
Although the orientation of Tn91 7 within strain SB. 1 had already been established, 
PCR reactions for this strain and strain 10.1 were carried out allowing for the 
transposon to be inserted either way round. As expected, only one reaction for each 
strain resulted in a PCR product. The PCR products were cloned and sequenced. 
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In strain 10.1, TOR began immediately prior. to base 4458, which is 72 bases before 
the end of the agrA gene. As discussed in section 1.6.1.1.2.1, agrA comprises the 
response regulator of a classical two component signal transduction system. In 
general, the phosphorylated gene product of a response regulator binds to a promoter 
and up-regulates target gene transcription. However, it has been suggested that AgrA 
does not activate transcription from P2 and of RNAIII by binding directly, but rather 
interacts with SarA to aid RNA polymerase to initiate transcription in some way 
which is not yet fully understood (Morfeldt et al., 1996b). In any case, absence of 
AgrA would prevent, by whatever mechanism, the proper functioning of the whole 
agr locus. 
In strain 5B. 1 it was found that Tn917 began following base 1796 of agr. However, a 
17 base gap in the agr sequence was identified comprising bases 1754 to 1770, 
inclusive. This deletion probably arose during insertion of Tn917 into the original 
mutant, 10, but it is just possible that these bases were missing in this isolate prior to 
transposon mutagenesis. If this latter hypothesis was true then, since the 17 bp 
deletion occurs just 25 bases upstream of the transposon insertion site, it would have 
been likely that this deletion would co-transduce with the transposon. However, the 
net effect of either of these mutations would be the same. The missing bases occur 
within the promoter, P2 and span the purine rich Shine Dalgarno (SD) sequence. 
Although binding of RNA polymerase is initiated at the -35 region of the promoter, 
which remained intact, this could not occur because the -10 sequence is also 
necessary for binding. In addition, the distance between the -35 and -10 sequences is 
critical. In any case, even if transcription could have occurred, the SD sequence 
functions as a ribosome binding site so that tRNA could not have been translated to 
give the AgrB gene product. The transposon in 5B. 1 was inserted 20 bases into ORF4 
which encodes the agrB gene. As discussed in section 1.6.1.1.2.2, the product of 
agrB is possibly involved in processing the gene product of agrD from 46 amino acid 
residues to its final form - the octapeptide signalling molecule, RAP (Balaban and 
226 
Novick, 1995; Ji et al., 1995; Ji et al., 1997). Without this signalling molecule, auto- 
induction of agr and RNAIII transcription, and hence some virulence gene 
expression, can not be activated. 
In this work, attempts to identify novel regulatory loci using Tn917 and screening for 
clones deficient in ß-haemolysin production led only to agr mutants. It may be that 
Tn917 exhibits a "hot spot" for the agr locus although this has not been reported by 
other workers. It is more likely that a lack of ß-haemolysin tends to correlate with an 
agr phenotype because agr is closely involved in the regulation of production of ß- 
haemolysin. Therefore, screening for p-haemolysin negative clones will tend to result 
in selection of those clones that are agr mutants. It is probably preferable to adopt an 
alternative virulence determinant as a screen, for example sar was identified by 
screening for a fibrinogen binding protein negative phenotype. 
There are many other methods used to identify virulence genes and some of these are 
discussed in Chapter 6. 
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CHAPTER 6 
General Discussion 
228 
6. GENERAL DISCUSSION 
The regulation of the production of virulence determinants by S. aureus is extremely 
complex, with the organism producing a wide range of extracellular factors, many of 
which have a role in pathogenicity. S. aureus can grow in a variety of environments, 
for example in foodstuffs, as well as in humans, and it is therefore important that it 
can recognise and respond to rapidly changing environments. Obviously, it would not 
make sense energetically for the bacterium to produce a full range of toxins when it is 
not in a host environment and it is therefore vital to have a mechanism by which the 
organism can recognise those signals which indicate that it has entered a host. 
A common way in which bacteria sense changes in their environment, and mediate a 
response by altering gene expression, is via two component sensor regulator systems 
(Parkinson and Kofoid, 1992; Stock et al., 1989). Such a system is encoded by the 
major global regulator of S. aureus, agr. This global regulator partly comprises a 
quorum sensing mechanism. The agr control mechanism is dependent on cell density 
which is signalled and sensed via an extracellular factor called RAP. RAP itself is 
encoded by the agr locus and acts to upregulate expression of the whole locus 
beginning at mid-late exponential growth phase (Balaban and Novick, 1995; Ji et al., 
1995). The sensor protein of the two component sensor regulator of agr, AgrC, has 
been proposed to respond to the levels of extracellular RAP and so transduce 
environmental signals to bring about changes in gene expression via the regulator, 
AgrA. Many other environmental factors affect expression of both agr and other 
virulence determinants. Some of these signals bring about alterations in virulence 
determinant gene expression in an agr-independent manner. 
A key environmental signal that indicates entry into a mammalian host is a change in 
temperature. Indeed many bacteria, including B. pertussis (Melton and Weiss, 1989) 
and S. f lexneri (Maurelli et al., 1994) exhibit a virulence phenotype at 37 OC and it has 
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been shown that S. aureus is no exception (see section 3.2.10). In fact, optimum 
expression of hld:: lacZ and production of a-haemolysin is obtained at 42 OC with 
levels at 37 OC greatly exceeding those found at 30 0C. 
Many environmental conditions have been examined in this work, of which several 
led to changes in hld:: lacZ expression and/or a-haemolysin production. Some of 
these conditions probably provoke a generalised stress response, i. e. exposure to 
ethanol or isopropanol, but many correspond to features found in an invasive 
environment. For example, osmolarity has been found to have a marked effect on the 
production of several extracellular proteins under the positive control of agr. 
Production of enterotoxins B and C (Genigeorgis and Sadler, 1966; Regassa and 
Betley, 1993), epidermolytic toxin A (Sheehan et al., 1992) and a-haemolysin (see 
section 3.2.7) is dramatically reduced in increased osmolarity (NaCI or sucrose). 
Similarly, hld:: lacZ expression is decreased in the presence of sucrose but, 
interestingly, increased in the presence of NaCl indicating that the effect on agr is not 
simply one of high osmolarity. Thus, it appears that production of these virulence 
factors is de-regulated from agr expression in NaCl. As suggested in section 3.3, the 
inhibitory effect of sucrose is probably also due to the fact that S. aureus can ferment 
sucrose, to give glucose and fructose, as the effects of sucrose are similar to those 
noted for glucose. 
Availability of some divalent cations can have a marked effect on the pathogenesis of 
many micro-organisms with Mg2+ being particularly important in the production of 
TSST-1 by S. aureus, especially associated with some types of tampon (Sarafian and 
Morse, 1987; Taylor and Holland 1989b). In this work it has been shown that 
decreased levels of available Mg2+ or Ca2+ lead to an increase in hld:: lacZ expression 
and an even greater increase in a-haemolysin production (see section 3.2.9). Some 
other conditions which may be indicators of the host environment are iron deprivation 
and changes in oxygen levels. Many pathogenic bacteria have developed systems for 
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scavenging iron including production of siderophores and, indeed, in S. aureus it has 
been found that decreased iron availability leads to an increase in both hld:: lacZ 
expression and a-haemolysin production (P. F. Chan, pers. comm. ). Similarly 
decreased oxygen availability, but not anaerobic growth, leads to an increase in 
hld:: lacZ expression and a-haemolysin production. Growing S. aureus in sodium 
bicarbonate at concentrations equivalent to those found in vivo leads to an increase in 
a-haemolysin production though not hld:: lacZ expression. 
Although the response of S. aureus to many environmental signals is mediated via 
agr, the production of some virulence determinants under the control of agr can also 
occur in an agr-independent manner, indicating that there is interaction with 
unidentified factors. In some instances, although a-haemolysin activity shows a 
similar response to hld:: lacZ expression following exposure to various environmental 
stimuli, the response is exaggerated. Conditions which de-regulate a-haemolysin 
production from agr have already been discussed but, in addition, tst expression 
which is positively regulated by agr, is also almost abolished in 1M NaCl (Chan and 
Foster, submitted). Expression of tst is also reduced, like a-haemolysin levels, in the 
presence of 20 mM sucrose (Chan and Foster, submitted). It is now known that many 
environmental stresses, including changes in growth phase, osmolarity and 
temperature, result in changes in bacterial DNA topology, specifically, supercoiling 
and that the level of supercoiling is important in the control of prokaryotic 
transcription (Dorman, 1994). The way in which environment influences DNA 
supercoiling is not yet understood but changes in intracellular ion concentrations may 
play a role since ions, for example K+, can alter the topology of DNA directly 
(Anderson and Bauer, 1978). Another possibility is that the enzymes that effect 
changes in DNA supercoiling, topoisomerases, are post-translationally modified by 
phosphorylation catalysed by protein kinases whose activity is environmentally 
regulated (Dorman, 1994). Thus, it may be that the effect of the changes in the 
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environment studied in this work is mediated, at least partly, via changes in DNA 
supercoiling. 
The regulation of agr itself in response to a changing environment is still not fully 
understood but since the product of the agrA gene comprises the regulatory element 
of a classical two component sensor regulator system it would seem likely that, in 
common with other such elements, its function is to influence transcription of target 
genes, although this has not yet been proven of AgrA. However, it is apparent from 
the phenotypic data obtained with the Tn917 mutant, 10.1 (see section 5.2.4), that 
AgrA is vital for the production of those virulence determinants under the control of 
agr. 
The complexity of the system has been demonstrated with the discovery of other 
global regulators in S. aureus. The best characterised of these is sar, which has been 
shown to interact with agr to upregulate activity of the P2 promoter of agr via SarA 
(Cheung et al., 1997; Morfeldt et al., 1996b). Whether SarA binds to the P3 promoter 
has been the subject of conflicting evidence although, at best, SarA binds to a much 
lesser extent to the P3 promoter (Cheung et al., 1997; Heinrichs et al., 1996; Morfeldt 
et al., 1996b). However, sar expression is unaffected by changes in temperature, 
increased NaCl levels or deprivation of Cat+, Mg2+ or iron (Chan and Foster, 
submitted) so it seems unlikely that sar levels control changes in agr expression, at 
least under certain environmental conditions. The activity of SarA may be controlled 
at the post-transcriptional level. It may also be that identified or novel regulatory loci 
play a part in agr control, possibly in response to changes in DNA supercoiling. It 
has been shown that SarA shows a density dependent effect in the up-regulation of 
RNAIII with RNAIII production in an sar mutant being strongly diminished at late 
log phase and conversely being increased in the presence of sar on a multicopy 
plasmid (Cheung et al., 1997). RNAII production in an sar mutant is much less 
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affected (Cheung et al., 1997) indicating that P2 promoter activity can occur 
independently of SarA, although at a lower rate. 
It is thus clear that sar plays a role in the regulation of agr, and it may be that sar 
interacts with the unphosphorylated form of AgrA which is produced constitutively, 
but at a very low level, from the P1 promoter of agr, although it has recently been 
demonstrated that expression from P1 is higher in vivo (Lowe et al., 1998). A low 
level of expression from the P2 promoter during early growth leads to a gradual 
accumulation of the signalling molecule RAP and concomitant increase in the level of 
phosphorylated AgrA (AgrA-P). Expression from the P3 promoter is negligible at 
this stage, as confirmed by the growth curve of the hld:: lacZ fusion strain, SH101 
(see Fig. 3.5). This is desirable for the cell since, if P3 was up-regulated too early, 
energy would be wasted producing toxins at an inappropriate time, and surface 
proteins necessary for colonisation and immune evasion would be down-regulated. 
Alternatively, it is possible that unphosphorylated AgrA binds to the agr P2 promoter 
directly or, in conjunction with SarA or another regulator, since expression from P2 is 
only partially reduced in an sar mutant. Although it has not been possible to establish 
that AgrA binds to P2 or P3, or indeed interacts with SarA (Morfeldt et al., 1996a/b), 
it is almost certain that AgrA or another factor, or factors, can bind to and up-regulate 
P2 and/or P3 since it has been shown that agr can produce virulence determinants in 
the absence of sar, although final levels are reduced. It may simply be that, in the 
SarA mutant, the density dependent up-regulation of RNAIII is delayed and similarly 
toxin production. Since the production of virulence determinants is not apparent until 
early stationary phase ordinarily, any delay in production could mean that nutrient 
availability becomes limiting prior to achieving the full potential for toxin production. 
The observation that a-haemolysin production is delayed some 2-3 hours in an sar 
mutant and reaches only 60 % of wild type levels (P. F. Chan, pers. comm. ) correlates 
with this hypothesis. By culturing an sar mutant in a chemostat continuous culture 
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where an inhibitory lack of nutrients can be avoided it would be possible to determine 
if finite levels of toxin production in such a strain could equal those reached in a wild 
type strain. 
If AgrA interacts with SarA once phosphorylated, then it would seem likely that 
expression from the P2 and P3 promoters of agr would increase gradually and appear 
to follow growth. This has been demonstrated not to be the case, with expression 
from the P3 promoter being negligible until the rapid rise late in exponential growth. 
This sharp increase occurs independently of any marked increase in sar expression. It 
is likely that it is the level of AgrA-P which controls agr P3 promoter activity. The 
level of AgrA-P is increased as the cell density increases due to the accumulation of 
RAP and transduction of this signal by AgrC. A proposed model for the way in 
which all these factors might interact is given in Fig. 6.1. 
It seems likely from the Tn551 mutants isolated during this work that there are 
probably other regulators yet to be identified. Five Tn551 mutants have been 
identified in which the transposon has most likely inserted into a different locus in 
each mutant and which show varying phenotypic characteristics. Although attempts 
to clone the chromosomal DNA flanking the Tn551 insertion site in each mutant 
proved unsuccessful, this must be the next step. Other methods available to do this 
include inverse PCR (Silver, 1993). Here, fragments between 300 bp and 3 kb of 
chromosomal DNA extending from one end of Tn551, and including a short sequence 
of the end of Tn551, would need to be excised from a gel and circularised (by self- 
ligation). Primers comprising each end of the Tn551 fragment would be designed and 
the PCR reaction would be carried out, allowing amplification out from each end of 
Tn551 into the circularised chromosomal DNA. The linear PCR products could then 
be DNA sequenced. 
Other techniques which are available to identify any novel regulatory loci also 
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Environmental stimuli 
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include a PCR-based strategy. Such a method was employed by Bayles (1993) who 
used degenerate sensor-gene specific primers to amplify DNA fragments from S. 
aureus. Two genes were identified, lytS and lytR, whose deduced amino acid 
sequences were found to be similar to those of other two component sensor regulator 
systems (Brunskill and Bayles, 1996). Characterisation of the IytS insertional mutant 
suggested that the gene products control the rate of autolysis in S. aureus. 
A completely different approach to identifying novel putative regulators is to employ 
the phenomenon known as "in vivo cross-talk". Using this method it is possible to 
identify novel sensors which can interact with known regulators in strains null in the 
usual sensor gene for a particular characteristic. By use of this technique two novel E. 
coli genes, evgS and evgA, have been cloned and sequenced forming both a sensor 
and regulator (Utsumi et al., 1994). These two genes were found to be structurally 
and functionally homologous to the two-component sensor regulator genes bvgA and 
bvgS which co-ordinately regulate virulence gene expression in B. Pertussis. 
Recently, fifty mutants of S. aureus showing reduced virulence were isolated by a 
method known as signature tagged mutagenesis (Mei et al., 1997). Here, a variety of 
plasmids are created, incorporating the Tn917 transposable element, each with a 
different DNA tag within this element. These tags comprise a variable central 
sequence flanked by invariant sequences which allow mutants to be differentiated 
from each other. Following infection of an animal with these various transposon 
mutants, and subsequent recovery, the tags in the recovered pool and the inoculum 
pool are separately amplified by PCR using primers based on the invariant flanking 
sequences. The PCR products are then used to probe the different tags in the 
inoculum pool. By identifying mutants that hybridise with tags from the inoculum 
pool but not the recovered pool it is possible to isolate mutants with reduced 
virulence. Thus genes which are necessary for virulence are tagged since the numbers 
of bacteria carrying mutations in these genes will be decreased in the infective 
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population. As has been described earlier, Tn917 then facilitates easy cloning of 
these genes in E. coll. 
A powerful technique which has been used in recent years to identify bacterial genes 
which are expressed during infection is known as in vivo expression technology 
(IVET) (Mahan et al., 1993). This method has been used to search for genes which 
allow S. typhimurium to cause a typhoid-like disease in mice (Mahan et al., 1993). 
purine auxotrophs of S. typhimurium cannot infect mice so that, by introducing a 
promoterless purine biosynthetic gene, purA randomly into the chromosome of a 
purA- strain and infecting an animal, only those bacteria in which the purA gene has 
inserted downstream of a promoter active during infection will be able to survive. 
Thus S. typhimurium chromosomal DNA is partially digested and resulting fragments 
cloned upstream of a promoterless purA gene fused to a promoterless lacZY gene to 
form a plasmid. The plasmids are then introduced into a purA- strain of S. 
typhimurium. Similar to the suicide vectors used in S. aureus, described earlier, these 
plasmids cannot replicate in S. typhimurium and so antibiotic resistance (bla) will 
only be conferred to those clones in which the plasmid has integrated into the 
chromosome. Therefore the bacteria which survive in the mouse can then be 
harvested and assayed in vitro for expression of lacZ. In particular, by identifying 
clones in which lacZ is not expressed during in vitro growth, it is possible to identify 
genes which are specifically active during infection. 
Using this method in S. aureus, six previously identified genes have been found to be 
expressed in vivo, including agrA and the lipase gene, geh (Lowe et al., 1998). 
Eleven novel genes showing homology to genes in other organisms have also been 
found (Lowe et al., 1998). 
There is a long way to go before the way in which agr interacts with other factors and 
responds to physiological and environmental stimuli to control expression of 
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virulence determinants is fully understood. The part the different regulators identified 
to date play in this complex pattern of gene expression and protein production is still 
far from clear, and it seems likely that there are yet more novel regulatory 
components to be discovered. Much work remains in the quest to fully understand 
how pathogenic bacteria interact with their host to cause infection and disease. 
Further knowledge in this area will provide vital information which can be used in the 
struggle to control both S. aureus other pathogens. 
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Appendix A 
Al MEDIA 
A1.1 Growth media 
All growth media were made in 11 volumes in distilled H2O, unless other stated, and 
divided into 100 ml aliquots in Ehrlenmeyer flasks (250 ml) prior to autoclaving. 
Unless stated otherwise in the following text, Agar No. 1 (Oxoid) (1 % w/v) was used 
to make agar plates. 
Al.!.! Chemically defined media (CDM) 
A1.1.1.1 CDM (Hussein et al., 1991) 
Component '(7/1 
Glucose 10 
Na2HPO4 7 
KH2PO4 3 
MgS04.7H20 0.5 
L-aspartic acid 0.15 
L-glutamic acid 0.15 
L-isoleucine 0.15 
L-leucine 0.15 
L-proline 0.15 
L-threonine 0.15 
L-valine 0.15 
L-alanine 0.1 
L-arginine 0.1 
Glycine 0.1 
L-histidine 0.1 
L-lysine 0.1 
L-methionine 0.1 
L-phenylalanine 0.1 
L-serine 0.1 
L-tryptophan 0.1 
L-tyrosine 0.1 
L-cysteine 0.05 
Adenine sulphate 0.02 
Guanine HC1 0.02 
CaC12.6H20 0.01 
FeNH4(SO4)2.12H20 0.006 
MnSO4 0.005 
Pyridoxal 0.004 
Pyridoxamine diHCl 0.004 
D-pantothenic acid 0.002 
Riboflavin 0.002 
Nicotinic acid 0.002 
Thiamin HC1 0.002 
Biotin 1x 10-5 
Al 
A1.1.1.2 CDM (Holland et al., 1994) 
Component 
L-cystine 
L-glutamic acid 
L-aspartic acid 
L-proline 
L-arginine 
Glycine 
L-lysine HCI 
L-histidine 
L-threonine 
L-serine 
L-alanine 
L-valine 
L-isoleucine 
L-leucine 
L-tyrosine 
L-phenylalanine 
L-tryptophan 
L-methionine 
NH4C1 
Nicotinic acid 
Thiamine HCl 
MOPS 
Tricine 
K2HPO4.3H20 
K2SO4 
MgC12.6H20 
FeSO4.7H2O 
MnC12.4H20 
NaCl 
H3BO3 
CaC12.2H2O 
ZnSO4.7H20 
CuSO4.5H20 
(NH4)6(Mo)7024.4H20 
CoC12.6H20 
9/º 
0.22 
2.22 
2.22 
2.22 
0.33 
2.22 
0.56 
0.44 
2.22 
2.22 
2.22 
0.44 
0.56 
0.56 
0.17 
0.19 
0.06 
0.17 
0.51 
0.012 
6x 10-4 
8.37 
0.72 
3.01 
4.81 x 10-2 
0.27 
2.78 x 10'3 
1.58 x 10-5 
2.92 
2.47 x 10'5 
7.35 x 10'5 
2.88 x 10-6 
2.50 x 10-6 
3.71 x 10-6 
7.14 x 10-6 
A1.1.2 Tryptic soy broth roth (TSB) (Difco) 
TSB 30 g/1 
A1.1.3 Brain heart infusion broth (BHIB) (Oxoid) 
BHI 
A1.1.4 Luria-Bertani Broth (LB) 
37 g/1 
Tryptone (Difco Bacto) 10 g/I 
Yeast extract (Difco Bacto) 5 g/l 
NaCl 5 g/I 
A2 
The pH was adjusted to 7.2 using NaOH. Agar (Difco Bacto) (1.5 % w/v) was added 
for LB agar. 
A1.2 Media for transformation 
A1.2.1 SOB (Sambrook et al., 1989) 
Tryptone (Difco Bacto) 2% (w/v) 
Yeast extract (Difco Bacto) 0.5 % (w/v) 
NaCl 10 mm 
KCI 2.5 mM 
Once autoclaved and cooled, sterile supplements of MgCl2 and MgSO4 were added to 
10 mM each (final concentration). 
A l. 2.2 SOC (Sambrook et al., 1989) 
This was prepared by the addition of sterile glucose (10 mM final concentration) to 
SOB. 
A1.2.3 NZY broth (Stratagene) 
Casamino acids (Difco Bacto) 10 g 
Yeast extract (Difco Bacto) 5g 
NaCl 5g 
in 11 
Following autoclaving, the following sterile supplements were added prior to use: 
MgC12 (1 M) 12.5 ml 
MgSO4(1M) 12.5 ml 
Glucose (20 % w/v) 10.0 ml 
A1.2.4 Media for electroporation of S. aureus 
A1.2.4.1 B2 broth 
Casamino acids (Difco Bacto) 1% (w/v) 
Yeast extract Difco Bacto) 2.5 % (w/v) 
K2HPO4 0.1 % (w/v) 
Glucose 0.5 % (w/v) 
NaCI 2.5 % (w/v) 
A1.2.5 Media for protoplasting of S. aureus 
A1.2.5.1 DM3 agar 
Na succinate 67.5 g 
Agar (Difco Bacto) 4g 
The pH was adjusted to 7.2 in a total volume of 350 ml of distilled H2O. 
The medium was autoclaved, cooled to 65 OC, and the following sterile 
supplements were added: 
Casamino acids (5 % w/v) 50 m1 
Glucose (20 % w/v) 12.5 ml 
A3 
Yeast extract (10 % w/v) 25 ml 
KH2PO4 (1 M) pH 7.5 50 ml 
MgCl2 (1M) 10 ml 
Bovine serum albumin (5 % w/v) 5 ml 
Chloramphenicol 5 µg/ml 
A1.2.5.2 Penassay broth 
Penassay broth (Difco) 125 ml 
Distilled water 875 ml 
A1.3 Media for phage transduction of S. aureus 
ALM LK broth 
Tryptone (Difco Bacto) 1% (w/v) 
Yeast extract (Difco Bacto) 0.5 % (w/v) 
KCl 0.7 % (w/v) 
Agar (Difco Bacto) (1.5 % w/v) and Na citrate (0.05 % w/v) were added to make LK 
agar plates. 
Agar (Difco Bacto) (0.7 %) was added to LK broth to make soft agar overlay. 
A1.4 Media for virulence determinant assay agar plates 
A1.4.1 Haemolvsin test agar 
Blood agar base No. 2 (Difco) 39 g/l 
Following autoclaving and cooling to 50 0C, defibrinated sheep blood 5% (v/v) (TCS 
Biologicals) was added. 
A1.4.2 a-haemolysin test agar 
Blood agar base No. 2 (Difco) 
(for top and bottom agar) 
39 gn 
Following autoclaving bottom agar was poured. Top agar was cooled to 50 °C, 
defibrinated rabbit blood (TCS Biologicals) (10 % v/v) was added and used to 
overlay bottom agar (5 ml per plate). 
A1.4.3 DNase test agar 
DNA agar (Difco) Bottom agar: 42 g/l 
Following incubation for 48 hours at 37 OC, plates were overlaid with 0.5X DNA agar 
(5 ml per plate) containing methyl green (to a final concentration of 0.5 mg/ml 
obtained from a stock solution comprising 50 mg/ml in distilled H2O). 
A 1.4.4 Lipase test agar 
TPEY agar base (Difco) 60 g/l 
A4 
Once autoclaved, plates were poured and, when set, overlaid (5 ml) with TPEY agar 
containing Egg Yolk Enrichment [Beta Lab] (10 %). 
A1.4.5 Protease test agar 
BHI 37 g 
Agar No. ! [Oxoid] log 
in 500 ml 
Agar was autoclaved and, prior to pouring, molten 2X BHI agar was mixed with 
autoclaved 3% (w/v) dried skimmed milk (15 g dried skimmed milk [Boots plc] in 
500 ml distilled H2O) . 
A1.4.6 Hyaluronate lyase test agar 
BHI 37g 
Bovine serum albumin 1% (w/v) 
Na hyaluronate 0.04 % (w/v) 
Agar No. 1 [Oxoid] 10 g 
A2 BUFFERS AND STOCK SOLUTIONS 
All buffers were prepared in distilled water and stored at room temperature. 
Solutions for use in microbiological work and in vitro DNA manipulations were 
sterilised by autoclaving. 
A2.1 Miscellaneous solutions 
A2.1.1 TE 0 
Tris-HCl (pH 7.5) loo mm 
Na2EDTA (pH 8) lo mm 
This solution was diluted 1: 10 with distilled water to give TE, and autoclaved. 
A2.1.2 Phosphate buffered saline (PBS) 
NaCl 8g 
KCl 0.2 g 
Na2HPO4 1.44 g 
KH2PO4 0.24 g 
Distilled H2O 11 
The pH was adjusted to 7.5 using 1M HCl and the buffer was autoclaved in 100 ml 
aliquots. 
A2.1.3 phage buffer 
MgSO4 1 mm 
CaC12 4 mM 
Tris-HC1(pH 7.8) 50 mM 
NaC1 5.9 g/l 
Gelatin 1 g/1 
AS 
A2.2 Solutions for agarose gel electrophoresis 
Generally, unless stated otherwise in the text, agarose gels were 0.8 % (w/v) agarose 
(Gibco BRL) in 0.5X TBE. DNA which was to be gel purified was separated on an 
agarose gel made with 1X TAE. 
A2.2.1 TAE (50 X) 
Tris 242 g 
Glacial acetic acid 57.1 ml 
Na2EDTA (0.5 M pH 8.0) 100 ml 
Distilled water to 11 
Before use the buffer was diluted 1: 50. 
A2.2.2 TBE (10 X) 
Tris 108 g 
Boric acid 55 g 
Na2EDTA (0.5 M pH 8.0) 40 ml 
Distilled water to 11 
TBE was diluted 1: 10 with distilled water before use. 
A2.2.3 DNA sample buffer (10 X) 
Bromophenol blue 25 mg 
Ficoll (Mol. Wt. 400,000) 1.5 g 
Distilled water to 10 ml 
A2.3 Solutions for plasmid/chromosomal DNA preparations 
A2.3.1 Plasmid preparation Solution I 
Solution 1 was prepared in batches of 100 ml and autoclaved. 
Glucose 
Tris-HC1(pH 8.0) 
EDTA (pH 8.0) 
A2.3.2 Plasmid preparation Solution II 
50 mm 
25 mM 
10mM 
Solution II was prepared fresh on the day of use. 
NaOH 0.2 M 
Sodium dodecylsulphate 1% (w/v) 
A2.3.3 Plasmid preparation Solution III 
Potassium acetate (5M) 60 ml 
Glacial acetic acid 11.5 ml 
Distilled water to 100 ml 
A6 
A2.3.4 Qiagen buffer B1 
EDTA (pH 8.0,0.5M)) 50 mM 
Tris-HC1(p H8.0) 50 mM 
Tween-20 0.5 % (v/v) 
A2.3.5 Qiagen buffer B2 
Guanidine HCl 3M 
Tween-20 20 % (v/v) 
The pH was adjusted to 5.5 prior to use. 
A2.3.6 Qiagen buffer QBT 
NaCl 750 mM 
MOPS 50 mm 
Ethanol 15 % (v/v) 
Triton X-100 0.15 % (w/v) 
The pH was adjusted to 7.0 prior to use. 
A2.3.7 Qiagen buffer QC 
NaCl 1M 
MOPS 50 mM 
Ethanol 15 % (v/v) 
The pH was adjusted to 7.0 prior to use. 
A2.3.8 Qiagen buffer QF 
NaC1 1.25 M 
Tris-HCJ (pH 8.5) 50 mM 
Ethanol 15 % (w/v) 
The pH was adjusted to 8.5 prior to use. 
A2.4 Solutions for pulsed field gel eletrophoresis (PFGE) 
A2.4.1 Cell suspension buffer 
Tris-HC1(pH 7.5) 10 mm 
NaCl 20 mM 
EDTA 50 mM 
A2.4.2 Lysis buffer 
Tris-HCI (pH 7.5) 10 mm 
NaCl 50 mM 
Sodium deoxycholate 0.2 % (w/v) 
Sodium lauryl sarcosine 0.5 % (w/v) 
A7 
A2.4.3 Proteinase K reaction buffer 
EDTA (pH 8.0) 100 mm 
Sodium deoxycholate 0.2 % (w/v) 
Sodium lauryl sarcosine 1.0 % (w/v) 
Pronase 1 mg/ml 
A2.4.4 Wash buffer 
Tris-HCl (pH 8.0) 20 mM 
EDTA (pH 8.0) 50 mM 
A2.5 Solutions for Southern blots 
A2.5.1 SSC (20X) 
NaCl 175.3 g 
Trisodium citrate. 2H20 88.2 g 
Distilled water to 11 
The pH of the buffer was adjusted to 7.0 with 1M NaOH. 
A2.5.2 Denaturing solution 
NaOH 0.5 M 
NaCl 1.5 M 
A2.5.3 Neutralising solution 
Tris-HC1(pH 7.0) 1M 
NaCl 2M 
A2.5.4 Hybridisation solution 
SSC 5X 
Blocking reagent (Boehringer Mannheim) 0.5 % (w/v) 
N-lauroylsarcosine, Na-salt 0.1 % (w/v) 
SDS 0.2% (w/v) 
Blocking reagent was dissolved in hybridisation solution by heating at 50-70 OC for 
one hour. 
A2.5.5 Southern buffer 1 
Tris-HC1(pH 7.5) 100 mm 
NaCl 150 mM 
A2.5.6 Southern buffer 2 
Southern buffer 1 
Blocking reagent 0.5 % (w/v) 
in Southern buffer 1 
A8 
A2.5.7 Southern buffer 3 
Tris-HC1(pH 9.5) 
NaCl 
MgC12 
loo mm 
loo mm 
50 mM 
A2.5.8 Southern buffer 4 
Tris-HCl (pH 8.0) 
EDTA (pH 8.0) 
10mM 
1 mM 
A2.5.9 Southern colour solution 
NBT (50 µg/ml) 
BCIP (50 µg/ml) 
66 µ1 
33 µl 
in 15 ml Southern buffer 3 
A2.6 Solutions for assays 
A. 2.6.1 O=galactosidase assay buffers 
A2.6.1.1 AB buffer: 
NaCl 
K2HPO4 
KH2PO4 
Triton X-100 
100mM 
60mM 
40 mM 
0.1 % (v/v) 
A2.6.1.2 ' buffer: 
Na2HPO4.7H20 
NaH2PO4.7H20 
KC1 
MgSO4.7H20 
ß-Mercaptoethanol 
16.1 g 
5.5 g 
0.75 g 
0.246 g 
2.7 ml 
in 11 distilled H2O 
The pH was adjusted to 7.0 and the buffer was stored at 4 OC. 
A2.6.2 Haemolysin assay buffer (HA) 
NaCI (10 % w/v) 8.5 nil 
CaC12 (1 M) 2 ml 
in 100 ml sterile distilled H2O 
A2.7 Solutions for transformation 
A2.7.1 Solutions for transformation by protoplasting of S. aureus 
A2.7.1.1 SMM 
Sucrose 17.1 g 
Na maleate 0.23 g 
MgC12 0.4 g 
Distilled water 100 ml 
A9 
A2.7.1.2 SMMP 
SMM 100 ml 
BHI 7.4 g 
A2.7.2 Solutions for transformation of E. coli 
A. 2.7.2.1 Frozen storage buffer (FSB) 
KC1 100 mm 
MnC12.4H20 45 mM 
CaC12.2H20 10 mm 
HACoC13 3 mM 
K acetate (1 M, pH 7.5) 10 mm 
The K acetate was filter sterilised and stored at -20 T. A 10 mM K 
acetate/glycerol (10 % v/v) solution was prepared and salts were added as 
solids. The pH was adjusted to 6.4 using HCl and the solution was 
sterilised by filtration and stored at 4 T. 
A10 
